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INTRODUCTION
“Neuroscience is by far the most exciting branch of science because the brain is 
the most fascinating object in the universe. Every human brain is different - the 
brain makes each human unique and defines who he or she is.”
—— Stanley B. Prusiner
Compared to the objects we can see and touch around us, it has always been more 
challenging to get to know ourselves. Dating back almost 5000 years, ancient Egyptians 
believed that the heart was the center of emotions and intelligence. Likewise, the first 
and the most classic traditional Chinese medicine bible Hunangdi Neijing (literally The 
Yellow Emperor’s Classic of Internal Medicine) argues: ‘The heart is the organ similar to 
the monarch and is responsible for spirit and mental activity’. Hippocrates (460-379 
B.C.E.), the father of Western medicine, was one of the first to argue that the brain 
is the seat of thought, sensation, emotion and cognition. However, this view was not 
universally accepted. For example, the famous philosopher Aristotle (384-322 B.C.E.) 
clung to the belief that the heart was the center of intellect, and considered the function 
of the brain was to ‘cool the passions of the heart’. During the Roman empire, physician 
Galen (130-200 C.E.) embraced the Hippocratic view of brain via careful animal dis-
sections. From the Renaissance to modern centuries, human’s knowledge on the brain 
has been substantially expanded.1 Nowadays, the human brain, an organ comprising 
only 2% of total body weight, attracts continuous and increasing attention from the 
scientific world.
About the brain — an overview
The brain consists of three main parts: the cerebrum, the cerebellum, and the brain 
stem. In this thesis, I focus on the cerebrum, and only briefly mention the cerebellum.
With two hemispheres bridged by corpus callosum, the cerebrum is the largest part of 
the brain. The surface of the cerebrum is called the cerebral cortex, which has a folded ap-
pearance with hills (‘gyri’) and valleys (‘sulci’). Enabling large cortical surface in a limited 
skull size, cortical folding first occurred in the ancestors of mammals and is an important 
milestone along evolution. Characterized by the gyrification index, the human brain is 
the largest and most intensively folded primate brain.2 The cortex consists of gray matter, 
which contains neuronal cell bodies, neuropil, glial cells, synapses, and capillaries. The 
cerebral cortex is responsible for multiple functions, depending on the specific lobes 
(i.e., the frontal lobes, the temporal lobes, the parietal lobes, and the occipital lobes). 
Beneath the cerebral gray matter are long-range axons covered with a sheath of myelin, 
termed white matter, that connect different brain areas to each other. Myelination greatly 
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increases the speed of neurotransmitter signaling.3 In addition to the cortical gray and 
white matter, subcortical gray matter including the diencephalon, pituitary gland, limbic 
structures and the basal ganglia are present deeper in the cerebrum. These structures 
are involved in complex activities such as memory and emotion (e.g., hippocampus and 
amygdala), and hormone production (e.g., hypothalamus and pituitary gland).
As the second-largest part of the brain, the cerebellum locates underneath the oc-
cipital lobe and contains more than half the brain’s neurons. Similar to the cerebrum, 
the greatly folded cerebellum is divided into two hemispheres, with gray matter in the 
out layer and white matter deep inside. Although the most remarkable function of the 
cerebellum is coordinating body movements and motor skills learning, the cerebellum’s 
role in cognitive processes has attracted increasing research interest.4
Brain growth across gestation and childhood
The human brain development begins in the embryonic period (i.e., from conception 
to 8 weeks of gestation), when the neural stem cells (also called neural progenitor cells) 
appear, and the first brain structure—the neural tube—is formed.5 The fetal period (i.e., 
from the ninth gestational week through the end of gestation) is a critical phase char-
acterized by enormous subsequent neuron production, migration, and differentiation, 
and both the cerebellum and the cerebral cortex experience exponential volumetric 
increase during the second half of gestation.6 The human brain also gradually develops 
the characteristic mature pattern of gyral and sulcal folding by the end of gestation.
During the postnatal period and childhood brain growth continues but volume 
reductions add a level of complexity to the exponential growth in the fetal period. For 
example, there are continuous age-related increases in cerebral white matter volume 
Figure 1.1. Lobes of the brain 
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during childhood and early adulthood, but the volumes of frontal cortex and subcor-
tical structures such as the thalamus and nucleus accumbens show a decrease trend 
with age.7 Further, cortical thickness of most of the lateral frontal, lateral temporal, 
parietal and occipital isocortex show cubic trajectories, with a period of initial increase 
in childhood, followed by adolescent decline and stabilization in adulthood.8 Human 
myelination is also a largely postnatal process that peaks in early childhood.9
Neurodevelopment with the DOHaD framework
The attempt to discover the causes of abnormal development or non-communicable 
diseases has been long, and possibly it will remain an endless journey. Although genetic 
variability may be an answer, it is far from capturing the whole picture.10 In 1990s, 
David Barker and his colleagues reported associations between low birth weight and 
adverse health outcomes in childhood and adulthood, such as high systolic blood pres-
sure, elevated risk of mortality of cardiovascular disease, impaired glucose tolerance, 
and type II diabetes.11,12 Based on these findings, they developed the concept that early 
life, mostly prenatal, events can cause permanent changes in physiology that may later 
predispose people to disease, which was originally termed Barker Hypothesis, and is 
now known as the Developmental Origins of Health and Disease (DOHaD).10,13 This 
hypothesis has been supported by cumulative evidence, including studies among men 
and women who were born around the Dutch famine of 1944–1945, suggesting that 
prenatal exposure to undernutrition is predictive of not only cardio-metabolic conse-
quences, but also neuropsychiatric disorders such as schizophrenia in adult life.14 In 
addition, the effects of undernutrition are dependent of its timing. Much evidence from 
animal models and observational human studies shows that the period from conception 
to early childhood, namely the period when organogenesis and rapid body growth take 
place, is critical to the immediate and future health of the offspring. The underlying 
mechanisms mediating the programming effects of environmental adversities are less 
clear. Candidate explanations include excessive exposure to maternal glucocorticoids, 
dysregulation in the development of the hypothalamic-pituitary-adrenal (HPA) axis, 
irreversible changes in organ structure, and alteration in gene expression.15
In addition to cardiovascular and metabolic diseases that were the initial conditions of 
interest of DOHaD and remain as the dominant focus, neurodevelopmental diversities as 
consequences of early life exposure have gained attention in the recent decades. A largely 
consistent body of evidence related environmental chemical or other toxic substance ex-
posure to differences in neurodevelopment. For example, maternal gestational lead levels 
were inversely related to mental development in infants and toddlers;16,17 higher exposure 
to polycyclic aromatic hydrocarbons (PAHs) in fetal life was associated with IQ deficit 
and behavior problems at age 5-7 years;18,19 and prenatal exposure to tobacco predicted ir-
ritability, attention and behavioral problems, and cognitive impairment in childhood.20,21 
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The association of other perinatal (i.e., prenatal and early postnatal) determinants, such 
as maternal mental health and nutrients with neurodevelopment of the offspring has been 
investigated to a lesser extent.
Maternal mental health
Pregnancy can be both exciting and tough for the mother, physically as well as mentally. 
Mood swings during or following gestation are not rare, but symptoms beyond the normal 
range can have substantial clinical implications. In high-income countries, 10% - 13% women 
experience some type of mental disorders during the perinatal phase.22 These numbers can 
reach up to 15% - 20% in the settings of low- and middle-income countries.23 As the most 
common mental health issue among the pregnant women, perinatal depression not only 
affects the wellbeing of the mother, but also predicts adverse developmental outcomes in the 
offspring, including suboptimal neurodevelopment. For example, children born to women 
with major depressive disorder during pregnancy had lower motor development scores 
and lower language scores in infancy.24 More postpartum maternal depressive symptoms 
predicted a higher risk of autism spectrum disorders (ASD), lower intelligence, and more 
behavior problems of the child.25,26 However, investigations on the relation between maternal 
depression and child brain development, which may be the biological mechanism underly-
ing these cognitive or neuropsychiatric outcomes, remain limited. A few previous studies 
suggested that more maternal depressive symptoms during the perinatal phase were related 
to a larger amygdala of the offspring in childhood, and a sex difference was reported.27,28 
Associations between antenatal maternal depressive symptoms and right hippocampal 
volume in neonates were also found.29 However, there is limited research of the long-term 
effect of prenatal exposure to depressive symptoms on brain morphological development. In 
addition, since depression is a chronic condition with notable recurrence,30 it is important is 
take into account the persistency of exposure to depressive symptoms over time.
Maternal nutrients
Maternal nutrients during pregnancy are critical for intrauterine growth and develop-
ment of the child, because many nutrients cannot be synthesized by the fetus and must be 
obtained from the mother and transported through the placenta. Depending on the bio-
chemical and physiological features, deficiency of different nutrients during pregnancy 
may have distinct consequences on short- and long-term neurodevelopment of the child. 
Below, I discuss three important micronutrients: vitamin D, folate and fatty acids.
Vitamin D is a fat-soluble vitamin with the main source of natural sunlight. Since the 
major biological function of vitamin D involves maintaining normal blood levels of calci-
um and phosphorus, maternal vitamin D status during pregnancy has been mostly linked 
to bone health of the offspring.31-33 However, vitamin D is also an important neurosteroid 
that is involved in proliferation and differentiation of neurons,34 and vitamin D receptors 
Chapter 1. General introduction
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can be found in widespread brain tissue. Emerging evidence has related maternal vitamin 
D levels to child neurodevelopment. However, despite a few animal studies suggesting 
lower cortical volumes and greater lateral ventricle volume in rats born to vitamin D 
deficient mothers,35,36 it remains largely unknown whether maternal gestational vitamin 
D status predicts variation in brain morphology of the offspring in humans.
Folate also belongs to the vitamin family and involves in deoxythymidylate synthesis, 
purine synthesis, and various methylation reactions as an important coenzyme. Folate 
deficiency of the mother during the periconceptional period is best known to increase 
the risk of neural tube defects (NTDs) of the fetus, which leads to miscarriage or severe 
birth defects.37 In addition, emerging evidence shows that exposure to low folate levels 
during pregnancy is also associated with long-term neuropsychiatric outcomes such as 
more behavioral problems and autistic traits in childhood.38,39. Embedded in the current 
cohort, smaller HC in utero and less total brain volume at age 6-8 years have been found 
in children exposed to low folate levels in pregnancy.40,41 With brain imaging data of 
children aged 9-11 years, investigating prenatal folate status in relation to brain devel-
opmental trajectories across fetal life and childhood would provide insights on the long-
term effects of intrauterine folate exposure, as well as the age-dependent brain plasticity.42
Fatty acids and their associated derivatives are the primary components of lipids. 
Most fatty acids can be endogenously synthesized by human, but linoleic acid (LA) and 
α-linolenic acid (ALA) are essential fatty acids that must be obtained from food and serve 
as the precursors of other polyunsaturated fatty acids (PUFAs) from the omega-3 (ω-3) 
and omega-6 (ω-6) families. Long chain PUFAs (LC-PUFAs) such as docosahexaenoic 
acid (DHA) and arachidonic acid (ARA) are also termed conditionally essential fatty 
acids because of the inefficient endogenous production. PUFAs are primarily involved 
in lipid metabolism, and therefore have been mostly related to cardiovascular and 
metabolic outcomes. To date, investigations on the impact of maternal status of fatty 
acids, including trans fatty acids (TFAs) that are primarily found in industrial oil, on 
child brain development remain scarce, despite the evidence suggesting roles of specific 
fatty acids (e.g., ω-3 PUFAs) in the process of neurogenesis and neuroplasticity.43-45
Gestational duration
Gestational age at birth (GAB) is an important indicator of obstetric outcome. Both 
preterm (i.e., GAB<37 weeks) and post-term (i.e., GAB>42 weeks) birth have been 
associated with elevated mortality in neonates and infants.46,47 Long-term neurodevel-
opmental outcomes related to GAB are frequently reported. Further, a few previous 
studies have shown that preterm birth is associated with differences in brain morphol-
ogy, such as less gray and white matter volumes across infancy and adulthood.48-50 
However, there has been no study examining the relation between GAB as a continuum 
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and long-term brain development, which has important clinical implication given the 
worldwide prevalence of elective cesarean deliveries oft en between 37-39 weeks.51
Unveiling determinants of brain development with epidemiology and 
neuroimaging
Randomized controlled trials (RCTs) are the gold standard for establishing cause-eff ect 
relations, but they cannot always be easily implemented in reality and frequently 
encounter ethic issues. Stemming from the investigations into the causes of the 19th-
century cholera epidemics by John Snow, modern epidemiology has become the study 
of ‘the distribution and determinants of health-related events in specifi ed populations, 
and the application of this study to the control of health problems’.52 Applying advanced 
epidemiological methods enables investigators to identify determinants of health or 
developmental conditions while minimizing biases in observational studies.
With the rapid growth of modern neuroimaging modalities, cerebral tissue and 
function can now be assessed quantitatively, thus the potential for reproducible evalu-
ation is unlocked.53 Without radiative hazards, magnetic resonance imaging (MRI) is 
a non-invasive modality to obtain brain data with high quality. Brain morphological 
outcomes such as volumetric measures can be then estimated aft er data reconstruction 
using soft ware such as FreeSurfer or FSL. In addition, diff usion tensor imaging (DTI) 
is a unique MRI technique that measures the extent of diff usion in all directions in the 
three-dimensional space and hence maps the anisotropy of water diff usion in the brain, 
thus refl ecting the organization and architecture of white matter fi bers.
A major concern on current neuroimaging studies is limited sample sizes,54 which 
potentially brings the issue of inadequate statistical power especially when a number 
Figure 1.2. White matter microstructure of the brain
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of confounding factors should be taken into account. With a large sample size, this 
population-based neuroimaging study enabled the application of modern epidemio-
logical methods to minimize various biases and obtain valid results. In addition, the 
prospective design warranted the temporal relations between the determinants and 
outcomes of interest, and the application of repeated measures contributed to a more 
comprehensive understanding from a longitudinal perspective.
THIS THESIS
General aim
Using data from one of the largest pediatric neuroimaging studies worldwide, the aim of 
this thesis was to use epidemiological methods to investigate prospective associations of 
several modifiable perinatal determinants (i.e., maternal depressive symptoms, maternal 
nutrients, and gestational duration) with brain morphology and white matter micro-
structure in children aged 9-11 years old. I also aimed to study whether any observed 
brain differences are in turn related to neurodevelopmental outcomes of the child.
Setting
All studies in this thesis were embedded in the ongoing Generation R Study, a popula-
tion-based prospective cohort from fetal life onwards in Rotterdam, the Netherlands. 
Pregnant women with an expected delivery date between April 2002 and January 2006 
were eligible for participation in the study. Data collection started upon recruitment 
in pregnancy and participants and their children were followed up in the preschool 
period (0-4 years), early childhood (6 years), mid-childhood (10 years), and early 
adolescence (13 years).55 Maternal and paternal psychopathology was assessed repeat-
edly using validated questionnaires from mid-gestation onwards. Biological samples 
such as maternal blood collected in pregnancy were assayed to determine the status 
of several nutrients. Ultrasound assessment was performed at each trimester to collect 
information on anthropometry including head circumference (HC) of the fetus, as well 
as to assist pregnancy dating (ultrasound in the first trimester).56 In addition, children 
were invited to participate in a brain imaging session that included high-resolution 
structural, diffusion tensor, and resting-state functional MRI sequences at age 6-8 years 
and 9-11 years.57,58
Outline
In chapter 2, the association of maternal depressive symptoms across the perinatal pe-
riod and childhood with offspring brain morphology and white matter microstructure 
at age 6-8 years (section 2.1) and 9-11 years (section 2.2) was examined. Chapter 3 
18
focused on the association of maternal nutrients during pregnancy, including vitamin 
D (section 3.1), folate (section 3.2), PUFAs (section 3.3), and TFAs (section 3.4) with 
child brain morphology at age 9-11 years. In addition, earlier brain measures such 
as HC in fetal life and total brain volume at age 6-8 years were examined in section 
3.2 and section 3.4. In chapter 4, the relation between gestational duration and brain 
morphometry at age 9-11 years was examined. The main findings of these studies are 
presented, and practical implications with future directions are discussed in chapter 5. 
Chapter 6 gives a brief summary of this thesis.
Chapter 1. General introduction
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ABSTRACT
Background: Prenatal maternal depression has been associated with multiple problems 
in offspring involving affect, cognition and neuroendocrine functioning. This suggests 
that prenatal depression influences neurodevelopment. However, the underlying neu-
rodevelopmental mechanism remains unclear. We prospectively assessed whether ma-
ternal depressive symptoms during pregnancy and at the child’s age 3 years are related 
to white matter microstructure in 690 children. The association of paternal depressive 
symptoms with childhood white matter microstructure was assessed to evaluate genetic 
or familial confounding.
Methods: Parental depressive symptoms were measured using the Brief Symptom 
Inventory. In children aged 6-9 years, we used diffusion tensor imaging to assess white 
matter microstructure characteristics including fractional anisotropy (FA) and mean 
diffusivity (MD).
Results: Exposure to maternal depressive symptoms during pregnancy was associated 
with higher MD in the uncinate fasciculus and to lower FA and higher MD in the 
cingulum bundle. No associations of maternal depressive symptoms at the child’s age of 
3 years with white matter characteristics were observed. Paternal depressive symptoms 
also showed a trend towards significance for a lower FA in the cingulum bundle.
Conclusions: Prenatal maternal depressive symptoms were associated with higher 
MD in the uncinate fasciculus and the cingulum bundle. These structures are part of 
the limbic system, which is involved in motivation, emotion, learning, and memory. 
As paternal depressive symptoms were also related to lower FA in the cingulum, the 
observed effect may partly reflect a genetic predisposition and shared environmental 
family factors and to a lesser extent a specific intrauterine effect.
2.1. Parental depression and child white matter
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INTRODUCTION
Stress, anxiety or depression during pregnancy may affect fetal development and thus 
negatively impact offspring (reviewed in Dunkel Schetter, 2011; Goodman, 2007; Mul-
der et al., 2002). Prenatal depression has been related to low birth weight and preterm 
birth, affective problems, poor cognitive functioning, and impaired neuroendocrine 
functioning. Previously, we demonstrated that prenatal maternal depressive symptoms 
were related to decreased fetal (head) growth (El Marroun et al., 2012; Henrichs et al., 
2010), behavioral and emotional problems (El Marroun et al., 2014), and executive 
functioning problems in childhood (El Marroun et al., 2017). These findings suggest 
that prenatal maternal depression influences neurodevelopment through underlying 
mechanisms that have yet to be elucidated.
Neuroimaging can be used to better understand the underlying neurobiological ef-
fects of prenatal maternal depression on offspring. Recently, Sandman and colleagues 
showed that exposure to maternal depressive symptoms was associated with cortical 
thinning in 6-to-9 year old children, particularly in the prefrontal cortex (Sandman, 
Buss, Head, & Davis, 2015). Similarly, our own research group showed a thinner supe-
rior frontal cortex in children exposed to maternal depressive symptoms (El Marroun 
et al., 2016). However, brain regions do not function in isolation as they are intercon-
nected through a vast network of myelinated axons. Thus, it is important to study the 
structural connectivity of the brain as well.
Very limited information is available on the associations of prenatal maternal depres-
sion with the structural connectivity in offspring. To our knowledge only three studies 
from two cohorts have been published on this specific topic. A recent study in neonates 
(6-14 days of age) from the Growing Up in Singapore Towards Healthy Outcomes 
(GUSTO) study demonstrated that prenatal maternal depression was associated with 
lower fractional anisotropy (FA) and axial diffusivity (but not volume) in the right 
amygdala (Rifkin-Graboi et al., 2013). At follow-up around 4.5 years of age, prenatal 
depressive symptoms were associated with larger volumes of the right amygdala, while 
postnatal depressive symptoms were related to higher FA in the right amygdala, par-
ticularly in girls (Wen et al., 2017). Further, in a subgroup of the Alberta Pregnancy 
Outcomes and Nutrition (APrON) cohort maternal depressive symptoms were related 
to diffusivity measures of white matter tracts emanating from the inferior frontal and 
middle temporal region, which included the uncinate, the inferior-fronto-occipital and 
arcuate fasciculi (Lebel et al., 2015).
In the current study, we will investigate the relation between prenatal exposure to 
maternal depressive symptoms and white matter microstructure assessed using diffu-
sion tensor imaging (DTI) in childhood (6-9 years). A challenge in investigating this 
research question is to disentangle whether an association reflects an actual intrauter-
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ine effect or whether it is confounded by genetic and environmental factors. To address 
this, we used a prospective design taking into account maternal depressive symptoms 
during pregnancy, maternal depressive symptoms at the child’s age 3 years as well as 
paternal depressive symptoms during pregnancy. Using maternal depressive symptoms 
at 3 years will provide information on whether specific timing of the exposure to de-
pressive symptoms is important. Furthermore, prenatal exposure to paternal depressive 
symptoms will provide insight as to whether genetic factors or confounding by shared 
environmental family factors play a role (G. D. Smith, 2008b).
Based on our prior findings that maternal depressive symptoms were related to de-
creased cortical thickness in the frontal brain region (El Marroun et al., 2016), and on 
prior literature showing emotional problems in children prenatally exposed to maternal 
depressive symptoms (Dunkel Schetter, 2011; El Marroun et al., 2014; Goodman, 2007; 
Goodman et al., 2011), we hypothesize that children exposed to prenatal depressive 
symptoms will have atypical white matter microstructure, particularly in the limbic 
system. The limbic system is involved in motivation, emotion, learning, and memory. 
Like the approach used in the study of Lebel et al. 2015 in which white matter tracts 
were selected based on the findings in cortical thickness, we focused on five different 
white matter tracts that are either in the frontal brain area (forceps minor), connect 
the frontal brain area with other parts of the brain (superior and inferior longitudinal 
fasciculus), or are part of the limbic system (cingulate and uncinate fasciculus).
MATERIALS AND METHODS
Study population
This study reports findings from the Generation R Study; a population-based cohort in 
Rotterdam (the Netherlands) designed to identify environmental and genetic determi-
nants of maternal and child development, including physical and mental health, from 
fetal life onwards (Jaddoe et al., 2012). The Medical Ethics Committee of the Erasmus 
Medical Centre approved the protocol for this neuroimaging study.
In total, 1070 children aged 6-to-9 years were scanned in a neuroimaging study 
component (White et al., 2013). Subjects with missing data (n=37, 3.5%), poor data 
quality (n=255, 23.8%), or major cerebral abnormalities (n=2, 0.2%) were excluded 
from the analyses. Children of mothers who used antidepressants were excluded (n=36, 
3.3%). Another 50 (4.7%) children were excluded because of missing information 
on prenatal maternal depressive symptoms. Further, children with pervasive devel-
opmental problems or autism were also excluded (n=54) as they may have different 
neurodevelopmental trajectories (Courchesne et al., 2007). The final study population 
consisted of 636 children . Children with psychiatric problems such as attention deficit 
2.1. Parental depression and child white matter
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hyperactivity disorder (ADHD) and aggressive problems (n=78) were oversampled, 
thus a sensitivity analysis was performed excluding these children.
Prenatal exposure to maternal and paternal depressive symptoms
Depressive symptoms were assessed with the Brief Symptom Inventory (BSI) at, on 
average, 20.6 weeks of gestation. The BSI is a validated self-report questionnaire with 
53 items (Derogatis & Melisaratos, 1983), which define a spectrum of psychiatric symp-
toms; in the current study we used the six-item depression scale. Internal consistency 
for the depression scale was α=0.80. At the child’s age of 3, the BSI was assessed again 
to determine maternal depressive symptoms. Paternal depressive symptoms during 
pregnancy were assessed using the same instrument (BSI) at the same time in a separate 
questionnaire for fathers. Parents with a score higher than 0.75 have clinically relevant 
depressive symptoms according to the Dutch norm data in the manual (de Beurs, 2004).
Magnetic Resonance Imaging
Prior to neuroimaging, all children were first familiarized with MRI scanning during 
a mock scanning session. All images were acquired using the same sequence on the 
same scanner (3 Tesla GE 750 Discovery). DTI data were acquired using a single-shot, 
echo-planar sequence with the following parameters: TR=11.000 ms, TE=83 ms, flip 
angle=90, matrix=128×128, FOV=256×256 mm, slice thickness=2 mm, number of 
slices=77, acquisition time=7 min 40 s. In total, 35 volumes with diffusion weight-
ing (b=1000 s/mm2) and 3 volumes without diffusion weighting (b=0 s/mm2) were 
acquired.
Image preprocessing and probabilistic fiber tractography
The technical details of the image preprocessing and fiber tractography in our cohort 
have been extensively described previously (Muetzel et al., 2015). Data were processed 
using the functional MRI of the Brain’s Software Library (FMRIB, FSL) and the Camino 
Diffusion MRI Toolkit (Cook et al., 2006). Image processing tools were performed in 
Python v2.7 through the Neuroimaging in Python Pipelines and Interfaces package 
v0.92) (Gorgolewski et al., 2011). First, using the FSL “eddy_correct” tool (Jenkinson 
& Smith, 2001) images were adjusted for eddy-current and motion induced artifacts 
(Haselgrove & Moore, 1996). Using the FSL Brain Extraction Tool (S. M. Smith, 2002) 
non-brain tissue was removed. The diffusion tensor was fit using the RESTORE method 
implemented in Camino (Chang, Jones, & Pierpaoli, 2005). Common scalar maps, that 
is, fractional anisotropy (FA) and mean diffusivity (MD) were computed. Fully auto-
mated probabilistic fiber tractography was performed using the FSL plugin, “AutoPtx” 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx) (de Groot et al., 2015). The tracts used in 
the current study are shown in Figure 1.
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Additional measures
The following demographic information was collected: maternal age at intake, educa-
tional level, ethnicity, prenatal smoking and alcohol use, maternal diet, age of the child 
at MRI and IQ assessment, and gender of the child. Educational level was categorized 
into three levels: primary (no or primary education), secondary (lower and interme-
diate vocational training), and higher (higher vocational education and university) 
education. Maternal ethnicity was defined according to the classification of Statistics 
Netherlands and was categorized in Dutch, non-Dutch Western and non-Dutch non-
Western. Information on maternal smoking and alcohol use during pregnancy was 
collected with questionnaires during each trimester. Maternal smoking was categorized 
into: ‘never smoked in pregnancy’, ‘smoked until pregnancy was known’ and ‘continued 
to smoke in pregnancy’. Maternal alcohol use was categorized in: ‘never drank in preg-
nancy’, ‘drank until pregnancy was known’, ‘continued to drink in pregnancy occasion-
ally’ and ‘continued to drink in pregnancy frequently’. We assessed maternal diet during 
pregnancy using a food frequency questionnaire, and computed a diet quality score 
(Nguyen et al., 2017). Non-verbal IQ in children was assessed using two subtests of a 
Dutch IQ test: Snijders-Oomen Niet-verbale intelligentie Test–Revisie (SON-R 2½-7) 
Figure 1. White matter tracts of interest. The five tracts used in the analyses: blue = cingulum bundle, green= 
uncinate fasciculus, orange = superior longitudinal fasciculus, cream= forceps minor, and purple = inferior 
fronto-occipital fasciculus. A = Anterior, P = Posterior.
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(Tellegen, Winkel, B., & Laros, 2005). Information on child emotional and behavioral 
problems was assessed at 6 years using the well-validated Child Behavior Check List 
(CBCL) (Achenbach & Rescorla, 2000).
Statistical analyses
The associations of maternal and paternal depressive symptoms during pregnancy 
with FA and MD were analyzed using linear regression analyses. Maternal or paternal 
depressive symptoms were used as determinants and childhood white matter char-
acteristics were used as outcomes. Because there were no a priori hypotheses about 
specific hemispheric effects and the correlation between the left and right white mat-
ter tracts are high (Spearman’s r > 0.70), we initially averaged the data of the left and 
right hemisphere. When trends of associations between depressive symptoms and the 
outcome were observed (two-tailed p<0.10), we ran additional models for the left and 
right white matter tracts separately. Next, the method of Julious was used to compare 
the effect estimates of the left and the right hemisphere (Julious, 2004).  Based on the 
change-in-estimate method (Mickey & Greenland, 1989) of 5%, maternal drinking 
habits and maternal diet were not used as covariates as these variables did not affect 
the association. Likewise, gestational age at birth did not confound the association of 
interest if birth weight was also controlled for. All models were corrected for maternal 
age at intake, educational level, smoking during pregnancy and maternal depressive 
symptoms at 3 years, child gender, age at scanning, birth weight, and emotional and 
behavioral problems in childhood. A false discovery rate (FDR) correction for multiple 
testing was applied to adjust for multiple testing. Spearman correlation coefficients 
were calculated of maternal and paternal depressive symptoms. On average, 6.5% of 
data across the covariates was missing. To avoid the bias of complete case analysis, we 
accounted for missing information on the confounders by using multiple imputation 
methods; 10 imputed datasets were generated using a fully conditional specified model 
to handle missing values and were based on the relations between all variables (Green-
land & Finkle, 1995). Only the pooled estimates of the analyses of these 10 imputed 
datasets are reported.
RESULTS
Table 1 shows the demographic information of the study group (n=636). Children 
(50.6% boys) were born at a mean gestational age of 39.9 weeks with a mean birth 
weight of 3443 grams, and the average IQ was 102.8. These demographics characteris-
tics were very similar when we excluded children with psychiatric problems (ADHD 
and Aggressive problems) that were oversampled (Supplemental Table 1).  Maternal 
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Age at intake 30.8 ± 4.8
Depressive symptoms during pregnancy .27 ± .54
   Clinically relevant depressive symptoms (%) 13.0
Depressive symptoms at 3 years .12 ± .30
   Clinically relevant depressive symptoms (%) 4.9
Educational level (%)
   Primary 6.4
   Secondary 44.4
   Higher 49.2
Ethnicity
   Dutch 67.6
   Non-Dutch Western 6.4
   Non-Dutch Non-Western 26.0
Alcohol use (%) #
   Never drank in pregnancy 35.7
   Drank until pregnancy was known 13.5
   Continued to drink in pregnancy occasionally 40.0
   Continued to drink in pregnancy frequently 10.8
Smoking habits (%)
   Never smoked in pregnancy 76.5
   Smoked until pregnancy was known 6.9
   Continued to smoke in pregnancy 16.6
Paternal characteristics
Age at intake 32.9 ± 5.3
Prenatal depressive symptoms * .10 ± .28
   Clinically relevant depressive symptoms (%) 2.8
Child Characteristics
Gender (% boys) 50.6
Gestational age at birth (weeks) 39.9 ± 1.9
Birth weight (grams) 3444 ± 562
Non-verbal IQ at age 5 years 102.8 ± 14.1
Child emotional and behavioral problems at 6 years 21.5 ± 15.2
Age at MRI assessment (years) 8.0  ± 1.0
# Notes: Frequent continued alcohol use is defined as ‘1 or more glasses of alcohol per week in at least two 
trimesters’.
* Information about prenatal depressive symptoms of the father was available in n=461 children.
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and paternal depressive symptoms during pregnancy showed a low correlation (Spear-
man’s r=0.21). Maternal depressive symptoms during pregnancy had a low correlation 
with maternal depressive symptoms at 3 years (Spearman’s r= 0.34).
Fractional anisotropy
No associations were observed between prenatal maternal depressive symptoms and 
FA in the forceps minor, superior longitudinal fasciculus, and inferior fronto-occipital 
fasciculus (Table 2). A trend was present for the association of prenatal depressive 
symptoms with a lower FA in the cingulum bundle (B=-.008, 95% Confidence Interval 
Table 2. The association between prenatal maternal depressive symptoms and white matter tracts in children 
(total sample)
Prenatal maternal depressive 
symptoms
N
Fractional anisotropy (FA) Mean diffusivity (MD)
















Forceps minor 636 -.004 (-.004 to .006) .202 .001 (-.006 to .008) .767
Superior longitudinal fasciculus 636 -.002 (-.007 to .002) .353 .004 (-.001 to .008) .096
      Left superior longitudinal 
fasciculus
.004 (-.001 to .008) .121
      Right superior longitudinal 
fasciculus
.004 (-.001 to .008) .112
Uncinate fasciculus 636 -.001 (-.005 to .004) .790 .004 (-.000 to .008) .054
    Left uncinate fasciculus .005 (.000 to .009) .040
    Right uncinate fasciculus .003 (-.001 to .007) .146
Cingulum bundle 604 -.008 (-.017 to .000) .059 .007 (.002 to .012) .012
    Left cingulum bundle 607 -.006 (-.023 to .007) .215 .006 (.000 to .012) .047
    Right cingulum bundle
622 -.010 (-.019 to 
-.002)
.020 .008 (.002 to .013) .006
Inferior fronto-occipital fasciculus 636 -.002 (-.006 to .003) .449 .002 (-.002 to .006) .299
      Left inferior fronto-occipital 
fasciculus
      Right inferior fronto-occipital 
fasciculus
Notes: Linear regression analyses were used. B represents the association of prenatal maternal depressive symp-
toms with fractional anisotropy and MD in children. The regression models presented were adjusted for mater-
nal age, education and smoking, maternal depressive symptoms at 3 years and age and gender of the child, birth 
weight and emotional and behavioral problems at 5 years.
# The p-values of the 5 average white tracts of interest were corrected for multiple testing, but none of the 5 p-
values survived the FDR correction for multiple testing.
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(CI) -.017 to .000, p=.059), and prenatal maternal depressive symptoms were related to 
FA in the right cingulum bundle (B=-.010, 95%CI -.019 to -.002, p=.020).
Table 3. The association between maternal depressive symptoms at 3 years, paternal depressive symptoms and 
white matter tracts in children (total sample)
N
Fractional anisotropy Mean diffusivity (MD)
B (95% CI) p-value B (95% CI) p-value











Forceps minor 636 .000 (-.009 to .009) .970 .001 (-.010 to .013) .804
Superior longitudinal fasciculus 636 .005 (-.003 to .013) .198 -.005 (-.012 to .001) .121
Uncinate fasciculus 636 .000 (-.008 to .008) .942 .000 (-.006 to .006) .905
Cingulum bundle 604 -.003 (-.018 to .011) .647 -.001 (-.010 to .008) .904
Inferior fronto-occipital fasciculus 636 .003 (-.004 to .011) .343 -.002 (-.009 to .004) .467












Forceps minor 461 -.006 (-.017 to .004) .239 .002 (-.010 to .014) .752
Superior longitudinal fasciculus 461 -.002 (-.010 to .007) .728 -.002 (-.010 to .006) .629
Uncinate fasciculus 461 -.003 (-.012 to .006) .473 .002 (-.005 to .009) .604
Cingulum bundle 438 -.015 (-.031 to .001) .059 .003 (-.006 to .012) .536
    Left cingulum bundle 441 -.017 (-.033 to .002) .077
    Right cingulum bundle 451 -.015 (-.032 to .001) .067
Inferior fronto-occipital fasciculus 461 .004 (-.004 to .012) .298 -.004 (-.011 to .004) .309
Notes: Linear regression analyses were used. B represents the association of prenatal maternal depressive symp-
toms with fractional anisotropy and MD in children. The regression models presented were adjusted for mater-
nal age, education and smoking, maternal depressive symptoms at 3 years and age and gender of the child, birth 
weight and emotional and behavioral problems at 5 years.
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Diffusivity
No relations were observed between prenatal maternal depressive symptoms and 
MD of the forceps minor, superior longitudinal fasciculus or inferior fronto-occipital 
fasciculus (Table 2). Prenatal depressive symptoms were related to higher MD in the 
uncinate fasciculus (trend) (B=.004, 95%CI: -.000 to .008, p=.054) and in the cingulum 
bundle (B=.007, 95% CI: .002 to .012, p=.012). Subsequently, the left and right white 
matter tracts were separately analyzed. Maternal depressive symptoms during preg-
nancy were related to higher MD in the left uncinate fasciculus (B=.005, 95%CI: .000 to 
.009, p=.040), but not in the right uncinate fasciculus.
Maternal depressive symptoms at 3 years
Maternal depressive symptoms at 3 years were not related to FA or MD in the different 
white matter tracts as shown in Table 3.
Paternal depressive symptoms during pregnancy
Paternal depressive symptoms showed a trend towards significance for a lower FA in 
the cingulum bundle (Bcingulum bundle=-.015, 95% CI: -.031 to .001, p=.059), and 
this was seen in the left and right cingulum bundle (Bleft =-.017, 95%CI: -.033 to .002, 
p=.077 and (Bright =-.015, 95%CI: -.032 to .001, p=.067). Paternal depressive symptoms 
were not associated with FA in any of the other white matter tracts nor were paternal 
depressive symptoms during pregnancy associated with MD of the white matter tracts 
in childhood (Table 3).
Left and right hemisphere
Using the method of Julious, we found no differences between the estimates of the right 
hemisphere compared to those of the left hemisphere.
Sensitivity analyses
Children with psychiatric problems (ADHD and aggressive problems) were excluded. 
The associations of maternal depressive symptoms during pregnancy with MD in the 
cingulum and uncinate remained comparable (n=558, see Supplemental Table 2). Asso-
ciations of maternal and paternal depressive symptoms with white matter tracts in this 
subgroup (n=78 for maternal depressive symptoms and n=54 for paternal depressive 
symptoms) were in mostly same direction but were not statistically significant possibly 




In this prospective study, we examined the association between maternal depressive 
symptoms during pregnancy and white matter tract characteristics in childhood. 
Our results suggest that exposure to prenatal maternal depressive symptoms during 
pregnancy was associated with higher levels of diffusivity in the cingulum bundle. No 
relation of maternal depressive symptoms at 3 years with childhood white matter mi-
crostructure was observed. However, we did find that exposure to paternal depressive 
symptoms during pregnancy was associated with slightly lower FA of the cingulum 
bundle.
Existing literature
The existing literature concerning the potential consequences of maternal depressive 
symptoms during pregnancy for child brain development is sparse. Prenatal maternal 
depression has been associated with lower FA and axial diffusivity (but not in volume) 
in the right amygdala in young infants (Rifkin-Graboi et al., 2013), which is partly 
in line with the current findings. Using functional MRI, prenatal maternal depression 
has been linked to altered functional connectivity in the amygdala in early postna-
tal life (Qiu et al., 2015). Additionally, in children exposed to early socio-emotional 
deprivation (in Romanian orphanages) factional anisotropy values were significantly 
decreased in the uncinate fasciculus (Eluvathingal et al., 2006). Thus, although our 
study group was not a clinical sample, the results seem to be in accordance with the 
existing literature.
Explanations
First, as our results show an association of maternal depressive symptoms during 
pregnancy with white matter tract characteristics, but no associations of maternal 
depressive symptoms at the child’s age of 3 years with white matter microstructure. A 
potential mechanism may involve prenatal stress and distress in women with elevated 
depressive symptoms during pregnancy, which may lead to elevated hypothalamus–pi-
tuitary–adrenal (HPA) axis activity with the release of glucocorticoids (e.g. cortisol). 
Cortisol during pregnancy may then negatively influence offspring neurodevelopment 
in this vulnerable period, e.g., elevated maternal cortisol levels during pregnancy have 
been related to lower intelligence at age 7 years (LeWinn et al., 2009). Fetal exposure 
to synthetic glucocorticoids in mid-gestation (betamethasone treatment for fetal lung 
maturation in mothers at risk for preterm delivery) has been related to differences in 
the cingulate cortex and frontal brain regions (Davis, Sandman, Buss, Wing, & Head, 
2013). As exposure to depressive symptoms at 3 years was not related to white mat-
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ter microstructure, this may suggest that the brain is more susceptible to depressive 
symptoms in pregnancy.
Another potential explanation for this association could be parenting practices. 
Maternal depression, and even life-time maternal depression, has been related to poor 
parenting skills (Lovejoy, Graczyk, O’Hare, & Neuman, 2000). Depressed mothers 
have been found to be less responsive to child behavior, communicate less effectively, 
and have fewer positive interactions with their children. Further, mothers who are 
depressed are more likely to use corporal punishment (Chung, McCollum, Elo, Lee, & 
Culhane, 2004) and maternal depression has been linked to physical and verbal child 
abuse. Decreased white matter density in adolescents and young adults exposed to 
parental verbal abuse and physical neglect during childhood has been shown (Choi, 
Jeong, Rohan, Polcari, & Teicher, 2009; Huang, Gundapuneedi, & Rao, 2012). The 
white matter abnormalities were observed in areas such as the cingulum bundle and 
the fornix. However, the explanation of poor parenting practices is less likely as our 
results did not show a relation between maternal depressive symptoms at 3 years and 
childhood white matter microstructure.
A third potential mechanism to explain the relation between maternal depressive 
symptoms during pregnancy and childhood white matter microstructure is the presence 
of epiphenomena of depressive symptoms, e.g., smoking during pregnancy, unhealthy 
nutrition or low socioeconomic status. We attempted to adjust for these epiphenomena, 
but unmeasured residual confounding (e.g. poor prenatal care, or other lifestyle fac-
tors) might nonetheless be present.
Finally, a potential mechanism for our findings could be an underlying biological vul-
nerability (genetic predisposition) associated with both maternal depressive symptoms 
as well as white matter development. Depression is likely to be caused by a combination 
of genetic vulnerability and environmental factors. The heritability of perinatal depres-
sion was estimated at 54% in twins and 44% in siblings (Viktorin et al., 2015). Measures 
of white matter microstructure, such as FA, are also heritable (Kochunov et al., 2010). 
Interestingly, the genes encoding for brain-derived neurotrophic factor (BDNF) and 
catechol-O-methyl transferase (COMT) have been identified to be potentially involved 
in depression (Nestler et al., 2002; Opmeer, Kortekaas, & Aleman, 2010) and exert 
small effects on white matter development (Chiang et al., 2011; Thomason et al., 2010). 
Further, shared environmental family factors (e.g., poverty) may also explain the as-
sociation of depressive symptoms with structural connectivity. Next to this, genomic 
imprinting, which is a unique form of epigenetic regulation in mammals leading to 
the preferential expression of the maternal or paternal allele of certain genes with wide 
spread implications for the development and function of the brain, could play a role 
(Perez, Rubinstein, & Dulac, 2016). This potential explanation is likely as our results 
demonstrate that both maternal and paternal depressive symptoms were similarly 
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related to childhood FA in the cingulum suggesting that a heritable vulnerability or 
shared environmental family factors or the combination of both (epigenetic processes) 
may play a role in this relation. Further, if the effects are due to an intrauterine expo-
sure, then maternal exposure during pregnancy would have a clearly greater influence 
than paternal exposure on the child’s white matter microstructure (G. D. Smith, 2008a). 
In the current study, the confidence intervals of the estimates in the prenatal maternal 
models and paternal models are overlapping and thus the results suggest that this is not 
the case.
Strengths and weaknesses
The strengths of the study are the prospective design, the relatively large group of chil-
dren that underwent neuroimaging, and, particularly, the use of paternal depressive 
symptoms as a contrast. However, we acknowledge that this study has its limitations. 
We measured prenatal depressive symptoms of the mother and father only once during 
pregnancy. Therefore, we do not know whether depressive symptoms varied in intensity 
or were persistent throughout pregnancy. Although we used depressive symptoms of 
the father as a contrast in the current sample, paternal depressive symptoms were lower 
than maternal depressive symptoms, resulting in less power and precision. Further-
more, we only measured white matter microstructure parameters once, and therefore it 
is impossible to infer conclusions about neurodevelopmental trajectories. Moreover, we 
performed many statistical tests, and the FA and MD values of the different tracts were 
somewhat correlated. We used an FDR to correct for multiple testing, but none of the 
p-values survived this correction and therefore the results should be interpreted with 
caution. Finally, we were not able to investigate other important tracts, which are part 
of the limbic system including the fornix and terminal stria. These tracts are smaller 
and curved and thus more difficult to obtain via tractography.
CONCLUSION
Overall, our findings suggest that prenatal exposure to maternal depressive symptoms 
is associated with differences in the microstructure of white matter tracts in young chil-
dren. As paternal depressive symptoms were also related to decreased FA, the observed 
effect likely reflects a genetic predisposition or shared environmental family factors and 
to a lesser extent a specific intrauterine effect. It is thus important to take into account 
both fathers and mothers psychopathology in future studies. Longitudinal neuroimag-
ing studies are needed to explore structural and functional neurodevelopmental effects 
of prenatal exposure to depression.
2.1. Parental depression and child white matter
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Age at intake 30.8 ± 4.8
Depressive symptoms during pregnancy .26 ± .53
   Clinically relevant depressive symptoms (%) 12.4
Depressive symptoms at 3 years .15 ± .39
   Clinically relevant depressive symptoms (%) 4.8
Educational level (%)
   Primary 6.7
   Secondary 45.2
   Higher 48.1
Ethnicity
   Dutch 67.2
   Non-Dutch Western 6.6
   Non-Dutch Non-Western 26.2
Alcohol use (%) #
   Never drank in pregnancy 35.8
   Drank until pregnancy was known 13.2
   Continued to drink in pregnancy occasionally 39.5
   Continued to drink in pregnancy frequently 11.5
Smoking habits (%)
   Never smoked in pregnancy 76.6
   Smoked until pregnancy was known 6.9
   Continued to smoke in pregnancy 16.5
Paternal characteristics
Age at intake 33.2 ± 5.5
Prenatal depressive symptoms * .10 ± .29
   Clinically relevant depressive symptoms (%) 2.2
Child Characteristics
Gender (% boys) 49.3
Gestational age at birth (weeks) 39.9 ± 1.9
Birth weight (grams) 3443 ± 570
Non-verbal IQ at age 5 years 102.9 ± 14.2
Child emotional and behavioral problems at 6 years 18.8 ± 13.4
Age at MRI assessment (years) 7.9  ± 1.0
# Frequent continued alcohol use is defined as ‘1 or more glasses of alcohol per week in at least two trimesters’.
* Information about prenatal depressive symptoms of the father was available in n=407 children.
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Table S2. The association between prenatal maternal depressive symptoms and white matter tracts in children 
(sample without psychiatric disorders for sensitivity analyses)
Prenatal maternal depressive 
symptoms
N
Fractional anisotropy (FA) Mean diffusivity (MD)
B (95% CI) p-value # B (95% CI) p-value #
Forceps minor 558 -.003 (-.009 to .003) .298 -.001 (-.008 to .006) .881
Superior longitudinal fasciculus 558 -.002 (-.007 to .004) .446 .003 (-.001 to .008) .125
Uncinate fasciculus 558 -.001 (-.005 to .004) .784 .004 (.000 to .008) .053
    Left uncinate fasciculus 558 .005 (.000 to .010) .033
    Right uncinate fasciculus 558 .003 (-.001 to .007) .165
Cingulum bundle 527 -.007 (-.016 to .002) .152 .006 (.000 to .012) .033
    Left cingulum bundle 530 .006 (-.001 to .012) .072
    Right cingulum bundle 544 .007 (.001 to .013) .023
Inferior fronto-occipital fasciculus 558 .000 (-.005 to .004) .963 .002 (-.003 to .006) .399
Notes: Linear regression analyses were used. B represents the association of prenatal maternal depressive symp-
toms with fractional anisotropy and MD in children. The regression models presented were adjusted for mater-
nal age, education and smoking, maternal depressive symptoms at 3 years and age and gender of the child, birth 
weight and emotional and behavioral problems at 5 years.
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ABSTRACT
Objective: The authors examined associations of exposure to maternal depressive 
symptoms at different developmental stages from fetal life to preadolescence with child 
brain development, including volumetrics and white matter microstructure.
Methods: This study was embedded in a longitudinal birth cohort in Rotterdam, the 
Netherlands. Participants were 3,469 mother-child pairs with data on maternal depres-
sive symptoms and child neuroimaging at age 10. The authors also measured child 
emotional and behavioral problems at the time of neuroimaging. The association of 
maternal depressive symptoms with child brain development at each assessment was 
examined. Maternal depressive symptom trajectories were modeled across fetal life and 
childhood to determine the association of maternal depressive symptom patterns over 
time with child brain development.
Results: The single-time-point analyses showed that maternal depressive symptoms at 
child age 2 months were associated with smaller total gray matter volume and lower 
global fractional anisotropy (FA), whereas maternal depressive symptoms assessed 
prenatally or in childhood were not. The trajectory analyses suggested in particular that 
children exposed to persistently high levels of maternal depressive symptoms across 
the perinatal period had smaller gray and white matter volumes as well as alterations 
(i.e., lower FA) in white matter microstructure compared with non-exposed children. 
Furthermore, the gray matter volume differences mediated the association between 
postnatal maternal depressive symptoms and child attention problems.
Conclusions: Perinatal maternal depressive symptoms were consistently associated 
with child brain development assessed 10 years later. These results suggest that the 
postnatal period is a window of vulnerability for adversities such as maternal depres-
sive symptoms.
2.2. Maternal depression and child brain
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INTRODUCTION
Maternal depression is closely linked to the wellbeing of mothers and their offspring (1). 
There is clear evidence that perinatal (i.e., prenatal and postnatal) maternal depressive 
symptoms are associated with various adverse neonatal outcomes, such as low birth 
weight (2). Further, the long-term consequences of maternal depressive symptoms on 
offspring cognition, emotion and behavior are well documented. Children exposed to 
maternal depression in the postpartum period are more likely to develop internalizing 
and externalizing problems, and attention-deficit/hyperactivity disorder (ADHD) as 
young children and adolescents (3, 4).
To date, however, little is known about the neurobiology underlying the associations 
of maternal depressive symptoms with cognitive, emotional, and behavioral problems in 
offspring. Previous neuroimaging studies on prenatal or postnatal depression primarily 
focused on offspring limbic system development, in particular the structure and func-
tion of the amygdala and the hippocampus (5-10). A few other studies have adopted an 
exploratory whole-brain approach and suggested that prenatal and postnatal maternal 
depressive symptoms predict offspring cortical thinning in childhood, particularly in 
the frontal lobe (11, 12). There are also recent studies suggesting associations between 
perinatal maternal depression and child brain microstructure in various developmental 
phases (13). However, these findings are not consistent, and several important gaps 
remain. First, the critical period during which offspring brain development is most 
vulnerable to maternal depressive symptoms remains unclear. Second, although persis-
tently high depressive symptoms in mothers are associated with offspring internalizing 
and externalizing problems (14, 15), few studies have addressed whether persistence of 
depressive symptoms in mothers affects offspring brain development.
Our aim in this study was to explore whether maternal depressive symptoms repeat-
edly assessed from the perinatal period until child age ten years are associated with 
offspring brain development. We also examined the associations between empirically 
defined groups of maternal depressive symptom trajectories and child brain develop-
ment. And, finally, we investigated whether any observed brain differences mediated 
the association of maternal depressive symptoms with child problems.
METHODS
Setting
This study was embedded in the Generation R Study, a population-based cohort from 
fetal life onwards in Rotterdam, the Netherlands (16). Women with an expected deliv-
ery date between April 2002 and January 2006 were eligible. The study was approved 
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by the Medical Ethics Committee of the Erasmus Medical Center (EMC), Rotterdam. 
Written informed consent was obtained from all participants.
Study population
The children participating in Generation R were invited for a neuroimaging session at 
age ten years. In total, 4245 children visited the research center. Of these, 3992 children 
underwent the neuroimaging assessment. We excluded 134 children without data on 
maternal depressive symptoms. Further, 389 children were excluded due to insufficient 
quality of neuroimaging data, leaving 3469 mother-child pairs for the final analyses (see 
Figure S1 in the supplement).
Maternal depressive symptoms
Information on maternal psychopathology was obtained during pregnancy (on average 
at 20.6 weeks of gestation), postnatal period (child age two months), early childhood 
(age three years), and  preadolescence (age ten years) with the Brief Symptoms Inven-
tory (BSI) (17), a validated self-reported questionnaire containing 53 items. A weighted 
score for the depressive symptoms scale (6 items, each ranging from 0 to 4 points) was 
calculated by summing the item scores and dividing by the number of completed items. 
In line with the existing literature on the chronicity of maternal depressive symptoms 
(18), the depressive symptoms scores across the assessments were moderately corre-
lated (Spearman correlation coefficients ranging from 0.26 to 0.44), with the strongest 
correlation between depressive symptoms scores at 20 weeks of gestation and those at 
child age 2 months. The Cronbach’s α of the BSI depressive symptoms scale at the four 
assessments ranged from 0.82 to 0.85. Mothers also completed the Edinburg Postnatal 
Depression Scale (EPDS) at child age 2 months. Using the validated BSI cut-off of 0.75, 
we compared the dichotomized score with the EPDS (validated cut-off of 13) and found 
a sensitivity of 0.62 and a specificity of 0.97 (19), demonstrating moderate to good 
quality of the BSI’s measurement of clinical depression.
Scores on ‘interpersonal sensitivity’, ‘anxiety’, and ‘hostility’, also measured repeated-
lywith the BSI, were used to test the specificity of any observed association.
Neuroimaging
All children were familiarized with Magnetic Resonance Imaging (MRI) scanning during 
a mock scanning session. All images were acquired using the same sequence on the same 
scanner (3 Tesla GE 750w Discovery). Following a three-plane localizer scan, a high-
resolution T1-weighted inversion recovery fast spoiled gradient recalled sequence was 
acquired with the parameters: TR=8.77 ms, TE=3.4 ms, TI=600 ms, flip angle=10°, field 
of view (FOV)=220 mm×220 mm, Acquisition Matrix=220×220, slice thickness=1mm, 
number of slices=230. Diffusion tensor imaging (DTI) data were acquired using an 
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echo-planar sequence with three b=0 scans and 35 diffusion weighted images (b=1000 
s/mm2) with the following parameters: TR=12500 ms, TE=72.8 ms, FOV=240 mm×240 
mm, Acquisition Matrix=120×120, slice thickness=2 mm, number of slices=65.
Cortical reconstruction and volumetric segmentation were performed with Free-
Surfer v.6.0.0 (http://surfer.nmr.mgh.harvard.edu/). FreeSurfer procedures have shown 
good test-retest reliability across manufacturers and field strengths (20). The quality 
of FreeSurfer output was visually inspected, after which data with insufficient quality 
were eliminated. Metrics of volume, including total gray matter volume and total white 
matter volume, and volumes of the specific limbic structures were extracted. DTI data 
were processed using the functional MRI of the Brain’s Software Library (FMRIB,FSL) 
and the Camino Diffusion MRI Toolkit (21, 22). The diffusion tensor was fit using the 
RESTORE method implemented in Camino. Common scalar maps, including fractional 
anisotropy (FA) and mean diffusivity (MD), were computed. FA and MD are common 
measures to quantify white matter microstructure. FA describes the degree of anisotropic 
diffusion, while MD describes the average diffusion in all directions. Fully automated 
probabilistic fiber tractography was performed using the FSL plugin AutoPtx (https://
fsl.fmrib.ox.ac.uk/fsl/fslwiki/AutoPtx)(23). Diffusion image quality was assured by a 
combination of manual and automated checks, including the examination of slice-wise 
variation in the diffusion signal, the sum-of-square error of the tensor calculation, and 
inter-subject registration accuracy. 
Covariates
The following demographic variables were selected as potential confounders based on 
the literature (10, 14, 24): maternal ethnicity, marital status, educational level, monthly 
household income, number of individuals living in the household, maternal smoking, 
alcohol use, age at intake, child age at scan, sex, birth weight, and presence of siblings. 
In addition, information on maternal lifetime history of depression was collected dur-
ing pregnancy, and seeking professional help for depression postnatally was assessed by 
questionnaire. These variables were not considered as confounders but aided interpreta-
tion of the results. Maternal prenatal antidepressants use was assessed by self-report and 
pharmacy records and was explored in sensitivity analyses. Emotional and behavioral 
problems in children at age ten years were measured with the validated Brief Problem 
Monitor (BPM) for mediation analyses (25).
Statistical analysis
A hierarchical approach was used to examine the association of maternal depressive 
symptoms with offspring brain outcomes. In primary analyses, we examined global 
volumetric measures including total gray matter and total white matter volumes, and 
overall white matter microstructure measures including global FA and MD. If an asso-
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ciation with a global metric was observed, we performed post-hoc analyses of the corti-
cal thickness of specific brain lobes and the microstructure of predefined tracts: forceps 
major, forceps minor, uncinate fasciculus, inferior longitudinal fasciculus, superior 
longitudinal fasciculus, and cingulum bundle. Based on previous studies, volumes of 
specific limbic structures, including the thalamus, amygdala, and hippocampus were 
examined independently of global findings in supplementary analyses. Additionally, 
we tested for the presence of indirect effects as suggested by Hayes et al. (26) to examine 
whether the potential differences in brain measures mediated the association of mater-
nal depressive symptoms with child emotional and behavioral problems.
The association between maternal depressive symptoms at four specific time points 
(further referred to as single-time-point analyses) and offspring brain neuroimaging 
measures was examined separately with linear regression analyses to avoid inflated stan-
dard errors and unstable estimations due to collinearity of the repeated measures (27). 
Likewise, the models with total gray matter and white matter volume as the outcome 
were not adjusted for intracranial volume given the high correlation (r>0.89). We present 
initial unadjusted analyses and analyses adjusted for covariates selected using a change-
in-estimate criterion of 5%.
Because heterogeneity in the timing of the onset and persistence of maternal depres-
sion during perinatal period has been described (28), we aimed to identify between-
group difference rather than within-group variability. Hence, a latent class growth 
analysis (LCGA) was used to account for the interrelation of repeatedly measured 
maternal depressive symptoms. Trajectories of depressive symptoms were modeled in 
mothers for whom data were available from two or more time points (n=3071). Because 
the distribution of maternal depressive symptoms was skewed, the developmental trajec-
tories were modeled with censored normal distribution. The full-information maximum 
likelihood algorithm was used to handle missing data. Based on previous experience 
(14), models with two to five trajectories were estimated and compared. Model selection 
was further based on the bootstrap likelihood ratio test (BLRT), the Lo-Mendell-Rubin 
(LMR) test, and the Bayesian Information Criterion (BIC) (29). As a supplementary 
reference, a low Akaike’s Information Criterion (AIC) and high entropy were used to 
define good model fit. Interpretability of the groups was taken into account to decide on 
the number of groups. Models were not adopted if an additional group failed to provide 
substantive information. Subsequently, the associations between maternal depression 
trajectory membership and offspring brain neuroimaging measures were assessed with 
linear regression analyses. Individual’s posterior probability of trajectory membership 
was corrected in regression models to account for the uncertainty of the classification.
We additionally explored interaction by child sex in the above analyses. In sensitiv-
ity analyses we excluded 86 mothers who reported prenatal antidepressants use, as 
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exposure to maternal antidepressant has been associated with altered neonatal brain 
outcomes (30).
On average 5.8% of data on the covariates were missing (missing at random indicated 
by Little’s test) and were accounted for by multiple imputation. Determinants and out-
comes were not imputed; 10 imputed datasets were generated.
In this exploratory study, a false discovery rate (FDR) correction was applied to the 
primary volumetric and white matter microstructure outcomes in the adjusted models 
to minimize false positive findings due to multiple comparisons. The number of tests 
was 8 for single-time-point analyses and 6 for trajectory analyses. Statistical signifi-
cance was set as α < 0.05 (2-sided). Mplus v.7.1.0 was employed to perform LCGA; SPSS 
v.24.0 (including the PROCESS macro v.3.1 for mediation analysis) was used for all 
other analyses.
Non-response analyses
The characteristics of the 3469 participants were compared with those of the 523 par-
ticipants for whom data were not available on maternal depressive symptoms or child 
neuroimaging. Analysis of variance or the Kruskal-Wallis test was used for continuous 
variables and the chi-square test for categorical variables. The results showed that moth-
ers with missing data were younger on average (30.6±5.4 years for non-responders vs. 
31.2±4.8 years for responders), more often non-Dutch (42.9% vs. 58.8%), more often 
single (17.6% vs. 11.3%), and less highly educated (38.9% vs. 51.7%). Excluded children 




Table 1 summarizes the demographic and exposure information of the study popula-
tion. The mean age of the children at scanning was 10.1 years. Half (50.5%) of the chil-
dren were girls, and 58.7% had a Dutch national origin. The mean scores for maternal 
depressive symptoms at four time points ranged from 0.12 to 0.20.
Maternal depressive symptoms at specific time points and child brain 
development
Table 2 shows that higher maternal depressive symptom scores at all four time points 
were associated with smaller total gray matter volume in unadjusted models. After 
adjusting for covariates, only exposure to maternal depressive symptoms at child age 
two months was associated with smaller total gray matter volumes in offspring at age 
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Table 1. Demographic and exposure characteristics of the study population in a study of maternal depressive 




   Dutch 2039 58.8
   Non-Dutch Western 289 8.3
   Non-Dutch Non-Western 1141 32.9
Marital status , with partner 3078 88.7
Educational level
   Primary or lower 234 6.7
   Secondary 1440 41.5
   Higher 1795 51.7
Household income , €/month
   < 1200 234 6.7
   1200 – 2000 541 15.6
   2000 – 4000 1462 42.1
   > 4000 1232 35.5
Smoking
   Never smoked in pregnancy 2700 77.8
   Smoked until pregnancy was known 309 8.9
   Continued to smoke in pregnancy 460 13.5
Alcohol use
   Never drank in pregnancy 1267 36.5
   Drank until pregnancy was known 626 18.0
   Continued to drink in pregnancy occasionally 1247 35.9
   Continued to drink in pregnancy frequently 329 9.5
Child sex, male 1717 49.5
Siblings (Yes) 580 16.7
Mean SD
Maternal age at intake (years) 31.2 4.8
Maternal depressive symptoms scores
   20 weeks of gestation (n=2628) 0.2 0.4
   Child age 2 months (n=2330) 0.2 0.4
   Child age 3 years (n=2491) 0.1 0.3
   Child age 10 years (n=3006) 0.2 0.4
Child age at MRI scan (years) 10.1 0.6
Birth weight (grams) 3422.6 573.0
Number of individuals living in the household 2.2 0.8
a. Imputed statistics are shown (except for maternal depressive symptom scores).













































































































































































































































































































































































































































































































































































































































































































































































































































































ten. Specifically, a 1-point increase on the BSI depressive symptoms scale corresponded 
to a 7.29cm3 (0.96%) reduction in total gray matter; thus children exposed to the high-
est BSI score had up to 29.16cm3 (3.8%) less gray matter. The Cohen’s ƒ2 measure was 
0.004, indicating a small effect size. Post-hoc analyses showed that maternal depressive 
symptoms at two months were associated with thinner cortices in the left and right 
frontal lobe, and the left temporal lobe (Figure 1). No association was found with total 
white matter volume. Maternal depressive symptoms at other time points were not 
associated with total gray matter or white matter volume after taking into account the 
covariates.
In the supplementary analyses, no association was found between maternal depressive 
symptoms at any time point and volumes of the thalamus, amygdala, or hippocampus 
(see Table S1 in the supplement).
Table 2 also shows that maternal depressive symptoms at child age two months 
predicted lower offspring white matter FA, but the association did not survive multiple 
comparison correction. The Cohen’s ƒ2 was 0.003, indicating a small effect size. Post-
hoc analyses of specific tracts demonstrated that maternal depressive symptoms at two 
months were related to lower FA in the forceps minor (b=-0.01, 95% CI=-0.01 to -0.001, 
p=0.008) after correcting for the covariates. Again, maternal depressive symptoms at 
other time points were not associated with white matter microstructure.
Figure 1. Maternal depressive symptoms at child age 2 months and child cortical thickness. Models were adjusted 
for child age at the time of MRI scanning (the mean age at scanning was 10.1 years [SD=0.6]), child sex, ma-
ternal ethnicity, maternal age at intake, maternal education level, marital status, household income, child birth 
weight, maternal smoking, and maternal alcohol use. B represents the difference in thickness, in millimeters.
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No associations were observed between maternal symptoms of interpersonal sensi-
tivity, anxiety, or hostility and child brain outcomes at any time point. No interaction 
by child sex was observed in any association tested.
We found evidence suggesting that the child’s total gray matter volume mediated the 
association of maternal depressive symptoms at child age two months with child at-
tention problems at ten years (covariates adjusted unstandardized indirect effect=0.04, 
bootstrapped 95% CI=0.01 to 0.07; direct effect=-0.12, 95% CI=-0.17 to 0.40. Figure 
S2). This mediating association was not driven by cortical thickness of any specific 
brain lobe. The association of maternal depressive symptoms with internalizing or 
externalizing problems was not mediated by child brain morphology.
Maternal depressive symptoms trajectories and child brain 
development
The four-class model with quadratic and cubic terms was found to be the optimal model, 
with the lowest BIC and p-values < 0.05 for BLRT and LMR (Table S2). The average pos-
terior probabilities of the trajectories ranged from 0.79 to 0.89, which were satisfactory. 
Figure 2 shows the trajectory groups; the first and largest class (n=2120, 69.0%), termed 
‘no symptoms’, consisted of mothers reporting no or very few depressive symptoms 
at all time points. The second class (n=845, 27.5%), termed ‘low symptoms’, included 
mothers with a very modest and stable level of depressive symptoms. In the smallest 
group (n=43, 1.4%), maternal depressive symptoms sharply increased from moderate 
levels prenatally and at three years to high levels at age ten, thus this group was labeled 
‘increasing symptoms’. Finally, there was a group of mothers (n=63, 2.1%) with already 
high symptom levels in pregnancy that peaked in the early postnatal period. In these 
mothers, depressive symptoms were lower but remained above the clinical cutoff score 
at child ages three and ten years. This group was labeled ‘perinatal high symptoms’. 
Interestingly, a larger proportion of mothers with ‘perinatal high symptoms’ had a 
history of depression (71.2% vs. 20.6% for mothers with ‘no symptoms’, p<0.001), and 
more sought professional help for depression postnatally (41.9% vs. 0.4%, p<0.001).
Table 3 lists the adjusted association of the trajectory groups with child brain develop-
ment. Children whose mothers were in the perinatal high symptoms group had smaller 
total gray matter and total white matter volumes than the children whose mothers 
were in the no symptoms group. Specifically, children of mothers with perinatal high 
symptoms had a 21.09 cm3 (2.7%) less total gray matter volume and 15.57 cm3 (3.4%) 
less total white matter volume than those in the reference groups. No differences in 
cortical thickness between groups were found. Children whose mothers were in the low 
symptoms or increasing symptoms group did not differ in gray matter or white matter 
volumes from the reference group.
60
There were no differences in volumes of the thalamus, amygdala, and hippocampus 
between the maternal depressive symptoms trajectory groups (Table S1).
Moreover, children whose mothers were in the perinatal high symptoms group 
showed lower white matter FA than the reference group. Post-hoc analyses further in-
dicated that exposure to perinatal high symptoms was associated with lower FA in the 
forceps major (b=-0.01, 95% CI=-0.02 to -0.0003, p=0.04), the forceps minor (b=-0,01, 
95% CI=-0.02 to -0.001, p=0.03), and the uncinate fasciculus (b=-0.01, 95% CI=-0.02 
to -0.002, p=0.02). No associations were found between maternal depressive symptoms 
trajectories and MD. Again, no interaction by child sex was detected in any of these 
analyses.
Results obtained in the sensitivity analyses excluding mothers who reported prenatal 
antidepressants use were similar to the main analyses (Table S3).
Figure 2. Maternal depressive symptoms trajectories across fetal life and childhood. Maternal symptoms were 
assessed during pregnancy (on average at 20.6 weeks of gestation) and at child ages 2 months, 3 years, and 10 
years.


















































































































































































































































































































































































































































































































































































































































































































































































In this population-based study, maternal depressive symptoms in the postnatal period 
were associated with smaller gray matter in offspring. Children exposed to persistently 
high maternal depressive symptoms across the perinatal period had smaller gray and 
white matter volumes. Consistently, alterations (i.e., lower FA) in white matter micro-
structure were observed, particularly in the forceps minor. Notably, the gray matter 
volume differences mediated the association of postnatal maternal depressive symp-
toms with child attention problems.
Very few studies have focused on the associations of maternal depressive symptoms 
with child brain development, and results have been inconsistent. In line with previ-
ous literature (7, 10, 11, 30), we found no associations of prenatal maternal depressive 
symptoms with volumes of gray and white matter, amygdala, or hippocampus in the 
offspring, although some studies observed associations between prenatal maternal 
depression and amygdala or hippocampus volume in children at younger ages (10, 
31). Similarly, no relation was reported between postnatal maternal depression and 
amygdala volumes in offspring (10). In contrast, a longitudinal study suggested that 
persistent maternal depressive symptoms from birth until late childhood were related 
to larger amygdala in ten-year-old children (6). However, these findings should be 
interpreted with caution given the small sample size combined with limited adjustment 
for relevant confounding factors. Recent studies have reported associations between 
prenatal maternal depression and white matter structure in 1-month-old infants 
or 8-year-old children (5, 13). In addition, Lebel et al. (12) reported that postnatal 
maternal depressive symptoms were associated with white matter microstructure in 
preschool children. Although our results also suggested associations between perinatal 
maternal depressive symptoms and child global FA in white matter, these findings 
should be interpreted cautiously because they did not survive multiple comparison 
correction. Additionally, unlike a few previous studies that suggested sex-dependent 
effects of perinatal depression on amygdala volume or brain microstructure (10, 13), 
we observed no sex-specific associations. Possibly, differences in age and confounder 
adjustment explain these discrepancies. Finally, our post-hoc analysis showing that 
postnatal maternal depressive symptoms may be associated with thinner cortices in the 
frontal lobes is consistent with findings from a previous study (12).
Our study extends the existing literature of maternal depression and child brain 
development with trajectory analyses, which provide information beyond the single-
time-point analyses and account for the patterns of depressive symptoms over time. 
Maternal depressive symptoms in the perinatal period, in particular the postnatal 
period, are more likely to affect offspring brain development, which suggests a critical 
period of sensitivity. Furthermore, our study suggests that gray matter volume may 
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be involved in the neurobiological mechanism underlying the association of maternal 
depression with child attention problems, which has rarely been reported, highlighting 
the possibility that interventions reducing maternal depression may have lasting effects 
on child development.
The finding that maternal depressive symptoms at child age two months were associ-
ated with offspring brain development in childhood is very interesting, because much of 
postnatal brain development is experience-dependent (32). Previous studies have sug-
gested the postpartum months as a critical period for child behavioral outcomes, such 
as internalizing problems and responsiveness disturbance in those exposed to maternal 
depression (33, 34). Our results suggest this is also true for brain development. In the 
postnatal period, the brain undergoes rapid growth in gray matter, mainly as a result of 
synaptogenesis and dendritic arborization (35). The postnatal period is also when the 
primary myelination process in white matter occurs (36). White matter volume, on the 
other hand, increases steadily in both prenatal and postnatal periods (37). This may 
explain why smaller white matter volumes were observed only in children exposed to 
persistently high maternal depressive symptoms across the perinatal period.
Several potential mechanisms underlying our results deserve discussion. First, impaired 
mother-infant interaction may have a mediating role. For the infant, neural architecture 
must be formed within the embedding context of parents’ support (38). There is evidence 
showing that postpartum maternal depression predicts poor mother-infant attachment 
and parenting (1, 39, 40), which have both been related to smaller gray matter volumes 
and abnormal white matter microstructure development (41, 42). Second, early postnatal 
exposure to maternal depression predicted elevated cortisol levels in offspring (43), pos-
sibly as a result of the cortisol synchrony in mother-infant dyads through breastfeeding 
or physical interactions (44), which have been associated with altered brain structure, 
such as smaller limbic regions (45). Third and perhaps foremost, mothers in the perinatal 
high symptoms group suffered more from lifetime depression, and were more likely to 
have sought professional help for depression, suggesting an inherent vulnerability that 
increases the risk of developing depression particularly in the perinatal period (46). 
Thus, the genetic susceptibility to depression, which in turn may be related to offspring 
brain differences (47), could underlie the association observed in the perinatal period.
Most probably, more chronic and severe maternal depressive symptoms exert cumu-
lative effects on offspring brain development across the perinatal period or childhood. 
Indeed, the depressive symptoms scores were correlated from fetal life to childhood, in 
particular between depressive symptoms scores in the perinatal period. Women in the 
perinatal high symptoms group had the most chronic and severe depressive symptoms 
from their pregnancy onwards even though these symptoms decreased over time. Thus, 
we must be careful when interpreting the timing of effects, because depression is a 
chronic and recurrent disorder. The correlation of maternal depressive symptoms over 
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time makes it difficult to attribute any effect to a particular time point in development. 
Also, we cannot infer causality from this study; we can only speculate that the perinatal 
environment and genetic susceptibility together mediate the association of maternal 
depressive symptoms with child brain development.
The strengths of this study are the relatively large sample size, repeated assessments 
of depressive symptoms, and the combination of single-time-point analyses and 
trajectory analyses. Moreover, the population-based nature of the study enhances gen-
eralizability of the results. A few limitations must also be discussed. First, only cross-
sectional neuroimaging data were used, so we cannot determine whether the effects 
are permanent or transient. Second, although we adjusted for a number of potential 
confounding factors, unmeasured residual confounding by extraneous factors such as 
breastfeeding, diet, and maternal externalizing symptoms cannot be ruled out. Third, 
since the prevalence of depression was low in this study population, the power to detect 
an association may have been more limited than suggested by the sample size, and the 
results must be generalized carefully to more vulnerable populations.
In conclusion, this study shows that exposure to perinatal maternal depressive symp-
toms, but not to maternal depressive symptoms in childhood, is associated with brain 
morphological differences in the offspring assessed at age ten years. These findings 
suggest that the perinatal period, particularly the postnatal period, may be critical for 
prevention of maternal depressive symptoms in view of the long-term association with 
child brain development.
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Entropy AICc BICd LMRe BLRTf
2
i, s 0.744 14525.824 14580.092 P<0.001 P<0.001
i, s, q 0.890 16239.757 16306.084 P<0.001 P<0.001
i, s, q, c 0.924 16523.886 16602.273 P<0.001 P<0.001
3
i, s 0.665 14287.055 14359.412 P=0.006 P<0.001
i, s, q 0.635 14220.958 14311.404 P=0.010 P<0.001
i, s, q, c 0.686 14191.399 14299.935 P<0.001 P<0.001
4
i, s 0.734 14168.920 14259.366 P=0.004 P<0.001
i, s, q 0.703 14070.867 14185.433 P=0.080 P<0.001
i, s, q, c 0.738 14040.140 14178.825 P=0.004 P<0.001
5
i, s 0.677 14131.408 14239.944 P=0.124 P<0.001
i, s, q 0.749 13964.574 14103.259 P=0.252 P<0.001
i, s, q, c 0.761 13937.861 14106.694 P=0.567 P<0.001
a LCGA=Latent Class Growth Analysis
b i=intercept, s=slope, q=quadratic, c=cubic, all with significance in the models
c AIC=Akaike’s Information Criterion
d BIC=Bayesian Information Criterion
e LMR=Lo-Mendell-Rubin test

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A prospective population-based study of gestational 
vitamin D status and brain morphology in 
preadolescents





Low vitamin D level during pregnancy has been associated with adverse neurodevelop-
mental outcomes such as autism spectrum disorders (ASD) in children. However, the 
underlying neurobiological mechanism remains largely unknown. This study investi-
gated the association between gestational 25-hydroxyvitamin D [25(OH)D] concentra-
tion and brain morphology in 2597 children at the age of 10 years in the population-
based Generation R Study. We studied both 25(OH)D in maternal venous blood in 
mid-gestation and in umbilical cord blood at delivery, in relation to brain volumetric 
measures and surface-based cortical metrics including cortical thickness, surface area, 
and gyrification using linear regression. We found exposure to higher maternal 25(OH)
D concentrations in mid-gestation was associated with a larger cerebellar volume in 
children (b=0.02, 95%CI 0.001 to 0.04), however this association did not remain after 
correction for multiple comparisons. In addition, children exposed to persistently 
deficient (i.e., <25 nmol/L) 25(OH)D concentration from mid-gestation to delivery 
showed less cerebral gray matter and white matter volumes, as well as smaller surface 
area and less gyrification at age 10 years than those with persistently sufficient (i.e., 
≥ 50 nmol/L) 25(OH)D concentration. These results suggest temporal relationships 
between gestational vitamin D concentration and brain morphological development 
in children.
3.1. Maternal vitamin D and child brain
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INTRODUCTION
Vitamin D is an essential micronutrient that is mainly synthesized in the skin by expo-
sure to sunlight (Bendik et al., 2014). In fetal life, vitamin D is mainly transported from 
mother to fetus through the placenta in the form of 25-hydroxyvitamin D [25(OH)D] 
(McAree et al., 2013). Maternal serum 25(OH)D concentration and that of the fetus 
measured in cord blood are highly correlated (Glorieux et al., 1981; Kimball et al., 
2008), suggesting maternal vitamin D level is a reliable indicator of fetal vitamin D 
status.
Vitamin D deficiency is prevalent worldwide, with people living in Europe, the 
Middle East, and Asia at particular risk (Lips, 2007). It is also known that women, 
especially those in pregnancy, are more likely to be vitamin D deficient (Gellert et al., 
2017; Vinkhuyzen et al., 2016). Maternal vitamin D deficiency has repeatedly been 
associated with adverse birth outcomes such as fetal growth restriction and preterm 
birth (Bodnar et al., 2015; Leffelaar et al., 2010).  In recent years, emerging evidence 
also associates low maternal vitamin D level during pregnancy with long-term cogni-
tive and neuropsychiatric outcomes of the offspring. For instance, Keim et al. (Keim 
et al., 2014) found maternal vitamin D concentration in mid and late gestation was 
positively associated with child IQ at age 7. Two neonatal studies reported an associa-
tion of vitamin D deficiency with increased risk of schizophrenia (Eyles et al., 2018; 
McGrath et al., 2010). In addition, animal studies using rodents and epidemiological 
studies in humans showed that gestational vitamin deficiency was associated with an 
increased risk of autism spectrum disorders (ASD) or more autism-related phenotypes 
in offspring (Ali et al., 2019; Chen et al., 2016; Magnusson et al., 2016; Vuillermot et 
al., 2017), which has also been supported by the evidence from our present cohort 
(Vinkhuyzen et al., 2018; Vinkhuyzen et al., 2017). However, these relationships remain 
inconclusive due to some inconsistent findings. For example, maternal vitamin D levels 
during pregnancy were not related to ASD symptoms in children from 5 to 18 years 
old in a Spanish birth cohort (Lopez-Vicente et al., 2019), and a case-control study in 
Southern California, Unite States reported no association between neonatal vitamin D 
levels and ASD in childhood (Windham et al., 2019).
Using neuroimaging techniques, clear associations have been established between 
cognitive, emotional, and behavioral phenotypes and brain morphology. For instance, 
reduced brain volumes and less gyrification are frequently reported in children with 
poor cognitive outcomes or ASD (Arhan et al., 2017; Blanken et al., 2015; Duret et 
al., 2018; Libero et al., 2014; Pangelinan et al., 2011). To date, however, the evidence 
linking early life exposure to low vitamin D and brain development remains scarce. 
There are a few animal studies showing that rats exposed to vitamin D deficiency in 
gestation had a smaller brain volume and larger cerebral ventricles (Eyles et al., 2003; 
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Feron et al., 2005). Similarly, in studies in older adults using a cross-sectional design, 
a lower vitamin D concentration was associated with smaller brain volume and larger 
cerebral ventricles (Annweiler et al., 2013; Hooshmand et al., 2014). However, we know 
of no study exploring maternal gestational vitamin D status and brain morphology 
in children. Such studies may further our understanding of the biological mechanism 
underlying the established association between gestational vitamin D and child neuro-
developmental outcomes, and justify interventions such as vitamin D supplementation 
during pregnancy. Therefore, we investigated the association of maternal vitamin D 
concentration during pregnancy with offspring brain morphology at age 10 years. 
Based on the existing literature, we hypothesized that low gestational vitamin D level 
was associated with global alterations in brain morphology in children.
MATERIAL AND METHODS
Study design
This study was embedded in the Generation R Study (Kooijman et al., 2016), a 
population-based prospective cohort in Rotterdam, the Netherlands. Pregnant women 
living in the study area with an expected delivery date between April 2002 to January 
2006 were recruited. In total 8879 mothers were enrolled in the study prenatally, who 
gave birth to 8976 live-born children. The study has been approved by the Medical 
Ethics Committee of Erasmus Medical Center, Rotterdam. Written informed consent 
was obtained from all participants.
Participants
Of the 8976 mother-child dyads, we excluded 966 without any information on ges-
tational vitamin D concentration. This left 8010 children, of which 6156 visited the 
research center at age 9-11 years and were invited for a magnetic resonance imaging 
(MRI) assessment of the brain (White et al., 2018); among the 3363 children that un-
derwent brain MRI assessment, 2715 children had usable brain morphological data 
after quality inspection. We also randomly excluded 118 siblings to rule out potential 
clustered data (i.e., children born to the same mother and thus exposed to shared ge-
netic or environmental factors shaping their brain development), leaving 2597 children 
as the study population. Of these children, 2427 had vitamin D concentration informa-
tion in mid-gestation, 1706 had vitamin D concentration information at delivery, and 
1536 had information on both assessments (see Supplemental Figure S1 for the flow 
diagram).
3.1. Maternal vitamin D and child brain
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Vitamin D concentration
Maternal venous blood samples were collected during mid-pregnancy at a median 
gestational age of 20.4 (range 18.1-24.9) weeks. Cord blood from the umbilical vein 
was collected at delivery, at a median gestational age of 40.3 (range 27.6-43.4) weeks. 
Samples were analyzed using isotope dilution liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) at the Eyles Laboratory of the Queensland Brain Institute, 
University of Queensland, Australia. Vitamin D status was assessed by measuring 
25(OH)D, defined as the sum of 25-hydroxyvitamin D2 [25(OH)D2] and 25-hydroxyvi-
tamin D3 [25(OH)D3] in serum (Eyles et al., 2009). Assay accuracy was assessed us-
ing certified reference materials purchased from the Australian National Institute of 
Standards and Technology (NIST SRM 972a Levels 1-4). Further details of the assay 
methodology have been described elsewhere (Vinkhuyzen et al., 2016).
Structural neuroimaging
Prior to neuroimaging, all children were familiarized with MRI scanning during a 
mock scanning session. All images were acquired using the same sequence on the same 
scanner (3 Tesla GE MR 750w Discovery). Following a three-plane localizer scan, a 
high-resolution T1-weighted inversion recovery fast spoiled gradient recalled sequence 
was acquired. Detailed information on the sequence and imaging procedure can be 
found elsewhere (White et al., 2018).
Volumetric segmentation and cortical reconstruction were performed with Free-
Surfer v.6.0.0 (http://surfer.nmr.mgh.harvard.edu/). The standard reconstruction 
stream was applied, and surface-based models of white matter and gray matter were 
generated. Thickness maps for each subject were smoothed with a 10 mm full-width 
half-maximum Gaussian kernel. Local gyrification index (LGI) maps were smoothed 
using a 5 mm full-width half-maximum Gaussian kernel. The quality of surface re-
construction was visually inspected, after which data with insufficient quality were 
eliminated.
Covariates
Possible confounders were chosen based on prior literature (Morales et al., 2015; 
Vinkhuyzen et al., 2018; Whitehouse et al., 2012) and directed acyclic graphs (Shrier 
and Platt, 2008). Information on maternal age at intake, ethnicity, marital status, educa-
tion, household income, smoking and alcohol use in pregnancy, and vitamin supple-
ment use in pregnancy was collected at enrollment of the study with questionnaire. 
Maternal ethnicity was determined from the country of birth of the parents according 
to the largest ethnic groups in our study population and used to define broad categories 
based on similarities in skin color and/or cultural background (Eilers et al., 2013; Voor-
burg/Heerlen, 2004a; Voortman et al., 2015). The categories were Dutch, Non-Dutch 
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Western (European, North American, and Oceanian); Turkish and Moroccan; African 
(Cape Verdean, other African, Surinamese-Creole, and Dutch Antillean); and Other 
(Asian, Surinamese-Hindu, Surinamese-unspecified, and South and Central Ameri-
can). Educational level was categorized into primary or low, secondary, and higher 
(Voorburg/Heerlen, 2004b). Household income in pregnancy was categorized into less 
than €1200, €1200 to €2000, and more than €2000 per month. Maternal smoking and 
alcohol use in pregnancy were assessed in each trimester of pregnancy. Maternal smok-
ing was categorized into ‘never smoked in pregnancy’, ‘smoked until pregnancy was 
known’, and ‘continued to smoke in pregnancy’ (Roza et al., 2007). Maternal alcohol 
use was categorized into ‘never drank in pregnancy’, ‘drank until pregnancy was known’, 
‘continued to drink in pregnancy occasionally’, and ‘continued to drink in pregnancy 
frequently (defined as one or more glass/week for at least two trimesters)’. Child date 
of birth and sex were obtained from medical record at birth. Season of blood sampling 
was recorded at the moment of blood sampling of 25(OH)D.
Statistical analysis
Information on maternal or child characteristics was presented as mean (standard 
error) or median (95% range) for continuous variables and number (percentage) 
for categorical variables. First, 25(OH)D concentration was studied as a continuous 
variable. Second, 25(OH)D concentration was categorized to ‘deficient’, ‘insufficient’ 
and ‘sufficient’ groups using the cut-off of 25 nmol/L and 50 nmol/L (Garcia et al., 
2017; Osteoporosis, 2003; Vinkhuyzen et al., 2018); the ‘sufficient’ group was set as the 
reference. For a region of interest (ROI) approach, we used multiple linear regression 
to examine the association of 25(OH)D status in mid-gestation and at delivery with 
child brain volumetric measures, including total brain volume, cerebral gray matter 
volume, cerebral white matter volume, and cerebellar volume. Additionally, we associ-
ated 25(OH)D status across the two assessments with these measures to investigate 
whether exposure to consistently low 25(OH)D levels from mid-gestation to delivery 
was related to brain volumes in children. In a supplementary analysis, we also examined 
whether children exposed to low 25(OH)D at one assessment and sufficient 25(OH)D 
at the other assessment had different brain volumes than those with sufficient 25(OH)
D levels as assessed in maternal blood in mid-gestation and in umbilical cord blood. 
We also investigated 25(OH)D concentration in relation to volumes of subcortical 
structures (i.e., the thalamus, amygdala, hippocampus, putamen, pallidum, caudate, 
and accumbens) and the lateral ventricles in secondary analyses. For an exploratory 
surface-based brain analysis we used linear regression run in a custom-in-house pack-
age (‘QdecR’, http://github.com/slamballais/QDECR) at each cortical vertex to examine 
the association of gestational 25(OH)D concentration with cortical thickness, surface 
area, and gyrification. In the surface-based models for single vitamin D assessment, 
3.1. Maternal vitamin D and child brain
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25(OH)D concentration was introduced as a continuous variable only. Regression 
analyses were run in two models. The first analyses (Model 1) were adjusted for age at 
the neuroimaging assessment and sex of the child. In a second step, we further adjusted 
for other potential confounders (Model 2). In particular, we adjusted for season of 
blood sampling in mid-gestation and season of blood sampling at delivery simultane-
ously in the fully adjusted model (Model 2) when investigating 25(OH)D levels across 
the two assessments in relation to brain morphology.
We performed two sensitivity analyses to test the robustness of the primary analyses. 
First, information on 25(OH)D concentration and covariates between the participants 
and non-participants was compared to apply inverse probability weighting (IPW). This 
approach addresses selection bias and helps obtain results more representative for the 
initial population (Forns et al., 2018; Nohr and Liew, 2018). Inverse probability weights 
were calculated with logistic regression. Second, using information from genomic 
components (Medina-Gomez et al., 2015), we re-ran analyses including only the 1092 
children of  European ancestry to eliminate effect modification by ethnicity due to 
genetic or dietary variations.
Missing covariate data (proportions ranging from 1.5% to 15.1%) were accounted 
for by multiple imputation with the ‘Mice’ package (missing at random indicated by 
Little’s test) (van Buuren and Groothuis-Oudshoorn, 2011). A total of 10 imputed 
datasets were generated with 10 iterations. Only pooled results are reported. Statistical 
significance was set as α < 0.05 (2-sided). Furthermore, a false discovery rate (FDR) 
correction was applied to the two primary and two secondary analyses separately to 
minimize false positive findings due to multiple testing (Benjamini and Hochberg, 
1995). For the surface-based brain analyses, correction for multiple testing was per-
formed using built-in Gaussian Monte Carlo Simulations (Hagler et al., 2006). Cluster-
wise p-values were Bonferroni-corrected for two hemispheres (p<0.025), and a cluster 
forming threshold (CFT) of p=0.001 was selected for significance testing because it has 
shown high correspondence with actual permutation testing at the smoothing kernels 
used (Greve and Fischl, 2018; Muetzel et al., 2019). All analyses were run using the R 
statistical software (version 3.5.1).
RESULTS
Descriptive statistics
Table 1 shows the demographic information of the study population. Children (49.5% 
boys) were scanned at an average age of 10.1 years. Over half of them (57.3%) were of 
Dutch national origin. The median 25(OH)D concentration in mid-pregnancy was 53.8 
nmol/L, and the median 25(OH)D concentration at delivery was 31.0 nmol/L. 25(OH)
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D concentration at delivery was significantly correlated with 25(OH)D concentration 
in mid-pregnancy (r=0.56).
Table 1. Demographics of participants (n=2597)
Maternal characteristics
Ethnicity, N (%)
   Dutch 1489 (57.3)
   Non-Dutch Western 208 (8.0)
   Turkish and Moroccan 307 (11.8)
   African 278 (10.7)
   Other 315 (12.1)
Age at intake, mean (SD), years 30.8 (4.8)
Marital status (with partner), N (%) 2292 (88.3)
Education level, N (%)
   Primary or low 189 (7.3)
   Secondary 1084 (41.7)
   Higher 1324 (51.0)
Household income per month, N (%)
   < €1200 429 (16.5)
   €1200-2000 455 (17.5)
   > €2000 1713 (66.0)
Smoking, N (%)
   Never smoked in pregnancy 1983 (76.4)
   Smoked until pregnancy was known 243 (9.4)
   Continued to smoke in pregnancy 371 (14.3)
Alcohol use, N (%)
   Never drank in pregnancy 1046 (40.3)
   Drank until pregnancy was known 366 (14.1)
   Continued to drink in pregnancy occasionally 958 (36.9)
   Continued to drink in pregnancy frequently 227 (8.7)
Vitamin supplement use in pregnancy (Yes), N (%) 883 (34.0)
25(OH)D concentration (n=2427), median (95% range), nmol/L 53.8 (11.2, 110.7)
Season of blood sampling (n=2427), N (%)
   Spring 669 (27.6)
   Summer 468 (19.3)
   Autumn 621 (25.6)
   Winter 669 (27.6)
Child characteristics
Age at the neuroimaging assessment, mean (SD), years 10.1 (0.6)
Gender (boys), N (%) 1286 (49.5)
25(OH)D concentration in cold blood (n=1706), median (95% range), nmol/L 31.0 (7.3, 72.5)
Season of cord blood sampling (n=1706), N (%)
   Spring 500 (29.3)
   Summer 496 (29.1)
   Autumn 317 (18.6)
   Winter 393 (23.0)
Imputed data were shown (except for 25(OH)D concentration and season of blood sample collection).
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Gestational 25(OH)D concentration and child brain volumes
25(OH)D concentration in mid-gestation was positively associated with child total 
brain volume at age 10 years [b=0.49, representing 0.49 cm3 difference (larger) in total 
brain volume per 1 nmol/L increase of 25(OH)D concentration, 95% CI 0.37 to 0.61, 
p<0.001] in Model 1. However, after adjusting for the additional covariates, this as-
sociation did not remain (b=0.06, 95% CI -0.08 to 0.21, p=0.39). Higher 25(OH)D 
concentration in mid-pregnancy was also associated with larger volumes of cerebral 
gray matter, cerebral white matter, and the cerebellum in children when correcting 
for child age at the neuroimaging assessment and sex, but only the association with 
cerebellar volume remained after full adjustment, as shown in Table 2. However, this 
association did not survive after correcting for multiple testing. Likewise, 25(OH)D 
concentration at delivery was associated with child total brain volumes (b=0.73, 95% 
CI 0.52 to 0.94, p<0.001) in Model 1, but not in Model 2 (b=0.06, 95% CI -0.20 to 0.32, 
p=0.65). A similar pattern was observed for the associations of 25(OH)D concentration 
at delivery with volumes of cerebral gray and white matter, and cerebellar volume.





Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)
B 95% CI p-value B 95% CI p-value B 95% CI p-value
Model 1
Continuous 0.27 0.20, 0.33 <0.001 0.16 0.10, 0.21 <0.001 0.06 0.05, 0.08 <0.001
Categorical
  Sufficient 
(n=1316)
reference - - reference - - reference - -
  Insufficient 
(n=630)
-9.99 -14.66, -5.31 <0.001 -6.08 -10.11, -2.06 0.003 -2.64 -3.77, -1.51 <0.001






<0.001 -5.07 -6.31, -3.82 <0.001
Model 2
Continuous 0.02 -0.06, 0.10 0.65 0.03 -0.04, 0.10 0.45 0.02 0.001, 0.04 0.04
Categorical
  Sufficient 
(n=1316)
reference - - reference - - reference - -
  Insufficient 
(n=630)
-1.35 -6.17, 3.48 0.58 -1.97 -6.22, 2.28 0.36 -1.11 -2.31, 0.08 0.07
  Deficient (n=481) -3.24 -9.81, 3.34 0.33 -5.98 -11.72, -0.23 0.04 -1.34 -2.95, 0.27 0.10
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Next we tested the associations of categories of 25(OH)D levels with brain volumet-
ric measures. There was no evidence suggesting brain volume differences in children 
exposed to ‘deficient’ or ‘insufficient’ 25(OH)D concentration in gestation compared to 
those exposed to ‘sufficient’ 25(OH)D concentration after taking into account covari-
ates and multiple testing.
Of the 1536 children with 25(OH)D concentration data at both assessments, using the 
same cut-offs as above, 230 were defined as exposed to ‘consistently deficient’ 25(OH)
D concentration. Likewise, 168 were determined as ‘consistently insufficient’ and 291 
were determined as ‘consistently sufficient’. Table 3 shows the adjusted and unadjusted 
results, here we focus on the adjusted results only. Children exposed in utero to ‘consis-
tently insufficient’ 25(OH)D concentration had a smaller total brain volume (b=-18.20, 
95% CI -35.81 to -0.59, p=0.04) and a smaller cerebral white matter volume than the 
reference group [i.e., the 291 children exposed to ‘consistently sufficient’ 25(OH)D 
concentration from mid-gestation to delivery]. Also, children exposed to ‘consistently 
deficient’ 25(OH)D concentration showed a smaller total brain volume (b=-36.47, 95% 
CI -62.83 to -10.12, p=0.007), and smaller cerebral gray and white matter volumes 
at 10 years of age than the reference group. After FDR correction most associations 




Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)
B 95% CI p-value B 95% CI p-value B 95% CI p-value
Model 1
Continuous 0.39 0.28, 0.50 <0.001 0.24 0.14, 0.33 <0.001 0.10 0.08, 0.13 <0.001
Categorical
  Sufficient (n=376) reference - - reference - - reference - -
  Insufficient 
(n=656)
-9.88 -16.15, -3.60 0.002 -8.98 -14.33, -3.63 0.001 -2.10 -3.59, -0.61 0.006
  Deficient (n=674) -22.78
-29.03, 
-16.54
<0.001 -14.98 -20.31, -9.66 <0.001 -5.64 -7.12, -4.16 <0.001
Model 2
Continuous 0.01 -0.12, 0.15 0.83 0.02 -0.10, 0.14 0.79 0.03 -0.004, 0.06 0.08
Categorical
  Sufficient (n=376) reference - - reference - - reference - -
  Insufficient 
(n=656)
-3.95 -10.27, 2.38 0.22 -5.35 -10.87, 0.17 0.06 -0.96 -2.49, 0.56 0.22
  Deficient (n=674) -3.24 -10.88, 4.39 0.40 -3.65 -10.31, 3.00 0.28 -1.75 -3.59, 0.09 0.06
Model 1 was adjusted for child age at time of the neuroimaging assessment and sex; Model 2 was additionally 
adjusted for maternal ethnicity, marital status, education, age at intake, household income, smoking and alcohol 
use in pregnancy, vitamin supplement use in pregnancy, and season of blood sampling. Deficient is 25(OH)D 
concentration < 25 nmol/L; insufficient is 25(OH)D concentration 25 to < 50 nmol/L; sufficient is 25(OH)D 
concentration ≥ 50 nmol/L.
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remained, only the difference in total brain volume between the ‘consistently insuf-
ficient’ group and the reference group disappeared. No association was found between 
25(OH)D status from mid-gestation to delivery and cerebellar volume. In addition, no 
brain volumetric differences were observed between children exposed to low 25(OH)
D at one assessment only (n=606) and those with ‘consistently sufficient’ 25(OH)D 
concentration (data not shown).
Figure 1 shows the results of the subcortical structures. After adjusting for covariates, 
although a marginal positive association between 25(OH)D concentration in mid-ges-
tation and the volume of the pallidum was observed, gestational 25(OH)D concentra-
tion was not associated with the volume of any subcortical structures in children after 
correcting for multiple testing. We found no association between gestational 25(OH)
D concentration and lateral ventricle volume. 25(OH)D status from mid-gestation to 
delivery was not associated with the volume of the subcortical structures or the lateral 
ventricle (data not shown).




Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)




reference - - reference - - reference - -
Consistently 
insufficient













reference - - reference - - reference - -
Consistently 
insufficient
-7.02 -16.42, 2.38 0.14 -10.09 -18.43, -1.75 0.02a -1.09 -3.38, 1.21 0.35
Consistently 
deficient
-18.77 -32.90, -4.64 0.009a -14.77 -27.23, -2.32 0.02a -2.84 -6.25, 0.56 0.10
Model 1 was adjusted for child age at time of the neuroimaging assessment and sex; Model 2 was additionally 
adjusted for maternal ethnicity, marital status, education, age at intake, household income, smoking and alcohol 
use in pregnancy, vitamin supplement use in pregnancy, season of blood sampling in mid-gestation and season 
of blood sampling at delivery; n =230 for ‘consistently deficient’ group; n=168 for ‘consistently insufficient’ 
group; and n=291 for ‘consistently sufficient’ group. Deficient is 25(OH)D concentration < 25 nmol/L; insuf-
ficient is 25(OH)D concentration 25 to < 50 nmol/L; sufficient is 25(OH)D concentration ≥ 50 nmol/L.
a These p-values survived FDR correction for multiple testing.
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Gestational 25(OH)D concentration and child surface-based brain 
morphometry
In the analyses only adjusted for child age at the neuroimaging assessment and 
sex, 25(OH)D concentration in mid-gestation and at delivery was associated with 
widespread differences in cortical thickness, surface area, and gyrification in both 
hemispheres. However, after full adjustment for confounding variables, no association 
remained. Compared to children exposed to ‘consistently sufficient’ 25 (OH)D con-
centration from mid-gestation to delivery, those exposed to ‘consistently insufficient’ 
25 (OH)D concentration showed smaller surface area in the temporal region in the 
right hemisphere, and those exposed to ‘consistently deficient’ 25(OH)D concentration 
showed smaller surface area in the frontal and occipital region in the right hemisphere, 
Figure 1. Gestational 25(OH)D concentration and volumes of subcortical structures in children at age 10 years. 
Models were adjusted for child age at time of the neuroimaging assessment and sex, maternal ethnicity, age at 
intake, marital status, education, smoking and alcohol use in pregnancy, vitamin supplement use in pregnancy, 
household income, season of blood sampling, and child intracranial volume. n=2427 for 25(OH)D concentra-
tion in mid-gestation, and n=1706 for 25(OH)D concentration at delivery.
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as well as less gyrification in the temporal region in the left hemisphere after adjust-
ment for all covariates (Figure 2).
Sensitivity analyses
As shown in Table S1 and Table S2, results from inverse probability weighted regression 
were generally consistent with the main analyses. Table S3 and Table S4 demonstrate 
Figure 2. 25(OH)D status from mid-gestation to delivery in relation to surface-based cortical metrics in chil-
dren at age 10 years. Compared to children with ‘consistently sufficient’ 25(OH)D concentration (as assessed 
in maternal blood in mid-gestation and in umbilical cord blood, n=288), those exposed to ‘consistently insuf-
ficient’ 25 (OH)D concentration (n=165) had significantly smaller surface area in the colored regions (section 
A); those exposed to ‘consistently deficient’ 25(OH)D concentration (n=229) showed significantly smaller sur-
face area and less gyrification in the colored regions (section B, C). These associations remained if corrected 
for multiple comparisons. Model 1 was adjusted for child age at time of the neuroimaging assessment and sex; 
Model 2 was additionally adjusted for maternal ethnicity, marital status, education, age at intake, household 
income, smoking and alcohol use in pregnancy, vitamin supplement use in pregnancy, season of blood sampling 
in mid-gestation and season of blood sampling at delivery. Deficient is 25(OH)D concentration < 25 nmol/L; 
insufficient is 25(OH)D concentration 25 to < 50 nmol/L; sufficient is 25(OH)D concentration ≥ 50 nmol/L. 
LH=left hemisphere; RH=right hemisphere.
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that there were no associations between gestational 25(OH)D concentration and brain 
volumes at 10 years in children of European ancestry. However, the sample sizes of 
these analyses were considerably smaller.
DISCUSSION
In this population-based study, we found that exposure to persistently low vitamin 
D levels was associated with a smaller brain (specially less cerebral gray and white 
matter volumes) and differed surface-based cortical metrics such as surface area and 
gyrification in children, using repeated assessment of 25(OH)D concentration from 
mid-gestation to delivery. Also, there was a positive association between mid-gesta-
tional 25(OH)D concentration and offspring cerebellar volume, but this did not survive 
multiple comparison correction.
Research on gestational vitamin D status and brain morphology is scarce. In animal 
studies, rats born to vitamin D3-deficient mothers showed smaller cortical volumes 
and larger lateral ventricle volumes than controls (Eyles et al., 2003; Feron et al., 2005). 
Similarly, in cross-sectional human studies, low vitamin D concentrations have been 
associated with a smaller total brain volume and a larger lateral ventricle volume in 
adults and the elderly, albeit these findings are inconsistent (Annweiler et al., 2012; 
Annweiler et al., 2013; Zivadinov et al., 2013). In our study, we found an association 
between gestational 25(OH)D concentration and the offspring total brain only if we 
studied persistent vitamin insufficiency. In another study no association between 25 
(OH)D concentration and bilateral amygdala or hippocampus volume was found (An-
nweiler et al., 2010), which is in line with the current study. However, these studies are 
not comparable in terms of study design and subjects. Further, one study indicated 
that mothers with lower 25(OH)D concentration during pregnancy had offspring with 
smaller head circumference (as a marker for brain development) from the second tri-
mester until birth (Miliku et al., 2016), while in a recent study no association was found 
between gestational 25(OH)D concentration and infant head circumference at the age 
of 6 or 12 months (Hauta-Alus et al., 2019). Several explanations for the discrepancy 
with previous findings must be discussed.
First, as an important neurosteriod, vitamin D has important functions in the 
proliferation and differentiation of neurons, calcium signaling within the brain, neu-
rotrophic and neuroprotective actions, and may alter neurotransmission and synaptic 
plasticity (Cui et al., 2017; Groves et al., 2014). An emerging concept suggests that vita-
min deficiency may weaken the integrity of perineuronal nets (PNNs), thereby neural-
circuit function is disturbed and cognitive processes such as learning and memory are 
impeded (Mayne and Burne, 2019). These mechanisms may function at such a micro 
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level that brain morphological measures are not modalities with adequate sensitivity 
to capture any arising differences. Interestingly, we observed an association between 
maternal vitamin D concentration in mid-gestation and child cerebellar volume. This 
association remained when accounting for selection bias in the sensitivity analysis. 
Recent longitudinal studies suggested that deficient maternal vitamin D status in preg-
nancy is associated with adverse motor and social development in children in early 
childhood (Darling et al., 2017; Dhamayanti et al., 2019), which may be explained by 
the reduction in cerebellar volume because smaller cerebellum has been associated with 
worse motor and cognitive performance (D’Ambrosio et al., 2017). Moreover, emerging 
evidence shows that cerebellum involves in the complex neural underpinnings of ASD 
(Becker and Stoodley, 2013), suggesting a potential mediating role of cerebellum in the 
association of gestational vitamin D status with child autistic traits (Vinkhuyzen et al., 
2018). Further studies exploring such a mediation pathway are warranted.
Second, it is feasible that more prolonged exposure to vitamin D in gestation may 
exert a cumulative effect on child brain development, which is not evident with more 
transient prenatal exposures. Exposure to persistent vitamin D deficiency from mid-
gestation to delivery has been associated with more severe autism-related traits in our 
previous study (Vinkhuyzen et al., 2018). Our analysis suggests that exposure to per-
sistently deficient or insufficient 25(OH)D concentration from mid-gestation onwards 
is also associated with smaller brain volumes, which may be accounted for by reduced 
regional surface area rather than cortical thickness. Difference in brain volumes were 
reported in children with and without ASD at age 10 years (Lange et al., 2015), but such 
unspecific neurological findings can also be indicative of a higher risk for other child 
problems such as early onset schizophrenia (Arango et al., 2012). In contrast to our 
finding from the mid-gestational assessment, these results suggest that the cerebrum 
and not the cerebellum is most sensitive to vitamin D, and that multiple assessments 
are needed to reliably identify vitamin deficiency. In addition, these findings were not 
found when we analyzed only European children. This could possibly be explained 
by a reduced ability to detect small differences in far fewer subjects (in particular the 
‘consistently deficient’ group), but also an effect modification by ethnicity. Possibly, 
more pigmented children in the Netherlands are affected more by persistently low 
gestational vitamin D status (partly this could simply reflect less misclassification). 
Besides, interestingly, children exposed to persistent vitamin D deficiency and those 
with more autistic traits both showed decreased gyrification in the frontal, superior 
temporal and inferior parietal cortices in the left hemisphere when the same covariates 
were adjusted for (Blanken et al., 2015), suggesting that gyrification in these regions 
may play a role in the relationship between gestational vitamin D deficiency and autis-
tic traits in childhood.
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Third, gestational vitamin D concentration at both assessments was significantly 
associated with brain volumes and cortical metrics when only child age at the neuro-
imaging assessment and sex were adjusted for, while no significances remained when 
adjusting for all covariates. It has been suggested that education and income are both 
important indicators of family socioeconomic status (SES) that relates to child develop-
ment (Ahmadi Doulabi et al., 2017). Moreover, SES has been suggested as a determinant 
of smoking, alcohol use and vitamin supplement use in pregnant women (Najman et 
al., 1998; Skagerstróm et al., 2011; Sullivan et al., 2009). Therefore, it is possible that less 
rigorous control for confounding explains some of the previous findings.
The strengths of our study were the longitudinal study design to examine the tempo-
ral association of gestational vitamin D exposure with brain morphology, the inclusion 
of large sample size enabling us to detect small effects, and the implementation of IPW 
in the sensitivity analyses to reduce selection bias. Several limitations, however, should 
also be mentioned. First, vitamin D concentration in blood fluctuates with diet and sun 
exposure, and the half-life of vitamin D is relatively short, thus the assessed values at 
a specific time point may not be substantially representative for the average level over 
the target period. Additionally, as previously reported (Wegienka et al., 2016), vitamin 
D concentration measured in child cord blood was significantly lower than that of the 
mother in mid-gestation and no specific cut-offs have been established. Second, we 
measured 25(OH)D concentration only in mid-gestation and at delivery. The period 
of early pregnancy, which can be critical in terms of brain development, could not be 
investigated. Also, the possible influence of child 25(OH)D level at age 10 years cannot 
be ruled out. Third, child brain morphology was only assessed once in preadolescence, 
thus whether any observed association is transient or lasting, and whether gestational 
vitamin D concentration is associated with brain morphology in other developmental 
phases cannot be determined.
To the best of our knowledge, this is the first longitudinal study to investigate the as-
sociation between gestational vitamin D status and brain morphological development 
in children. We found limited evidence for associations between gestational vitamin D 
level at single assessments and child brain morphology at age 10 years, but observed dif-
fered brain volumes and cortical morphometry in children exposed to persistently low 
vitamin D levels from mid-gestation to delivery. Further studies are needed to ascertain 
the possible alterations in cerebellar volume and the more generalized gray and white 
matter changes, and explore how these findings are related to child neurodevelopment.
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3363 underwent MRI scan 
3318 with structural MRI data 
excluded 45 without structural MRI 
data 
excluded 603 with unusable 
structural MRI data 
8010 with 25(OH)D concentration data  
excluded 966 without data on 
gestational 25(OH)D concentration 
2715 with usable structural MRI data 
1706 with 25(OH)D concentration 
data at delivery 
2427 with 25(OH)D concentration 
data in mid-gestation 
8976 participated in pregnancy 
excluded 1854 loss to follow-up or 
did not participate at 9-10 years 
 
6156 participated at 9-10 years phase 
excluded 2589 did not visit 
neuroimaging research center  
3567 visited neuroimaging research center 
excluded 204 did not undergo MRI 
scan 
randomly excluded 118 siblings 
2597 as study population 
Figure S1. Flow diagram of study population selectionFigure S1. Flow diagram of study population selection
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Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)
B 95% CI p-value B 95% CI p-value B 95% CI p-value
Model 1
Continuous 0.29 0.22, 0.35 <0.001 0.17 0.11, 0.22 <0.001 0.07 0.05, 0.08 <0.001
Categorical
  Sufficient 
(n=1316)
reference - - reference - - reference - -
  Insufficient 
(n=630)
-11.82 -16.78, -6.87 <0.001 -6.56 -10.82, -2.29 0.003 -3.15 -4.41, -1.88 <0.001
  Deficient (n=481) -22.15 -27.66, -16.65 <0.001 -14.48 -19.24, -9.71 <0.001 -5.06 -6.33, -3.79 <0.001
Model 2
Continuous 0.03 -0.05, 0.10 0.53 0.03 -0.04, 0.10 0.39 0.02 0.004, 0.04 0.02
Categorical
  Sufficient 
(n=1316)
reference - - reference - - reference - -
  Insufficient 
(n=630)
-1.86 -6.96, 3.23 0.47 -1.80 -6.41, 2.82 0.45 -1.40 -2.71, -0.08 0.04




Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)
B 95% CI p-value B 95% CI p-value B 95% CI p-value
Model 1
Continuous 0.43 0.31, 0.54 <0.001 0.26 0.16, 0.37 <0.001 0.11 0.08, 0.14 <0.001
Categorical
  Sufficient 
(n=376)
reference - - reference - - reference - -
  Insufficient 
(n=656)
-11.59 -17.90, -5.29 <0.001 -9.53 -15.23, -3.84 0.001 -2.26 -3.84, -0.68 0.005
  Deficient (n=674) -25.20 -31.50, -18.90 <0.001 -16.75 -22.46, -11.05 <0.001 -5.96 -7.54, -4.38 <0.001
Model 2
Continuous 0.02 -0.12, 0.16 0.77 0.04 -0.09, 0.17 0.57 0.03 -0.002, 0.07 0.07
Categorical
  Sufficient 
(n=376)
reference - - reference - - reference - -
  Insufficient 
(n=656)
-4.24 -10.55, 2.06 0.19 -5.21 -11.04, 0.62 0.08 -0.92 -2.54, 0.70 0.27
  Deficient (n=674) -4.55 -12.35, 3.25 0.25 -5.32 -12.63, 1.99 0.15 -1.89 -3.87, 0.10 0.06
Model 1 was adjusted for child age at time of the neuroimaging assessment and sex; Model 2 was additionally 
adjusted for maternal ethnicity, marital status, education, age at intake, household income, smoking and alcohol 
use in pregnancy, vitamin supplement use in pregnancy, and season of blood sampling. Deficient is 25(OH)D 
concentration < 25 nmol/L; insufficient is 25(OH)D concentration 25 to < 50 nmol/L; sufficient is 25(OH)D 
concentration ≥ 50 nmol/L.
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Table S2. 25(OH)D status from mid-gestation to delivery in relation to child brain volume at age 10 years 




Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)




reference - - reference - - reference - -
Consistently 
insufficient










reference - - reference - - reference - -
Consistently 
insufficient
-9.58 -19.03, -0.13 0.05 -10.82 -19.30, -2.34 0.01 -1.35 -3.81, 1.10 0.28
Consistently 
deficient
-20.47 -34.39, -6.54 0.004 -18.02 -31.17, -4.87 0.007 -2.78 -6.72, 1.15 0.17
Model 1 was adjusted for child age at time of the neuroimaging assessment and sex; Model 2 was additionally 
adjusted for maternal ethnicity, marital status, education, age at intake, household income, smoking and alcohol 
use in pregnancy, vitamin supplement use in pregnancy, season of blood sampling in mid-gestation and season 
of blood sampling at delivery; n =230 for ‘consistently deficient’ group; n=168 for ‘consistently insufficient’ 
group; and n=291 for ‘consistently sufficient’ group. Deficient is 25(OH)D concentration < 25 nmol/L; insuf-
ficient is 25(OH)D concentration 25 to < 50 nmol/L; sufficient is 25(OH)D concentration ≥ 50 nmol/L.
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Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)
B 95% CI p-value B 95% CI p-value B 95% CI p-value
Model 1
Continuous -0.01 -0.12, 0.10 0.91 -0.03 -0.13, 0.07 0.59 0.01 -0.02, 0.03 0.68
Categorical
  Sufficient (n=707) reference - - reference - - reference - -
  Insufficient 
(n=264)
1.02 -5.84, 7.89 0.77 -0.59 -6.66, 5.48 0.85 0.36 -1.25, 1.98 0.66
  Deficient (n=46) -4.75 -19.22, 9.71 0.52 -2.91 -15.70, 9.89 0.66 1.46 -1.95, 4.86 0.40
Model 2
Continuous -0.07 -0.19, 0.05 0.25 -0.05 -0.16, 0.06 0.34 0.01 -0.02, 0.04 0.36
Categorical
  Sufficient (n=707) reference - - reference - - reference - -
  Insufficient 
(n=264)
3.78 -3.47, 11.03 0.31 0.04 -6.42, 6.49 0.99 0.08 -1.64, 1.79 0.93




Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)
B 95% CI p-value B 95% CI p-value B 95% CI p-value
Model 1
Continuous 0.01 -0.16, 0.17 0.95 -0.02 -0.16, 0.12 0.74 0.03 -0.01, 0.07 0.14
Categorical
  Sufficient (n=294) reference - - reference - - reference - -
  Insufficient 
(n=424)
-4.13 -11.46, 3.20 0.27 -7.72 -14.00, -1.44 0.02 -1.70 -3.38, -0.03 0.05
  Deficient (n=191) -2.43 -11.42, 6.55 0.60 0.25 -7.45, 7.95 0.95 -1.65 -3.70, 0.40 0.11
Model 2
Continuous -0.13 -0.32, 0.05 0.16 -0.13 -0.30, 0.03 0.11 0.02 -0.02, 0.06 0.33
Categorical
  Sufficient (n=294) reference - - reference - - reference - -
  Insufficient 
(n=424)
-0.87 -8.64, 6.90 0.83 -5.21 -11.91, 1.50 0.13 -1.51 -3.29, 0.27 0.10
  Deficient (n=191) 4.17 -6.14, 14.47 0.43 5.14 -3.75, 14.03 0.26 -1.40 -3.76, 0.96 0.25
Model 1 was adjusted for child age at time of the neuroimaging assessment, sex, and principal components of 
ancestry; Model 2 was additionally adjusted for maternal marital status, education, age at intake, household 
income, smoking and alcohol use in pregnancy, vitamin supplement use in pregnancy, and season of blood 
sampling. Deficient is 25(OH)D concentration < 25 nmol/L; insufficient is 25(OH)D concentration 25 to < 50 
nmol/L; sufficient is 25(OH)D concentration ≥ 50 nmol/L.
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Table S4. 25(OH)D status from mid-gestation to delivery in relation to child brain volume at age 10 years, 






Cerebral Gray Matter (cm3) Cerebral White Matter (cm3) Cerebellar Volume (cm3)




reference - - reference - - reference - -
Consistently 
insufficient
-1.27 -12.41, 9.87 0.82 -7.15 -16.97, 2.66 0.15 -0.27 -2.97, 2.43 0.85
Consistently 
deficient




reference - - reference - - reference - -
Consistently 
insufficient
-1.78 -13.76, 10.20 0.77 -8.89 -19.47, 1.69 0.10 -0.63 -3.56, 2.30 0.67
Consistently 
deficient
-6.89 -33.56, 19.78 0.61 11.03 -12.57, 34.63 0.36 -2.83 -9.45, 3.79 0.40
Model 1 was adjusted for child age at time of the neuroimaging assessment, sex, and principal components 
of ancestry; Model 2 was additionally adjusted for maternal marital status, education, age at intake, house-
hold income, smoking and alcohol use in pregnancy, vitamin supplement use in pregnancy, season of blood 
sampling in mid-gestation and season of blood sampling at delivery; n =15 for ‘consistently deficient’ group; 
n=98 for ‘consistently insufficient’ group; and n=220 for ‘consistently sufficient’ group. Deficient is 25(OH)D 
concentration < 25 nmol/L; insufficient is 25(OH)D concentration 25 to < 50 nmol/L; sufficient is 25(OH)D 
concentration ≥ 50 nmol/L.
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ABSTRACT
Background: Cumulative evidence shows that low maternal folate levels during preg-
nancy are associated with offspring neuropsychiatric disorders even in the absence of 
neural tube defects. However, the relationship between prenatal exposure to folate and 
brain development in late childhood has been rarely investigated.
Methods: In 2095 children from a prospective population-based cohort in Rotterdam, 
the Netherlands, we examined the association of maternal folate levels during pregnancy 
with downstream brain development in offspring. Maternal folate concentrations were 
measured from venous blood in early gestation. Child structural neuroimaging data 
were measured at age 9-11 years. In addition, measures of child head circumference 
using fetal ultrasound in the third trimester and total brain volume using magnetic 
resonance imaging at age 6-8 years were used for analyses with repeated assessments 
of brain development.
Results: Maternal folate deficiency (i.e., <7 nmol/L) during pregnancy was associated 
with smaller total brain volume (B=-18.7 cm3, 95% CI -37.2 to -0.2) and smaller cere-
bral white matter (B=-7.2 cm3, 95% CI -11.8 to -2.6) in children aged 9-11 years. No 
differences in cortical thickness or surface area were observed. Analysis of the repeated 
brain assessments showed that children exposed to deficient folate concentrations in 
utero had persistently smaller brains compared to controls from the third trimester to 
childhood (β=-0.4, 95% CI -0.6 to -0.1).
Conclusions: Low maternal folate levels during pregnancy are associated with altered 
offspring brain development in childhood, suggesting the importance of essential folate 
concentrations in early pregnancy.
3.2. Maternal folate and child brain
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INTRODUCTION
Folate is an essential water-soluble vitamin that can only be obtained from the diet. In 
adults, low folate levels have been related to an increased risk of cardiovascular disease 
mortality, cognitive dysfunction and many cancers [1-3]. Moreover, offspring of moth-
ers with low folate status during pregnancy has increased risks of neural tube defects 
(NTDs) and congenital heart defects [4]. Exposure to low folate levels in gestation has 
also been associated with other adverse outcomes such as low birthweight, childhood 
brain and spinal cord tumors, and metabolic consequences in children [5-7].
Recent research has also shown associations between maternal folate status during 
pregnancy and various long-term neuropsychiatric outcomes in offspring. For example, 
higher maternal folate concentrations and greater folate intake in early pregnancy were 
predictive of better cognitive and psychomotor development and less emotional prob-
lems in early childhood [8-10]. In addition, exposure to low folate status in gestation 
was associated with an increased risk of schizophrenia and more hyperactivity and peer 
problems in childhood [11, 12], and several studies suggested that higher maternal 
plasma folate levels and folic acid supplementation during pregnancy, notably when 
supplementation was initiated during the periconceptional period, were related to less 
autistic traits and lower risk of autism spectrum disorder (ASD) in the offspring [13].
Emerging evidence has suggested relationships between maternal folate status dur-
ing pregnancy and offspring brain development, which likely underlie the observed 
cognitive and behavioral outcomes. Previous work in our research group showed that, 
even in the absence of NTDs, lower maternal plasma folate concentrations in early 
pregnancy were associated with a smaller offspring head circumference (HC), an in-
dicator of global brain volume for fetus or neonates, at 30 weeks of gestation [14-16]. 
Embedded in the same cohort, we also found Dutch children exposed to low folate 
levels in utero had less total brain volume (TBV) at age 6 to 8 years [17]. A recent study 
based on three observational cohorts in the United States observed thicker cortices 
in children and adolescents with greater folic acid in gestation, which was associated 
with a lower risk of psychosis spectrum symptoms [18]. Given the complex growth 
trajectories of the human cerebral cortex and the inherent plasticity of the develop-
ing brain [19-21], studies describing the brain developmental trajectories related to 
prenatal folate exposure are needed.
Building on our previous work, our aim was to first investigate prospective asso-
ciations between maternal folate levels during pregnancy and child structural brain 
morphology at age 9-11 years. Second, we used repeated brain measures to examine 
prenatal exposure to folate in relation to the long-term trajectories of brain develop-
ment from fetal life to childhood. We expected that children exposed to low folate 




This study was embedded in the Generation R Study, a prospective cohort study in 
which pregnant women with an expected delivery date between April 2002 and January 
2006 were recruited [22]. The study was approved by the Medical Ethical Committee 
of the Erasmus Medical Center, and written informed consent was obtained prior to 
participation.
Participants
In total 8976 children were born to 8879 mothers participating during pregnancy. Of 
the 97 twin births, one child from each twin pair was randomly excluded. Further, 2848 
children were excluded due to the lack of information on maternal plasma folate con-
centration during pregnancy. Of the remaining 6031 children, 3766 visited our research 
center at age 9-11 years, and 2595 underwent a brain magnetic resonance imaging 
(MRI) with parental consent. After excluding those without a complete T1-weighted 
MRI (n=15), assessed using heterogeneous scanning parameters (n=18), with major 
incidental findings (n=15) [23], with braces (n=56), and with data of insufficient qual-
ity (n=396), 2095 children were determined as the study population (see Supplemental 
Figure S1 for the flow chart).
Maternal folate concentration
Venous blood samples were collected from the mothers in early pregnancy (mean=13.3 
weeks, SD=1.9 weeks), after which they were transported to a regional laboratory 
within 3 hours and centrifuged and stored at -80 °C [24]. Folate concentrations were 
analyzed using an immune electrochemiluminence assay on the Architect System 
(Abbott Diagnostics B.V.). The between-run coefficients of variation ranged between 
1.5 and 8.9%. The analytic range for plasma folate concentration was 1.8-45.3 nmol/L 
(0.8-20.0 ng/mL). A plasma folate concentration of less than 7 nmol/L (3.1 ng/mL) was 
considered ‘folate-deficient’ in our primary analysis [10, 14].
Neuroimaging
Prior to the MRI scanning, children underwent a mock scanning session to become 
familiar with the neuroimaging assessment. MR images were acquired on a 3-Tesla GE 
Discovery MR750w MRI System (General Electric, Milwaukee, WI, USA) scanner using 
an 8-channel head coil. T1-weighted sequences were obtained using a 3D coronal inver-
sion recovery fast spoiled gradient recalled sequence with the following parameters: 
repetition time=8.77 ms, echo time=3.4 ms, inversion time=600 ms, flip angle=10°, 
field of view=220 mm×220 mm, acquisition matrix=220×220, slice thickness=1mm, 
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number of slices=230, and arc acceleration=2. Volumetric segmentation and cortical 
reconstruction were performed with FreeSurfer v.6.0.0 (http://surfer.nmr.mgh.harvard.
edu/). The quality of the FreeSurfer output for each individual was visually inspected 
and rated on a three-point Likert-scale (insufficient/sufficient/excellent), after which 
data with insufficient quality were eliminated. In addition, utilizing an automated 
quality assessment (Q/A) program that provides a valid continuous measure of the 
quality of structural MRI images [25], we found that the automated Q/A metric was not 
correlated with maternal folate concentration (r=-0.02, p=0.31), suggesting that results 
were not due to poor quality data.
Covariates
Based on prior literature and directed acyclic graphs [8, 14, 17, 26], we selected the 
following potential confounding variables: child sex and age at neuroimaging, maternal 
age at enrollment, ethnicity, marital status, educational level, pre-pregnancy body mass 
index (BMI), parity, smoking and alcohol use during pregnancy, and family income. 
Information on child sex and date of birth (to calculate age at neuroimaging) was 
obtained from medical records. Maternal information on age at enrollment, ethnicity, 
marital status, educational level, parity, smoking and alcohol use during pregnancy, 
and family income was collected with questionnaires during pregnancy. Maternal pre-
pregnancy BMI was calculated by self-reported pre-pregnancy height and weight.
Additional measures
For the analysis with repeated assessments we used data on child HC measured by 
ultrasound in the third trimester (mean=30.4 weeks, SD=0.9 week) to estimate fetal 
brain volume using a validated formula: TBV=(1/2)×(π/6)×(HC/π)3 [27]. We also used 
TBV measured by MRI at child age 6-8 years (mean=7.7 years, SD=0.9 year) [28]. Child 
age at these assessments and gestational age at birth were obtained [29].
For supplementary analyses, self-report information on periconceptional maternal 
folic acid or vitamin supplement use was collected in 1720 mothers and assessed in 
relation to child brain morphology. In addition, information on mother-report Child 
Behavior Checklist (CBCL) at child age 10 years (mean=9.7, SD=0.3) was available in 
1803 children of the present study sample [30]. We used scores of the internalizing and 
externalizing subscales to examine maternal folate levels in relation to child emotional 
and behavioral problems that might be concomitant with brain morphological differ-
ences.
Statistical analyses
For descriptive statistics, continuous variables were analyzed using t-tests or Wilcoxon 
tests; categorical variables were analyzed using Chi-square tests. In a non-response 
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analysis, we compared maternal and child characteristics between participating 
children (‘respondents’) and those with information on maternal folate concentration 
during pregnancy but were not included in the study population (‘non-respondents’).
We used multiple linear regression with folate status as a dichotomized independent 
variable to investigate whether children exposed to deficient maternal folate concentra-
tions during pregnancy showed differences in global or regional brain volumes (i.e., 
TBV, cortical gray matter volume, cerebral white matter volume, and subcortical gray 
matter volume) compared to those with normal concentrations (the reference group). 
We also tested possible linear relationships by introducing maternal folate concentra-
tion as a continuous trait. Twelve children with a maternal folate concentration of 45.3 
nmol/L (i.e., the upper detection limit) were excluded from this analysis to rule out 
possible invalid values, and a quadratic term was introduced to test for non-linear 
relationships. For exploratory surface-based brain analyses we used linear regression 
run in a custom-in-house package (‘QdecR’, http://github.com/slamballais/QDECR) at 
each cortical vertex to examine the cortical metrics including cortical thickness and 
surface area [31].
In a follow-up analysis, we re-ran the analysis excluding children with preterm birth 
(i.e., gestation age at birth < 37 weeks), small for gestational age (SGA, defined as a SD 
score ≤ −2.3 and based on SD curves derived from the total Generation R cohort) [32], 
and/or born to mothers with gestational complications (i.e., preeclampsia, diabetes, 
and/or pregnancy-induced hypertension) to examine whether gestational and obstetri-
cal complications explained any observed association.
Second, we used linear mixed models to investigate the association of maternal 
folate levels with repeatedly assessed TBV in a sub-sample of 354 children with brain 
measurements at all three time points (i.e., the third trimester in gestation, 6-8 years, 
and 9-11 years). Prior to analyses, TBV was standardized using Z-transforms to gain 
comparability across measurements. Both intercept and slope were included as random 
effects in the model, and the restricted maximum likelihood (REML) estimation was 
used. Interactions of maternal folate levels with child age at assessments and sex were 
examined.
All regression analyses described above were performed using multi-stage models. 
The initial model (Model 1) was only adjusted for child sex and age at neuroimaging. 
Using a change-in-estimate criterion (i.e., candidate covariates were only included if 
their inclusion changed the effect estimate of maternal folate status more than 5%) 
[33], maternal age at enrollment, ethnicity, marital status, educational level, alcohol 
use during pregnancy, and family income were additionally adjusted for in Model 
2. Correction for child intracranial volume was performed for models with regional 
brain volumes (Model 3) to investigate whether any observed regional differences were 
independent of global effects.
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Since the established folate status cutoff (i.e., 7 nmol/L) is primarily based on hema-
tologic indicators or risk of NTDs [34], we ran a secondary analysis using less rigorous 
folate concentration cutoffs (i.e., 8, 9, 10, 11, and 12 nmol/L) to empirically explore a 
maternal folate level that might be specifically relevant for child brain development in 
the long term. The level of 8 nmol/L (3.5 ng/mL) was an earlier cutoff of the Erasmus 
MC laboratory prior to the publication of an international standard.
In supplementary analyses, we examined the relation between maternal folic acid 
supplementation in the periconceptional period and child brain volumes. We also 
investigated the association of maternal folate levels during pregnancy with child 
emotional and behavioral outcomes at age 10 years using linear regression. The CBCL 
internalizing and externalizing scores were square root transformed prior to analysis 
due to skewed distribution of the raw values.
In addition, we performed a sensitivity analysis using targeted maximum likelihood 
estimation (TMLE) because it outperforms naïve regressions and propensity-score 
methods in minimizing the impact of model misspecification and near-violation of 
the practical positivity assumption (i.e., when children with certain combinations of 
confounders were rarely exposed to maternal folate deficiency during pregnancy) [35, 
36].
On average, 5.2% of the covariates were missing, which was accounted for using 
multiple imputation (missing at random indicated by Little’s test) [37]. A total of 20 
imputed datasets were generated and we report the pooled results (for the sensitivity 
analysis we report the results from the first imputed dataset). Statistical significance 
was set as α<0.05 (two-sided) and false discovery rate (FDR) was used to correct for 
multiple testing for each of the three regional brain volumes [38]. For the surface-
based analyses, correction for multiple testing was performed using built-in Gaussian 
Monte Carlo Simulations [39]. Cluster-wise p-values were Bonferroni corrected for the 
two hemispheres (p<0.025), and a cluster forming threshold (CFT) of p=0.001 was 
selected for significance testing because it has shown high correspondence with actual 
permutation testing at the smoothing kernels used [31, 40]. All statistical analyses were 




Table 1 shows descriptive statistics on maternal and child characteristics between 
folate-deficient and folate-normal groups. Children underwent neuroimaging at ap-
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proximately 10 years-of-age. Folate-deficient mothers were younger, lower educated, 
had less family income, and were more often single parents than folate-normal mothers.
As shown in the non-response analysis (Supplemental Table S1), there were no 
significant differences in child sex or age at neuroimaging between respondents and 
non-respondents. However, participating mothers were older, more often Dutch, 
higher educated, less often single parents, had higher family income, and were less 







Age at enrollment, years 27.8 (5.9) 30.9 (4.5) <0.001
Ethnicity
 Dutch 33 (32.0) 1216 (61.0)
<0.001 Non-Dutch Western 8 (7.8) 246 (12.3)
 Non-Dutch non-Western 62 (60.2) 530 (26.6)
Marital status (with partner) 74 (71.8) 1793 (90.0) <0.001
Highest education completed
 Primary or secondary 85 (82.5) 896 (45.0)
<0.001
 Higher 18 (17.5) 1096 (55.0)
Pre-pregnancy BMI 24.1 (4.8) 23.4 (4.0) 0.18
Parity (≥1) 48 (46.6) 756 (38.0) 0.10
Smoking during pregnancy
 Never 74 (71.8) 1519 (76.3)
0.37
 Yes 29 (28.2) 473 (23.7)
Alcohol use during pregnancy
 Never drank in pregnancy 50 (48.5) 721 (36.2)
<0.001 Drank until pregnancy was known 23 (22.3) 299 (15.0)
 Continued drinking throughout pregnancy 30 (29.1) 972 (48.8)
Family income, €/months
 ≤ 2000 73 (70.9) 584 (29.3)
<0.001
 > 2000 30 (29.1) 1408 (70.7)
Breastfeeding duration, months 3.5 (3.7) 4.5 (3.7) 0.005
Plasma folate concentration, nmol/L 5.9 (0.8) 20.1 (8.7) <0.001
Child characteristics
Age at neuroimaging, years 10.1 (0.5) 10.1 (0.6) 0.39
Sex (male) 51 (49.5) 983 (49.3) 0.97
Gestational age at birth, weeks 39.5 (2.4) 40.0 (1.7) 0.05
Imputed statistics were displayed. Continuous data were presented in mean (SD) and compared using t-test or 
Wilcoxon test; categorical data were presented in number (%) and compared using Chi-square test.
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often smokers but more often alcohol consumers during pregnancy. In particular, 
respondents had higher folate concentrations than non-respondents (19.4 nmol/L vs. 
16.6 nmol/L, p<0.001).
Mothers who used folic acid or vitamin supplement in the periconceptional period 
were less likely folate deficient during pregnancy than those who did not (1.0% vs. 
25.2%, p<0.001).
Maternal folate status and child brain volumes
Table 2 shows the relationships between maternal folate status and child brain volumes. 
In the fully adjusted model 2, children exposed to deficient maternal folate concentra-
tions during pregnancy showed a smaller TBV (B=-18.7, 95% CI -37.2 to -0.2, in cm3) 
compared to the reference group. Children exposed to low folate during pregnancy also 
showed smaller cerebral white and subcortical gray matter volumes, where cerebral 
white matter volume remained significant after additional correction for intracranial 
volume (Model 3). In addition, analyzing maternal folate concentration along a con-
tinuum was positively associated with TBV (B=0.5, 95% CI 0.04 to 1.0) and cerebral 
white matter volume (B=0.2, 95% CI 0.02 to 0.5) of the child after full adjustment for 
covariates. Differences in cerebral white matter volume disappeared when child intra-
cranial volume was additionally corrected for, suggesting a global effect (Supplemental 
Table S2). We found no evidence for a quadratic relationship between maternal folate 
concentration and either TBV or cerebral white matter volume.
Table 2. Maternal folate status during pregnancy and child brain volumes at age 10 years
Folate status Model
Total brain volume Cortical gray matter Cerebral white matter
Subcortical gray 
matter
B 95% CI p-value B 95% CI p-value B 95% CI p-value B 95% CI p-value
Normal - ref - - ref - - ref - - ref - -
Deficient
1 -46.8 -65.4, -28.1 <0.001 -18.6 -27.9, -9.2 <0.001 -21.9 -30.4, -13.5 <0.001 -1.9 -2.7, -1.1 <0.001
2 -18.7 -37.2, -0.2 0.05 -3.8 -13.0, 5.4 0.41 -12.7 -21.2, -4.2 0.003a -0.9 -1.7, -0.1 0.03a
3 - - - 2.0 -3.2, 7.2 0.44 -7.2 -11.8, -2.6 0.002a -0.5 -1.0, 0.1 0.10
B’s represent the volumetric difference (in cm3) of children exposed to deficient maternal folate concentrations 
(<7 nmol/L, n=103) compared to those with normal maternal folate concentrations (≥7 nmol/L, n=1992).
Model 1 was adjusted for child sex and age at neuroimaging.
Model 2 was additionally adjusted for maternal age at enrollment, ethnicity, marital status, educational level, 
alcohol use during pregnancy, and family income.
Model 3 was additionally adjusted for child intracranial volume.
a <0.05 after a false discovery rate (FDR) correction (for p-values of regional measures in Model 2 and Model 
3 separately).
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After excluding children with preterm birth, SGA, or exposed to maternal compli-
cations (n=239), maternal folate deficiency (i.e., <7 nmol/L) was still associated with 
a smaller white matter volume (B=-7.2, 95% CI -12.0 to -2.3) that was independent 
of TBV. In addition, the positive relation between maternal folate concentration as a 
continuum and child TBV remained (B=0.5, 95 CI% 0.04 to 1.0).
When using 8, 9, 10, 11, or 12 nmol/L as the cutoff, children exposed to folate 
deficiency in utero still showed less TBV, smaller cerebral white matter, and smaller 
subcortical gray matter than the reference group. However, the volumetric differences 
in both cerebral white matter and subcortical gray matter disappeared after additional 
correction for intracranial volume (see Figure 1).
Maternal folate status and child cortical metrics
Of the 2095 children, 2084 had available data for surface-based analyses, of which 102 
were exposed to folate deficiency during pregnancy. After adjusting for child sex and 
age at neuroimaging, children exposed to deficient folate concentrations in gestation 
displayed thicker cortices in the frontal lobe in the left hemisphere, and smaller surface 
area in the frontal and temporal lobes bilaterally. After full adjustment for covariates, 
however, no differences in cortical thickness or surface area remained.
Maternal folate status and child TBV trajectories
Figure 2 shows cross-sectional differences in TBV between the folate-deficient group 
and the folate-normal group at each of the three time points, suggesting that children 
exposed to deficient maternal folate concentrations in pregnancy had consistently less 
TBV over time. Results from the linear mixed model showed that children exposed to 
deficient folate concentrations during pregnancy had persistently smaller brain than 
the reference group from the third trimester to childhood (see Table 3). We observed 
no relationships between maternal folate concentration as a continuum and child TBV 
trajectories. We found no evidence for interactions between maternal folate levels and 
child age or sex.
In addition, no differences in child TBV trajectories were found when <8, 9, 10, 11, 
or 12 nmol/L was used to define folate deficiency.
Maternal supplement use and child brain volumes
Maternal folic acid supplementation in the periconceptional period predicted higher 
TBV (B=36.1, 95% CI 48.3 to 24.0), cortical gray matter volume (B=17.4, 95% CI 23.5 
to 11.3), cerebral white matter (B=11.8, 95% CI 17.3 to 6.2), and subcortical gray matter 
volume (B=1.6, 95% CI 2.1 to 1.0) in children after adjusting for child sex and age at 
neuroimaging. However, no differences were present when correcting for all covariates.








             
          Figure 1. Maternal folate deficiency and child brain volumes at age 10 years, a comparison of using different 
cutoffs. Estimated brain volumetric differences (with 95% CI) of children exposed to maternal folate deficiency 
(determined using cutoff values of 7 to 12) during pregnancy compared to the reference group. The sample 
sizes for the deficient group and reference group were n=1992 vs. n=103 using cutoff value of 7; n=1913 vs. 
n=182 using cutoff value of 8; n=1817 vs. n=278 using cutoff value of 9; n=1525 vs. n=370 using cutoff value 
of 10; n=1644 vs. n=451 using cutoff value of 11; and n=1547 vs. n=548 using cutoff value of 12, respectively. 
Model 1 was adjusted for child sex, age at neuroimaging, maternal age at enrollment, ethnicity, marital status, 
educational level, alcohol use during pregnancy, and family income. Model 2 was additionally adjusted for child 
intracranial volume, and was only used for the volumes of regional brain structures (i.e., cortical gray matter, 
cerebral white matter, and subcortical gray matter) to investigate whether any observed regional differences 
were independent of global effects.
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Maternal folate status and child emotional and behavioral outcomes
Supplemental Table S3 shows the results of maternal folate levels during pregnancy in 
relation to child emotional and behavioral problems at age 10 years. When only child 
sex and age at the CBCL assessment were adjusted for, children born to folate-deficient 
Figure 2. Maternal folate status and child brain developmental trajectories. The sample size for the deficient 
group (i.e., <7 nmol/L) and normal group was n=29 and n=325, respectively. Brain assessment was performed 
in the third trimester (mean=30.4 weeks of gestation), middle childhood (mean=7.7 years), and late childhood 
(mean=10.1 years). Standardized total brain volume was adjusted for child sex and age at assessment, maternal 
age at enrollment, ethnicity, marital status, educational level, alcohol use during pregnancy, and family income.
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117
mothers were 0.3 (95% CI 0.1 to 0.6) points higher in the square root transformed 
CBCL internalizing score at age 10 years compared to those born to folate-normal 
mothers. These findings did not remain after adjustment for all covariates. Maternal 
folate deficiency during pregnancy was not related to child behavioral problems in 
either model. Further, there was no evidence suggesting any association of maternal 
folate level as a continuum with child emotional or behavioral problems.
Sensitivity analysis
Analyses using TMLE showed consistent results with the main analyses: compared to 
the reference group, folate-deficient children had lower TBV (B=-23.7, 95% CI -42.3 to 
-5.1) and cerebral white matter volume (B=-15.1, 95% CI -22.8 to -7.5) at 10 years-of-
age, including longitudinal brain volumetric differences (β=-0.5, 95% CI -0.7 to -0.3) 
from the third trimester to late childhood.
DISCUSSION
We found evidence of reduced brain volumes in children exposed to low folate levels 
in gestation using a prospective population-based study. The analysis of the repeatedly 
measured TBV strengthened this finding and revealed that the lower volumes likely 
originated from fetal life and persisted across childhood. Thus, in spite of the inherent 
plasticity of the developing brain, global decreases in brain volume may persist even 
nine-to-eleven years after exposure to deficient folate status during pregnancy, suggest-
ing long-term subtle consequences of exposure to low folate levels in utero [21].
Despite a few studies on folate and brain morphology in geriatric populations [41, 
42], investigations on maternal folate status during pregnancy and offspring brain 
Table 3. Maternal folate status during pregnancy and child brain development from the third trimester to child-
hood
Maternal folate status N Model
Standardized total brain volume (Z-score)
β 95% CI p
Normal 325 - ref - -
Deficient 29
1 -0.5 -0.8, -0.2 0.001
2 -0.4 -0.6, -0.1 0.02
β’s represent the difference in Z-scores of children exposed to deficient maternal folate concentrations (<7 
nmol/L, 87 observations corresponding to 29 subjects) compared to those with normal maternal folate concen-
trations (≥7 nmol/L, 975 observations corresponding to 325 subjects). One score stands for one SD.
Model 1 was adjusted for child sex and age at neuroimaging.
Model 2 was additionally adjusted for maternal age at enrollment, ethnicity, marital status, educational level, 
alcohol use during pregnancy, and family income.
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development are limited. Embedded in the present cohort, low maternal folate concen-
trations in gestation were associated with a smaller fetal HC in the third trimester [14]. 
This is supported by Scholtz et al. [12], who reported a positive association between 
maternal folate in early pregnancy and offspring HC at birth. Findings from the current 
study extend our previous work showing less TBV in school-age children exposed to 
low folate levels in gestation [17]. Interestingly, we also observed smaller white mat-
ter volume that was independent of TBV reduction in offspring exposed to deficient 
maternal folate concentrations (i.e., <7 nmol/L), which has not been reported before. 
Another recent study reported an association between prenatal exposure to folic acid 
fortification and thicker cortices in the frontal and temporal regions in American youth 
[18]. We did not find similar differences in cortical thickness; however, variations in 
age range, race and ethnicity, and neuroimaging techniques, or our more stringent 
cluster-wise p-value threshold may explain this discrepancy.
Our study showed that the relation between prenatal folate levels and brain volume in 
childhood was not likely explained by gestational or obstetrical complications, imply-
ing that exposure to low folate in utero may have specific impact on brain development. 
Several mechanisms are possible. In animal studies, folate deficiency during pregnancy 
results in brain tissue loss in offspring via the selective upregulation of folate receptors 
and heterogeneous nuclear ribonucleoprotein-E1, which are in turn associated with 
increased cell loss and premature differentiation of fetal tissues [43]. An experimental 
study with rats suggests that maternal folate deficiency increases neuronal apoptosis in 
the cortex of offspring [44]. Also, it is known that prenatal folate deficiency increases 
the risk of NTDs in offspring, and defects in the skull are commonly observed in NTDs 
[45, 46]. Thus, even in the absence of NTDs, prenatal folate deficiency could exert a 
subtle adverse impact on the normal skull development of fetus, potentially by dis-
rupting the proliferation of neuro crest stem cells that generate a diverse array of cell 
types (including bone cells) during development [47, 48]. This could lead to a reduced 
intracranial volume that restricts the physical space for brain growth. Moreover, as an 
important coenzyme, folate involves in various biological processes such as DNA and 
purine synthesis and placental amino acid transportation that are critical for normal 
fetal growth [49, 50]. The disturbance of these processes due to low folate levels likely 
has nonspecific influences on multiple brain structures, resulting in global alterations 
in brain development.
DNA methylation may be another mechanism underlying the association between 
prenatal folate exposure and brain development. Maternal folate depletion has been 
associated with DNA methylation changes that can lead to increased oxidative DNA 
damage in the brains of adult mice [51]. Other animal studies also show that maternal 
folic acid supplementation increases DNA methylation and DNA methyltransferase 
expression and activity in the brain of offspring [51, 52]. An epigenome-wide meta-
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analysis found that maternal plasma folate during gestation was associated with DNA 
methylation levels of genes implicated in neurodevelopment, such as ACP2 and GRM8 
[53]. APC2 is essential for axonal projections and may underlie the observed differ-
ences in white matter volume [54]. GRM8 encodes a glutamate receptor interacting 
with neurotransmitters in the central nervous system and thus is involved in synaptic 
signaling [55]. A recent randomized trial also suggests that continued folic acid supple-
mentation (400 µg/d) throughout the second and third trimesters of pregnancy results 
in significantly lower DNA methylation levels at several brain development related 
genes in newborns, including LINE-1, IFG2, and BDNF [56].
Interestingly, the difference between the TBV trajectory curves of the two groups 
appears to become less over time, especially from birth to middle childhood (Figure 2), 
although not statistically significant. In humans, brain plasticity allows for considerable 
adaptation and enhances the efficiency of the developing brain in response to experi-
ences, which is crucial for optimal neurodevelopment [57, 58]. In the Dutch Hunger 
Winter study, reduced TBV in the elderly was not observed in all subjects exposed to 
prenatal famine [59], implying that prenatal adverse effects on brain development may, 
over a lifetime, be compensated by postnatal factors or ageing. The normalization of 
neurodevelopment may occur in certain, yet unknown phases after birth. However, we 
found no evidence of an interaction with time (child age) in the analysis of repeated 
measured TBV to support this hypothesis. Follow-up study waves including large 
brain neuroimaging datasets from adolescence into adulthood are needed for future 
investigations into the long-term effects of maternal folate status on offspring brain 
developmental trajectories. It is also worth noting that, Figure 1 suggests a dose effect 
of maternal folate concentrations during pregnancy on TBV as well as the volumes of 
cerebral white matter and subcortical gray matter of the child, which plateaus after 
10 nmol/L. Although most regional volumetric differences disappeared after correc-
tion for intracranial volume, we cautiously speculate that a maternal plasma folate 
concentration of 10 nmol/L or above, which is higher than that for preventing NTDs, 
predicts optimal brain development of the offspring. Further investigations are needed 
to confirm this threshold.
We found no associations between maternal folic acid supplementation in the peri-
conceptional period and child brain volumes when adjusting for all covariates (i.e., 
child sex and age at neuroimaging, maternal age at enrollment, ethnicity, marital status, 
educational level, alcohol use during pregnancy, and family income). It could be that 
compared to plasma folate levels, self-reported supplement use was more subjected to 
information bias, and more highly correlated with socioeconomic indicators that were 
simultaneously adjusted for in the model, including educational level and income. In 
addition, maternal folate intake from non-supplement sources is important for child 
brain development, and these were not systematically collected in our study.
120
Embedded in the same cohort, Steenweg de Graaff et al. [8] reported more emotional 
problems in toddlers exposed to prenatal folate deficiency. However, the current study 
showed no relation between maternal folate levels and child emotional or behavioral 
problems at age 10 years after full adjustment for covariates. These findings are in line 
with our previous findings at 6-8 years [17], suggesting an absence of relation between 
maternal folate levels during pregnancy and offspring emotional or behavioral prob-
lems across mid- and late childhood. However, since these emotional and behavioral 
outcomes were collected at the same age (i.e., 10 years) as the MRI measures, the lack 
of an association may not necessarily exclude the possibility that clinically relevant 
emotional or behavioral problems could emerge later in development. Major psy-
chiatric illnesses, such as mood and psychotic disorders tend to emerge during late 
adolescence and early adulthood and are thought to be associated with developmental 
brain trajectories in late childhood and adolescence [60, 61]. Thus, the brain differences 
we show may be associated with an elevated risk of general psychopathology at later 
stages of development. In addition, the regional volumetric reduction in white matter 
we observed in children born to folate-deficient women is very interesting. White mat-
ter tracts are known to mediate the essential connectivity and enable human cognitive 
capacities [62], and previous studies have shown that larger white matter volume is 
associated with favorable cognitive outcomes such as higher intelligence quotient (IQ) 
and information proceeding speed in children and adolescents [63, 64]. Since prenatal 
exposure to folate deficiency has been associated with poorer cognitive performance in 
childhood [17], further studies examining the role of white matter in this relation are 
warranted.
This study has several strengths. Our longitudinal design allows for the detection 
of temporal relationships between prenatal folate exposure and brain development 
assessed 10 years later. Further, the analysis of repeated brain measures provides 
valuable insights into gestational folate status in relation to brain morphology from 
a developmental perspective. Moreover, in the sensitivity analysis we supported our 
primary findings by applying TMLE to minimize bias due to unbalanced exposure dis-
tribution. Some limitations of this study should also be acknowledged. First, maternal 
folate concentrations were only measured in early pregnancy, so we cannot determine 
whether exposure to folate in the other phases in gestation is associated with brain 
development in children. Second, we used ultrasound to estimate fetal TBV. While 
such measures are less accurate than measured by MRI, direct comparisons show 
correlations above 0.9 [15, 27]. In addition, scanner differences between the two MRI 
assessments might not be entirely eliminated by standardization. Third, due to being 
an observational design, residual confounding variables such as genetic predisposition 
or effects caused by other nutrients cannot be ruled out, thus no causal conclusion can 
be drawn. Finally, the non-response analysis showed that respondents were exposed 
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to higher folate levels in gestation, and were from families with higher socioeconomic 
status than non-respondents, indicating possible attrition.
To conclude, in line with the evidence on the neuroprotective effects of prenatal folic 
acid supplementation [65], low maternal folate levels during pregnancy are prospec-
tively associated with reduced offspring brain volumes that persist into late childhood. 
The global volumetric differences originate from fetal life and persist throughout child-
hood. Therefore, the importance of adequate folate levels (e.g., via periconceptional 
folic acid supplementation) in pregnancy on child brain development is a vital public 
health message, which could be particularly true in low and middle-income countries 
where the prevalence of folate deficiency among women of reproductive age is still not 
optimal, or in higher-income countries, including much of Europe, where folic acid 
fortification is not mandatory [66-68]. Further investigations are needed to track the 
observed brain differences throughout the lifespan and explore their potential neuro-
psychiatric consequences.
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3766 visited research center at 9-11 years 
1171 no neuroimaging assessment 
8976 participated in pregnancy 
97 that was (one of) a twin 
8879 children 
2848 without data on maternal folate 
concentration in gestation  
6031 with gestational folate concentration data  
2265 declined to participate or loss to follow-
up or no show at 9-11 years 
15 without T1-weighted MRI, 18 with 
heterogeneous scanning parameters, 15 with 
major incidental findings, 56 with braces, 
and 396 with data of insufficient quality 
 
2095 as study population 
2595 underwent neuroimaging assessment 
Figure S1. Flow chart 
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Maternal age at enrollment, years 30.8 (4.7) 29.3 (5.2) <0.001
Maternal ethnicity
 Dutch 1249 (59.6) 1827 (49.1)
<0.001 Non-Dutch Western 254 (12.1) 446 (12.0)
 Non-Dutch non-Western 592 (28.3) 1450 (38.9)
Maternal marital status (with partner) 1867 (89.1) 3063 (85.3) <0.001
Maternal highest education completed
 Primary or secondary 981 (46.8) 2173 (60.4)
<0.001
 Higher 1114 (53.2) 1422 (39.6)
Maternal pre-pregnancy BMI 23.4 (4.1) 23.6 (4.3) 0.24
Parity (≥1) 804 (38.4) 1760 (45.2) <0.001
Maternal smoking during pregnancy
 Never 1593 (76.0) 2419 (69.6)
<0.001
 Yes 502 (24.0) 1059 (30.4)
Maternal alcohol use during pregnancy
 Never drank in pregnancy 771 (36.8) 1708 (48.2)
<0.001 Drank until pregnancy was known 322 (15.4) 498 (14.1)
 Continued drinking in pregnancy 1002 (47.8) 1336 (37.7)
Family income, €/months
 ≤ 2000 657 (31.4) 1227 (41.7)
<0.001
 > 2000 1438 (68.6) 1715 (58.3)
Breastfeeding duration, months 4.5 (3.7) 4.6 (3.8) 0.36
Maternal plasma folate concentration, nmol/L 19.4 (9.1) 16.6 (8.9) <0.001
Child age at neuroimaging, years 10.1 (0.6) 10.2 (0.8) 0.25
Child sex (male) 1034 (49.4) 2015 (51.2) 0.17
Child gestational age at birth, weeks 40.0 (1.8) 39.8 (2.0) <0.001
Imputed data were used for respondents. Continuous data were presented in mean (SD) and compared using 
t-test or Wilcoxon test; categorical data were presented in number (%) and compared using Chi-square test.
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Table S2. Maternal folate concentration during pregnancy and child brain volumes at age 10 years
Model
Total brain volume Cortical gray matter Cerebral white matter Subcortical gray matter
B 95% CI p-value B 95% CI p-value B 95% CI p-value B 95% CI p-value
1 1.5 1.0, 2.0 <0.001 0.7 0.5, 0.9 <0.001 0.6 0.4, 0.8 <0.001 0.1 0.03, 0.1 <0.001
2 0.5 0.04, 1.0 0.03 0.2 -0.1, 0.4 0.19 0.2 0.02, 0.5 0.03 0.02 -0.0002, 0.04 0.05
3 - - - -0.1 -0.2, 0.1 0.36 0.04 -0.1, 0.2 0.55 0.003 -0.01, 0.02 0.64
B’s represent the volumetric difference (in cm3) of children (n=2083) per 1 nmol/L increase in maternal folate 
concentration during pregnancy.
Model 1 was adjusted for child sex and age at neuroimaging.
Model 2 was additionally adjusted for maternal age at enrollment, ethnicity, marital status, educational level, 
alcohol use during pregnancy, and family income.
Model 3 was additionally adjusted for child intracranial volume.
Table S3. Maternal folate status during pregnancy in relation to child emotional and behavioral problems at 
age 10 years
Maternal folate levels during pregnancy Model
CBCL emotional problems CBCL behavioral problems
B 95% CI p-value B 95% CI p-value
Normal - ref - - ref - -
Deficient 1 0.3 0.1, 0.6 0.01 0.1 -0.1, 0.4 0.34
2 0.2 -0.1, 0.5 0.14 -0.01 -0.3, 0.3 0.97
Continuum 1 -0.01 -0.01, 0.002 0.06 -0.004 -0.01, 0.002 0.20
2 -0.002 -0.01, 0.004 0.54 0.0001 -0.01, 0.01 0.97
B’s represent the difference in the square root transformed child CBCL internalizing or externalizing score of 
the folate-deficient (i.e., <7 nmol/L) group compared to the reference group, or per 1 nmol/L increase in mater-
nal folate concentration. The sample size was 1802 (1724 normal vs. 78 deficient) for the analysis of emotional 
problems, and was 1801 (1723 normal vs. 78 deficient) for the analysis of behavioral problems. When using 
folate concentration as a continuum, 10 children exposed to maternal folate concentration of 45.3 nmol/L (the 
upper detect limit) were excluded in both analyses.
Model 1 was adjusted for child sex and age at CBCL assessment.
Model 2 was additionally adjusted for maternal age at enrollment, ethnicity, marital status, educational level, 
alcohol use during pregnancy, and family income.
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ABSTRACT
Background: Emerging evidence suggests an association of maternal polyunsaturated 
fatty acids (PUFAs) concentrations during pregnancy with child cognitive and neuro-
psychiatric outcomes such as intelligence and autistic traits. However, little is known 
about prenatal maternal PUFAs in relation to child brain development, which may 
underlie these associations.
Objective: We aimed to investigate the association of maternal PUFA status during 
pregnancy with child brain morphology, including volumetric and white matter mi-
crostructure measures.
Design: This study was embedded in a prospective population-based study. In total, 
1553 mother-child dyads of Dutch origin were included. Maternal plasma glycerophos-
pholipid PUFAs were assessed in mid-pregnancy. Child brain morphological outcomes 
including total gray and white matter volumes, and white matter microstructure 
quantified by global fractional anisotropy and mean diffusivity were measured using 
magnetic resonance imaging (including diffusion tensor imaging) at age 9-11 years.
Results: Maternal ω-3 long-chain PUFAs (LC-PUFAs) concentrations during preg-
nancy had an inverted U-shaped relation with child total gray volume (linear term: 
β=16.7, 95% CI 2.0, 31.5; quadratic term: β=-1.1, 95% CI -2.1, -0.07) and total white 
matter volume (linear term: β=15.7, 95% CI 3.6, 27.8; quadratic term: β=-1.0, 95% CI 
-1.8, -0.16). Maternal gestational ω-6 LC-PUFAs levels did not predict brain volumetric 
differences in children, albeit the linolenic acid concentration was inversely associated 
with child total white matter volume. Maternal PUFA status during pregnancy was not 
related to child white matter microstructure.
Conclusions: Sufficient maternal ω-3 PUFAs during pregnancy may be related to more 
optimal child brain development in the long-term. In particular, exposure to lower ω-3 
PUFAs concentrations in fetal life was associated with less brain volume in childhood. 
Maternal ω-6 LC-PUFAs were not related to child brain morphology.
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INTRODUCTION
Fatty acids play vital physiological roles as components of complex lipids involved 
in metabolism, gene transcription, and cell signaling (1, 2). Humans are able to syn-
thesize most fatty acids, but polyunsaturated fatty acids (PUFAs) from the omega-3 
(ω-3) family and the omega-6 (ω-6) family must be obtained from diet such as fatty 
fish and plant-based oils. Moreover, the ability of PUFA biosynthesis is substantially 
determined by rate-limiting enzymes for fatty acid metabolism, which are encoded by 
genetic variants that are robustly related to ethnicity (3).
The embryo and fetus are dependent on the placenta for its supply of PUFAs as essen-
tial nutrients to maintain proper physiological functioning (4). Emerging evidence has 
linked maternal PUFA levels during pregnancy to fetal growth, neonatal respiratory 
distress syndrome, and childhood metabolic outcomes such as adiposity (5-7). More 
recent studies also suggested associations between prenatal PUFA status and neuro-
development in children. For example, previous work in our research group showed 
that a lower maternal gestational plasma PUFA ω-3 to ω-6 ratio, manifested by lower 
ω-3 PUFAs and higher ω-6 PUFAs, predicted more emotional problems and autistic 
traits in the offspring at age 6 years (8, 9). Also, a lower PUFA ω-3 to ω-6 ratio in 
cord blood was related to more subclinical attention deficit and hyperactivity disorder 
(ADHD) symptoms in 7-year-old Spanish children (10). In addition, ω-3 PUFAs during 
pregnancy were positively related to childhood cognitive function such as sequential 
processing and intelligence quotient (IQ) (11, 12), and lower gestational ω-6 PUFAs 
were associated with less externalizing behaviors in children at age 6-7 years (9, 13).
The biological basis underlying the neurodevelopmental outcomes related to PUFA 
status in fetal life remains largely unknown. A general hypothesis posits that specific 
PUFAs such as eicosapentaenoic acid (EPA, C20:5ω-3), docosahexaenoic acid (DHA, 
C22:5ω-3), arachidonic acid (ARA, C20:4ω-6), and adrenic acid (C22:4ω-6) are criti-
cal components for the development of the central nervous system given their role in 
neuronal membranes, neurogenesis, and myelination (14-16). However, we know of no 
studies relating prenatal exposure to PUFAs to brain morphology in childhood (17).
In this population-based study, we aimed to investigate the prospective associations 
between maternal PUFA status during pregnancy and child brain development. Due to 
a lack of prior knowledge, an exploratory approach was used to primarily investigate 
global measures. Based on the studies described above, we hypothesized that higher 
ω-3 PUFAs, in particular higher DHA, and lower ω-6 PUFAs during pregnancy were 





This study was embedded in the Generation R Study, an ongoing prospective cohort 
in Rotterdam, the Netherlands (18). Pregnant women living in Rotterdam with an ex-
pected delivery date between April 2002 and January 2006 were invited to participate. 
The Generation R Study has been approved by the Medical Ethical Committee of the 
Erasmus Medical Center. Written informed consent was obtained from all participants 
or their caregivers.
Participants
We included mother-child dyads with a Dutch origin (determined by the country of 
birth of the mother’s parents) given the ethnic differences in PUFA intake and metabo-
lism, and related confounder patterns (19, 20). In total, 4153 children were born to 
4096 Dutch mothers enrolled during pregnancy; of these, 57 children were randomly 
excluded as one of each twin pair to eliminate clustered data (21). Further, 748 children 
were excluded due to missing information on maternal fatty acids concentrations 
during pregnancy. Of the remaining 3348 children, 1693 visited the research center 
and underwent neuroimaging assessment at age 9-11 years. After quality control, 1553 
children with usable neuroimaging data were included as the study population (see 
Supplemental Figure 1 for the flow chart).
Maternal fatty acid assessment
As previously described (9), maternal non-fasting venous samples were drawn in mid-
pregnancy and stored at room temperature before being transported to the regional 
laboratory for processing and storage for future studies. The samples were centrifuged 
and thereafter stored at -80 °C. For the fatty acid analysis, plasma samples were trans-
ported to the Division of Metabolic Diseases and Nutritional Medicine, University of 
Munich Medical Center, in 2010. After being thawed, plasma glycerophospholipid fatty 
acids were analyzed and the composition was determined by a sensitive and precise 
high-throughput method (see Supplemental Method for more details) (22). The av-
erage coefficient of variation was 15.7%. The concentrations of individual fatty acids 
are expressed as weight percentage (%, wt:wt) of all glycerophospholipid fatty acids 
detected with a chain length between 14 and 22 carbon atoms. The plasma total fatty 
acid concentration was measured in mg/L. Since bio-magnification of PUFAs with 
20 and 22 carbons and bio-reduction of PUFAs with 18 carbons in the placenta have 
been shown (23), we summed concentrations of long-chain PUFAs (LC-PUFAs) with 
20 and 22 carbon atoms from the ω-3 and ω-6 families separately (referred to as ω-3 
LC-PUFAs and ω-6 LC-PUFAs hereafter) in the primary analyses. Alpha-linolenic acid 
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(ALA) and linolenic acid (LA), the two precursor PUFAs with 18 carbon atoms, as 
well as specific individual PUFAs including EPA, DHA, ARA, and adrenic acid were 
examined in the secondary analyses. In addition, the concentrations of all PUFAs (i.e., 
those with 18 to 22 carbon atoms) from the ω-3 and ω-6 families (referred to as ω-3 
and ω-6 PUFAs) were reported in a supplementary analysis to allow comparison with 
prior studies of fatty acids. The full profile for each fatty acid used in this study, includ-
ing both the relative (%, wt:wt) and absolute (mg/L) concentrations, can be found in 
Supplemental Table 1.
Neuroimaging
Prior to the magnetic resonance imaging (MRI) scanning, children underwent a mock 
scanning session to become familiar with the neuroimaging assessment. All images 
were acquired on a 3-Tesla GE Discovery MR750w MRI System (General Electric, Mil-
waukee, WI, USA) scanner using an 8-channel head coil. High-resolution T1-weighted 
sequences were obtained using a 3D coronal inversion recovery fast spoiled gradient 
recalled (IR-FSPGR, BRAVO) sequence. Diffusion tensor imaging (DTI) data were 
acquired using an axial spin echo, echo planar imaging sequence with three b = 0 scans 
and 35 diffusion-weighted images. T1-weighted images were rated for imaging quality 
both during and after the MRI acquisition. Further information on the neuroimaging 
procedure and quality control is described elsewhere (24).
Volumetric segmentation and cortical reconstruction were performed with Free-
Surfer v.6.0.0 (http://surfer.nmr.mgh.harvard.edu/), and the standard reconstruction 
stream was applied. The quality of FreeSurfer output was visually inspected, and data 
with insufficient quality were eliminated. DTI data were processed using the Functional 
MRI of the Brain Software Library and the Camino Diffusion MRI Toolkit (25, 26). 
The diffusion tensor was fitted using the RESTORE method implemented in Camino. 
The quality of the diffusion images was assessed using a combination of manual and 
automated checks. Common scalar maps including global fractional anisotropy (FA) 
and mean diffusivity (MD) were computed to quantify whole-brain white matter mi-
crostructure. FA is a scalar that provides a rotationally invariant measure of hydrogen 
diffusion within a voxel, and MD describes the average diffusion in all directions (27).
Covariates
Based on prior literature investigating childhood health outcomes related to prenatal 
PUFAs exposure (8, 9, 28), we selected the following covariates: child sex and age at the 
time of neuroimaging, and maternal age at enrollment, educational level (categorized as 
‘primary or below’, ‘secondary’, and ‘higher’), marital status (‘single’ or ‘with partner’), 
pre-pregnancy body mass index (BMI), psychopathology, smoking (‘never smoked’, 
‘smoked until pregnancy was known’, or ‘continued smoking throughout pregnancy’), 
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alcohol use (‘never drank’, ‘drank until pregnancy was known’, ‘continued drinking oc-
casionally’, or ‘continued drinking frequently’ defined as ‘1 or more glasses of alcohol 
per week in at least two trimesters’), vitamin supplement use (‘yes’ or ‘no’), total energy 
intake and diet quality during pregnancy, gestational age at fatty acid assessment, and 
family income (‘<1200€’, ‘1200-2000€’, or ‘>2000€’ per month). Child sex and date of 
birth (to calculate age at neuroimaging) were obtained from medical records. Maternal 
pre-pregnancy BMI was calculated by self-reported pre-pregnancy height and weight. 
Information on all other covariates was collected with questionnaires during pregnancy. 
Maternal dietary intake was assessed with a 289-item food frequency questionnaire, 
from which diet quality was calculated as adherence to Dutch dietary guidelines (29).
Additional measures
Information on child academic performance at age 12 years, indexed by the CITO 
[Centraal Instituut voor Test Ontwikkeling (English: Central Institute for Test Develop-
ment)] score (https://www.cito.nl/), was available in 736 children in the present sample. 
The CITO test assesses language and mathematic skills at the end of primary education 
in the Netherlands. We standardized the CITO raw score ranging between 500 and 550 
using Z-transformation, with a higher score indicating higher academic achievement. 
Child age at the CITO test was also assessed.
Statistical analyses
For descriptive statistics, continuous variables were presented as mean (standard devia-
tion, SD) and categorical variables were presented as number (%). In a non-response 
analysis, we compared maternal and child characteristics between participants with 
complete data on the predictor and the outcome (‘respondents’) and those with 
information on the predictor but without data on the outcome (‘non-respondents’). 
Continuous variables were compared with t-test or Wilcoxon tests; categorical vari-
ables were compared with Chi-square tests. Based on non-response analysis, inverse 
probability weighting was applied to all analyses to account for attrition (30).
In the primary analyses, we related maternal ω-3 and ω-6 LC-PUFAs concentrations 
during pregnancy to child total gray and white matter volumes and white matter micro-
structure at age 9-11 years using multiple linear regression. As suggested by studies on 
PUFAs and cardiovascular outcomes (31, 32), non-linearity was tested by introducing 
quadratic terms to the linear model, and we compared the model fit with the likelihood 
ratio test (33). In a next step, non-linear associations were depicted with natural cubic 
splines. Potential sex differences were tested by adding an interaction term to the model. 
In post-hoc analyses, we associated maternal LC-PUFAs levels with the volumes of 
individual brain lobes (i.e., the frontal lobe, temporal lobe, parietal lobe, and occipital 
lobe) to investigate which brain lobes accounted for the global volumetric differences. 
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We also examined ALA, LA, EPA, DHA, ARA, and adrenic acid in secondary analyses. 
In a supplementary analysis, we examined maternal ω-3 and ω-6 PUFAs to allow com-
parison with previous studies of maternal PUFA status and child neurodevelopment.
In a follow-up analysis, we related maternal LC-PUFAs levels during pregnancy and 
child brain morphology at age 10 years to child CITO score at age 12 years. Further, 
we performed a mediation analysis to investigate whether any observed brain differ-
ences mediated the association between prenatal exposure to LC-PUFAs and academic 
performance of the child.
All regression analyses described were performed using multi-stage models. The 
initial model (Model 1) was only adjusted for child sex and age at neuroimaging (age at 
the CITO test when the CITO scores were the outcome measures). In Model 2, we ad-
ditionally adjusted for maternal age at enrollment, educational level, smoking and alco-
hol use, diet quality during pregnancy, and family income. In Model 3, maternal plasma 
total fatty acid concentration was additionally adjusted for to investigate whether any 
observed differences were independent of absolute fatty acid concentration (34).
To rule out that fatty acid transfer abnormalities from mother to the fetus in the 
third trimester due to shortened gestational duration and/or placenta dysfunction (5, 
35) drive results, we re-ran the primary analyses after excluding children with preterm 
birth (defined as a gestational age at birth <37 weeks) and/or small for gestational age 
(SGA, defined as a SD score ≤ −2.3 and based on SD curves derived from the total 
Generation R cohort) in sensitivity analyses (36, 37).
We used multiple imputation to account for missing data on covariates (missing at 
random indicated by Little’s test) (38, 39). A total of 20 imputed datasets was generated 
with 20 iterations, and only pooled results are reported. Statistical significance was 
set as α<0.05 (two-sided). To minimize false positive findings, a multiple comparison 
correction using the Benjamini-Hochberg method was performed for primary analy-
ses, and only the p-values of the linear terms were corrected for non-linear model. All 




Table 1 shows descriptive statistics of the maternal and child characteristics of the study 
population. Children underwent neuroimaging assessment at age 10.1 (range: 8.9 to 
12.0) years, and there were slightly more girls (51.4%) than boys. Maternal plasma ω-6 
LC-PUFAs concentrations during pregnancy were higher than ω-3 LC-PUFAs concen-
trations (14.7% vs. 6.5 %, wt:wt). Non-response analysis showed that compared to par-
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Table 1. Descriptive information (N=1553)1
Statistics
Maternal characteristics
Age at enrollment, year, mean (SD) 31.9 (4.0)
Educational level, n (%)
 Primary or below 25 (1.6)
 Secondary 527 (33.9)
 Higher 1001 (64.5)
Marital status (with partner), n (%) 1462 (94.1)
Pre-pregnancy BMI, mean (SD) 23.1 (3.9)
Psychopathology during pregnancy (GSI)2, mean (SD) 0.2 (0.2)
Smoking during pregnancy, n (%)
 Never 1192 (76.8)
 Smoked until pregnancy was known 153 (9.9)
 Continued smoking throughout pregnancy 208 (13.4)
Alcohol drinking during pregnancy, n (%)
 Never 451 (29.0)
 Drank until pregnancy was known 244 (15.7)
 Continued drinking occasionally 660 (42.5)
 Continued drinking frequently3 198 (12.7)
Family income, €/month, n (%)
 < 1200 63 (4.1)
 1200-2000 206 (13.3)
 > 2000 1284 (82.7)
Vitamin supplementation use (yes), n (%) 620 (39.9)
Total energy intake, kcal, mean (SD) 2154.9 (483.7)
Diet quality, score, mean (SD) 8.1 (1.5)
Gestational age at fatty acid assessment, week, mean (SD) 20.6 (1.1)
Plasma total fatty acid concentration, mg/L, mean (SD) 1651.9 (216.5)
Plasma ω-3 LC-PUFAs4 concentration, %, wt:wt5, mean (SD) 6.5 (1.4)
Plasma ω-6 LC-PUFAs4 concentration, %, wt:wt5, mean (SD) 14.7 (1.6)
Child characteristics
Sex (male), n (%) 771 (49.6)
Age at neuroimaging assessment, year, mean (SD) 10.1 (0.6)
1. Statistics of the first imputed dataset were reported.
2. GSI-global severity index.
3. Defined as ‘1 or more glasses of alcohol per week in at least two trimesters’.
4.  LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 20 to 22 
carbon atoms in this study.
5. Weight percentage of all glycerophospholipid fatty acids.
3.3. Maternal polyunsaturated fatty acids and child brain
139
ticipating mothers, non-participating mothers were younger (30.9 vs. 31.9 years), lower 
educated (with higher education: 52.7% vs. 64.5%), had less family income (>2000 €/
month: 76.7% vs. 82.7%), and had a lower plasma total fatty acid concentration (1620.9 
vs. 1651.9 mg/L) and a lower ω-3 LC-PUFA level (6.2% vs. 6.5%, wt:wt, Supplemental 
Table 2).
Maternal PUFAs and child brain volumes
Table 2 demonstrates the association of maternal LC-PUFA levels during pregnancy 
with child total gray and white matter volumes at age 10 years. First, we examined the 
linear model. In the minimally adjusted model (Model 1), higher maternal ω-3 PUFAs 




Total gray matter volume (cm3) Total white matter volume (cm3)
β 95% CI p-value β 95% CI p-value
linear model
ω-3
Model 1 4.3 1.7, 6.8 <0.001 3.0 1.0, 5.1 0.003
Model 2 1.9 -0.33, 4.1 0.10 2.1 0.27, 3.9 0.02
Model 3 1.83 -0.40, 4.0 0.11 2.03 0.16, 3.9 0.03
ω-6
Model 1 -1.0 -2.9, 0.83 0.28 0.46 -1.0, 2.0 0.55
Model 2 0.48 -1.5, 2.5 0.64 1.2 -0.32, 2.8 0.12
Model 3 0.50 -1.5, 2.5 0.62 1.3 -0.28, 2.8 0.11
non-linear model (results from Model 3 only)
ω-3 16.7 2.0, 31.5 0.034 15.7 3.6, 27.8 0.014
(ω-3)^2 -1.1 -2.1, -0.07 0.04 -1.0 -1.8, -0.16 0.02
ω-6 1.7 -21.4, 24.7 0.89 15.6 -4.7, 35.9 0.13
(ω-6)^2 -0.04 -0.82, 0.74 0.92 -0.49 -1.2, 0.20 0.17
1.  LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 20 and 22 
carbon atoms in this study.
2.  Linear regression was used to examine maternal LC-PUFAs concentrations in relation to child brain volumes. 
β’s represent volumetric differences per 1 %, wt:wt increase in ω-3 or ω-6 LC-PUFAs concentrations. Model 
1 was adjusted for child sex and age at neuroimaging. Model 2 was additionally adjusted for maternal age at 
enrollment, educational level, smoking and alcohol use in pregnancy, diet quality in pregnancy, and family 
income. Model 3 was additionally adjusted for maternal plasma total fatty acids concentration (mg/L). All 
models were weighted by inverse probability to count for attrition. N=1397.
3.  Using likelihood-ratio test, non-linear model shows better model fit than the linear model.
4.  Adjusted p-value ≤ 0.05 after multiple comparison correction using the Benjamini-Hochberg method. Only 
p-values for the linear terms in the non-linear model were corrected for multiple comparison.
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levels during pregnancy were associated with both higher total gray matter volume 
(β=4.3, 95% CI 1.7, 6.8, cm3) and higher total white matter volume (β=3.0, 95%CI 1.0, 
5.1, cm3) in children. In the model fully adjusted for covariates (Model 2), only the 
association of maternal ω-3 LC-PUFAs levels with total white matter volume remained 
(β=2.1, 95% CI 0.27, 3.9, cm3). This association was independent of plasma total fatty 
acid concentration of the mother (Model 3). Maternal ω-6 LC-PUFAs concentrations 
during pregnancy were not related to child total gray or white matter volume in any 
model.
Next, we tested non-linear associations of maternal ω-3 LC-PUFAs concentrations 
with child total gray and white matter volumes. We found evidence that a quadratic 
term improved the model fit compared to the linear model. After adjusting for all 
covariates, both the slope and the quadratic terms of the independent variable (i.e., 
maternal ω-3 LC-PUFAs concentrations) were associated with the dependent variables 
(i.e., child total gray and white matter volumes, see Table 2). Figure 1 visualizes these 
inverted U-shaped relations, suggesting that both low and high maternal ω-3 LC-PUFA 
levels during pregnancy were associated with lower child total gray and white mat-
Figure 1. Maternal ω-3 LC-PUFAs concentrations during pregnancy in relation to child brain volumes at age 10 
years. LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 20 and 
22 carbon atoms in this study. Linear regression was used to examine maternal ω-3 LC-PUFAs concentrations 
in relation to child brain volumes. The curve and shadow represent mean values and 95% CIs of child total gray 
or white matter volume predicted by maternal plasma ω-3 LC-PUFA concentrations (%, wt/wt) during preg-
nancy. Non-linear relations were depicted with natural cubic splines, with one knot placed at the median (6.4). 
Model was adjusted for child sex and age at neuroimaging assessment, maternal age at enrollment, educational 
level, smoking and alcohol use during pregnancy, diet quality, family income, and maternal plasma total fatty 
acids concentration (mg/L), and was weighted by inverse probability to count for attrition. N=1397.
3.3. Maternal polyunsaturated fatty acids and child brain
141
ter volumes. However, the confidence intervals suggest that the lower end of the ω-3 
LC-PUFAs concentrations (e.g., <7%, wt:wt) drives the non-linear association with 
both gray and white matter volumes more than the higher end (e.g., >8%, wt:wt). In 
the post-hoc analyses, we found that maternal ω-3 LC-PUFAs concentrations during 
pregnancy had a similar inverted U-shaped association with the volume of the frontal 
lobe (Supplemental Figure 2), which likely accounted for the findings with global gray 
and white matter. We found no evidence for non-linear relations between maternal 
ω-6 LC-PUFAs levels and child total gray or white matter volume. No evidence for sex 
differences was found in any model (Supplemental Table 3 shows the results stratified 
by sex).
Table 3 shows the results of the analysis of the individual PUFAs. After adjustment for 
all covariates, we observed an inverse linear relation between maternal LA concentra-
Table 3. Maternal plasma concentrations of individual PUFAs during pregnancy in relation to child brain vol-




Total gray matter volume (cm3) Total white matter volume (cm3)
β 95% CI p-value β 95% CI p-value
Linear model
ALA 4.9 -25.3, 35.1 0.75 -7.3 -32.8, 18.3 0.58
LA -1.0 -2.3, 0.30 0.13 -1.3 -2.3, -0.29 0.01
EPA -1.5 -9.7, 6.6 0.71 1.4 -5.6, 8.5 0.69
DHA 2.2 -0.70, 5.1 0.14 2.64 0.23, 5.0 0.03
ARA 0.12 -2.1, 2.3 0.91 0.89 -0.82, 2.6 0.31
Adrenic acid 17.4 -10.9, 45.8 0.23 9.4 -15.8, 34.6 0.46
Non-linear model5
ALA - - - - - -
LA - - - - - -
EPA - - - - - -
DHA - - - 19.6 4.5, 34.7 0.01
(DHA^2) - - - -1.6 -3.0, -0.3 0.02
ARA - - - - - -
Adrenic acid - - - - - -
1.  PUFAs - polyunsaturated fatty acids.
2.  ALA - α-linolenic acid; LA - linolenic acid; EPA - eicosapentaenoic acid; DHA - docosahexaenoic acid; ARA 
- arachidonic acid.
3.  Linear regression was used to examine maternal individual PUFAs levels in relation to child brain volumes. 
β’s represent volumetric differences per 1 %, wt:wt increase in individual PUFAs concentrations. Model was 
adjusted for child sex and age at neuroimaging assessment, maternal age at enrollment, educational level, 
smoking and alcohol use during pregnancy, diet quality, family income, and maternal plasma total fatty acids 
concentration (mg/L), and was weighted by inverse probability to count for attrition. N=1397.
4.  Using likelihood-ratio test, non-linear model shows better model fit than the linear model.
5.  Results are only shown if there is evidence for non-linear relations.
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tions and total white matter volume in children. In addition, there was evidence for an 
inverted U-shaped association between maternal DHA concentrations and child total 
white matter volume (Supplemental Figure 3). We found no evidence suggesting linear 
or non-linear relations between maternal ALA, EPA, ARA, or adrenic acid concentra-
tions and child total gray or white matter volume.
Higher maternal ω-3 LC-PUFAs concentrations during pregnancy predicted higher 
child CITO scores at age 12 years (β=0.06, 95% CI 0.01, 0.10) in models fully adjusted 
for covariates. Also, both total gray and total white matter volumes at age 10 years were 
positively related to child CITO scores (β=0.002, 95% CI 0.001, 0.003; and β=0.002, 
95% CI 0.001, 0.004, respectively). In a subgroup of 484 children exposed to maternal 
ω-3 LC-PUFA concentrations of 7%, wt:wt or below (cut-off based on inflection point 
in the relation between maternal ω-3 LC-PUFAs concentrations and child total gray 
and white matter volumes, see Figure 1), the mediation analysis showed a significant 
indirect effect of total gray matter volume (β=0.02, bootstrapped 95% CI 0.0003, 0.04) 
and of total white matter volume (β=0.01, bootstrapped 95% CI 0.0003, 0.03) at age 
10 years in the relation between maternal ω-3 LC-PUFAs concentrations during preg-
nancy and child CITO scores at age 12 years in unadjusted analyses. There was no 
evidence of an indirect effect after adjusting for all covariates.
The analyses on maternal ω-3 and ω-6 PUFAs concentrations in relation to child 
total gray and white matter volumes yielded similar results to the primary analyses 
(Supplemental Table 4), except for an inverted U-shaped relation between maternal 
ω-6 PUFAs and child total white matter volume, suggesting that high ω-6 PUFAs 
concentrations (e.g., >36%, wt:wt) were associated with reduced total white matter 
volume in children (Supplemental Figure 4). Since this relation was not observed when 
analyzing ω-6 LC-PUFAs, this finding was likely driven by the inclusion of LA given its 
inverse association with total white matter volume of the child.
Maternal PUFAs and child white matter microstructure
As shown in Table 4, maternal ω-3 or ω-6 LC-PUFAs concentrations during pregnancy 
were not related to child global FA or MD at age 10 years in any model, and no sex 
differences were found. No association was found between the individual PUFAs con-
centrations of the mother and white matter microstructure of the child either (data 
not shown). In addition, there were no relations between maternal  ω-3 or ω-6 PUFAs 
concentrations and child white matter microstructure (Supplemental Table 5).
Sensitivity analyses
After excluding 94 children who were born preterm or SGA, results were very consis-
tent with the findings in the total study population.
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DISCUSSION
In a prospective population-based study, we found a non-linear association of maternal 
ω-3 PUFAs concentrations during pregnancy with total gray and white matter volumes 
in the offspring 10 years later. In contrast, maternal gestational ω-6 LC-PUFAs con-
centrations were not related to volumetric differences in total gray or white matter of 
the child, only LA concentration was inversely associated with child total white matter 
volume. Maternal PUFAs during pregnancy were not related to child white matter 
microstructure.
Most of the existing studies relating PUFAs to human brain morphology were 
performed in adults and elderly persons, and suggested larger brain volumes and 
superior white matter microstructure in participants with higher DHA levels or fish 
oil supplementation, which is rich in ω-3 PUFAs (40, 41). Investigations on maternal 
PUFA status during pregnancy and offspring brain morphology remain sparse. In a 
randomized controlled trial (RCT), Ogundipe et al. (42) observed larger total gray mat-
ter volumes in 24 male infants born to mothers with DHA and ARA supplementation 
in pregnancy than in the placebo group. Our study showed lower total white matter 
volume in children born to women with low DHA during pregnancy, but maternal 




Global Fractional Anisotrophy Global Mean Diffusivity
β 95% CI p-value β 95% CI p-value
ω-3
Model 1 0.06 -0.02, 0.14 0.15 -0.0001 -0.01, 0.01 0.99
Model 2 0.01 -0.06, 0.09 0.74 -0.001 -0.01, 0.01 0.78
Model 3 0.01 -0.06, 0.09 0.72 -0.002 -0.01, 0.01 0.74
ω-6
Model 1 0.002 -0.07, 0.07 0.95 0.001 -0.01, 0.01 0.88
Model 2 0.03 -0.04, 0.10 0.45 0.002 -0.01, 0.01 0.63
Model 3 0.03 -0.04, 0.10 0.47 0.002 -0.01, 0.01 0.58
1.  LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 20 and 22 
carbon atoms in this study.
2.  Linear regression was used to examine maternal LC-PUFAs concentrations in relation to child white matter 
microstructure. β’s represent differences in the indicators of white matter microstructure per 1 %, wt:wt in-
crease in ω-3 or ω-6 LC-PUFAs concentrations. Model 1 was adjusted for child sex and age at neuroimaging 
assessment. Model 2 was additionally adjusted for maternal age at enrollment, educational level, smoking 
and alcohol use during pregnancy, diet quality, and family income. Model 3 was additionally adjusted for 
maternal plasma total fatty acids concentration (mg/L). All models were weighted by inverse probability to 
count for attrition. N=1348.
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DHA or ARA levels were not related to child total gray matter volume at age 10 years. 
No evidence for sex differences was found. Different timing of child brain assessment 
may explain the heterogeneous findings. In addition, an animal study reported thin-
ner rostral (i.e., frontal) neocortex in mouse offspring of mothers fed with a deficient 
ω-3 PUFA diet during pregnancy (43). Our results correspond to this finding, because 
a thinner cortex corresponds to less gray matter volume, and we could attribute the 
volumetric differences to the frontal lobe.
Our results suggest not only that children exposed to lower ω-3 PUFAs during preg-
nancy may have less total gray and white matter volumes, but the inverted U-shaped 
curve suggests an inverse association of ω-3 PUFAs above a certain level (e.g., 8%, 
wt:wt) during pregnancy with global brain volumes in childhood. This, however, is a 
less robust explanation given the upper boundary of the estimated association with 
brain volumes at higher ω-3 PUFAs concentrations. Moreover, this finding is not sup-
ported by prior animal or human studies. Therefore, we cautiously speculate that this 
represents a ceiling effect, i.e., there is no further benefit of prenatal ω-3 PUFAs on 
long-term brain development at levels above 8%.
Several explanations for the reduced global brain volumes in children exposed to low 
maternal ω-3 PUFA levels are possible. First, although the basis for the proliferation, 
migration, and molecular specification is the embryonic period, the human brain ex-
periences accelerated growth in the second half of gestation, manifested by substantial 
neurogenesis, axonal growth, dendritic differentiation, and synaptogenesis (44, 45). 
ω-3 PUFAs serve as elements of the cell membrane and, as suggested by animal studies, 
may enhance neurogenesis across fetal life and adulthood via modulating membrane 
proteins, cytokines and/or neurotrophins, and increasing levels of signaling factors 
involved in synaptic plasticity (46-48). In particular, DHA, which is highly enriched 
in neuronal and synaptic membranes (49, 50), may play a critical role in the regulation 
of synapse formation and cell proliferation through its effects on cellular phosphatides 
such as phosphatidylserine (51, 52). Suboptimal neurogenesis and synaptogenesis due 
to low ω-3 PUFAs (and DHA) may potentially lead to reduced brain volumes of the 
fetus persisting into childhood. Second, low maternal ω-3 PUFA levels during preg-
nancy have been related to decreased expression of certain genes such as brain-derived 
neurotrophic factor (BDNF) and leukemia inhibitory factor (LIF) in the offspring as 
a result of altered DNA methylation (53, 54). Higher BDNF has been associated with 
larger gray matter volumes in humans (55), and a smaller cerebral cortex was observed 
in fetal mice with reduced LIF levels due to decreased neurogenesis (56). Third, ex-
posure to lower ω-3 PUFAs in utero has been related to metabolic outcomes such as 
increased risk of obesity and lower high-density lipoprotein (HDL) in childhood (5, 
57). Obese children aged 8-10 years had less regional gray matter than those with a 
normal weight (58). Therefore, low ω-3 PUFAs in fetal life may exert an indirect impact 
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on the long-term brain development. Since LA competes with ω-3 PUFAs for the de-
saturation enzymes, the reduced total white matter volume in children exposed to high 
maternal LA concentrations during pregnancy might be attributed to the concurrent 
low ω-3 PUFAs levels.
Although both maternal LC-PUFAs concentrations during pregnancy and child 
total gray and white matter volumes at age 10 years were positively related to child 
academic performance at age 12 years, brain morphology did not mediate this effect. 
However, it is important to note that, given the limited sample size, our mediation 
analysis was likely underpowered to detect moderate mediation effects (59). Studies 
with larger sample sizes are needed to investigate whether global brain morphological 
differences underlie the associations between prenatal PUFAs exposure and cognitive 
development in childhood.
ω-3 PUFAs involve in myelin and have been related to improved white matter integ-
rity characterized by increased FA in adults (60, 61). However, we observed no associa-
tions between maternal gestational PUFA status and child white matter microstructure. 
Human myelination is largely a postnatal process that continues into early adulthood, 
and postpartum factors such as optimal early life nutrition may contribute to alleviat-
ing or eliminating the adverse impact of exposure to low ω-3 PUFAs during pregnancy 
on myelination (62, 63). In addition, compared to fatty acids with 24 carbons such as 
nervonic acid (C24:1ω-9) and lignoceric acid (C24:0), ω-3 and ω-6 PUFAs are possibly 
less sensitive markers for myelination (64).
The strengths of this study include the prospective design, the relatively large sample 
size, and the application of inverse probability weighting to account for selection bias 
due to loss to follow-up. Several limitations also need to be acknowledged. First, ma-
ternal PUFAs were only measured in mid-pregnancy. We could thus not capture PUFAs 
fluctuations in the periconceptional period that can be critical for embryonic neurode-
velopment. However, mid-gestational PUFAs can serve as a proxy of the average level 
because the absolute concentrations of most PUFAs are stable across pregnancy (65). 
Further studies incorporating measures of PUFA status of the child could elucidate the 
cumulative and/or interaction effects of PUFAs levels across fetal life and childhood on 
long-term brain development. Second, we only examined child brain morphological 
measures at age 10 years. Future studies using other neuroimaging modalities such 
as functional MRI with repeated assessments are warranted to better understand the 
role of prenatal PUFAs exposure in the brain developmental trajectory. Third, due to 
the population-based nature, we were not able to assess gestational PUFAs exposure in 
relation to brain development in disadvantaged children, such as those with SGA and/
or low birth weight with sufficient power. Finally, since this is an observational study, 
although we adjusted for several variables including maternal diet and lifestyle, which 
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were likely related to both maternal PUFA status and child brain development, genetic 
or residual environmental confounding factors impede drawing causal conclusions.
To conclude, a low maternal ω-3 PUFAs level during pregnancy was associated with 
reduced total gray and white matter volumes in the offspring in late childhood. Further 
studies are warranted to ascertain the causal relationship to justify ω-3 PUFAs supple-
mentation in pregnant women with low ω-3 PUFAs levels for child brain development 
in the long term.
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SUPPLEMENTAL METHOD. FATTy ACIDS ASSAy
A total of 100 µl of plasma, 100 µl of internal standard B, and 0.6 ml methanol (pre-
cooled to 5°C) were mixed in glass tubes. The precipitated proteins were separated 
from the methanolic phase by centrifugation at 900 g for 5 min, and 25 µl sodium 
methoxide solution was added to the methanolic supernatant containing mainly polar 
lipids. Following selective synthesis of methyl esters from glycerophospholipid fatty 
acids at room temperature for 3 min, fatty acid methyl esters (FAMEs) were extracted 
by adding 300 µl hexane and shaking the tubes for 30 s. The upper hexane phase, which 
contains the extracted glycerophospholipid FAMEs, was transferred into a 2 ml vial. 
The extraction was repeated and combined extracts were dried under nitrogen flow 
at room temperature. The dry residue was taken up in 50 µl hexane (containing 2 g/l 
BHT) for gas chromatography analysis.
To evaluate lipid compositions in the methanolic supernatant after plasma protein 
precipitation and to compare the recovery of plasma phospholipids (PhLs) in the 
methanolic supernatant with the recovery of PhLs in Folch extracts, the supernatant 
was deposited on a Thin-layer chromatography (TLC) plate. Lipid classes were sepa-
rated by TLC and fatty acids bound in the different lipids were converted to FAMEs by 
acid catalyzed transesterification.
To optimize base catalyzed transesterification and FAME extraction, a model sample 
containing 100 µl water (representing plasma), 100 µl internal standard B, and 100 µl 
octadecane standard (not participating in the reactions) was applied. The ratio of the 
peak areas of methyl pentadecanoate to octadecane was used as indicator for trans-







3348 children with information on 
maternal fatty acids 
3141 children invited at 9-11 years 
4153 Dutch children participating since pregnancy 
57 (one) of twin children 
702 did not show up at research 
center 
746 without attending 
neuroimaging assessment 
1693 underwent neuroimaging 
assessment at 9-11 years 
1553 with usable neuroimaging data 
207 withdrew or loss to follow-up 
748 without information on 
maternal fatty acids (%, wt:wt) 
140 excluded after QC 
4096 children 
1397 with usable MRI data 1348 with usable DTI data 
2439 visited research center  
at 9-11 years 
Figure S1. Flow diagram of study population
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Figure S2. Maternal ω-3 LC-PUFAs concentrations during pregnancy in relation to child frontal lobe volume at 
age 10 years. LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 
20 and 22 carbon atoms in this study. Linear regression was used to examine maternal ω-3 LC-PUFAs concen-
trations in relation to child frontal lobe volume. The curve and shadow represent mean values and 95% CIs of 
child frontal lobe volume predicted by maternal plasma ω-3 LC-PUFA concentrations (%, wt/wt) during preg-
nancy. Non-linear relations were depicted with natural cubic splines, with one knot placed at the median (6.4). 
Model was adjusted for child sex and age at neuroimaging assessment, maternal age at enrollment, educational 
level, smoking and alcohol use during pregnancy, diet quality, family income, and maternal plasma total fatty 
acids concentration (mg/L), and was weighted by inverse probability to count for attrition. N=1397.
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Figure S3. Maternal DHA concentrations during pregnancy and child total white matter volume at age 10 years. 
DHA - docosahexaenoic acid. Linear regression was used to examine maternal DHA concentrations in relation 
to child white matter volume. The curve and shadow represent mean values and 95% CIs of child total white 
matter volume predicted by maternal plasma DHA concentrations (%, wt/wt) during pregnancy. Non-linear 
relations were depicted with natural cubic splines, with one knot placed at the median (4.9). Model was adjusted 
for child sex and age at neuroimaging assessment, maternal age at enrollment, educational level, smoking and 
alcohol use during pregnancy, diet quality, family income, and maternal plasma total fatty acids concentration 
(mg/L), and was weighted by inverse probability to count for attrition. N=1397.
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Figure S4. Maternal ω-6 PUFAs concentrations and child total white matter volume at age 10 years. PUFAs - 
polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 18 to 22 carbon atoms in this study. 
Linear regression was used to examine maternal ω-6 PUFAs concentrations in relation to child white matter 
volume. The curve and shadow represent mean values and 95% CIs of child total white matter volume predicted 
by maternal plasma ω-6 PUFA concentrations (%, wt/wt) during pregnancy. Non-linear relations were depicted 
with natural cubic splines, with one knot placed at the median (36.3). Model was adjusted for child sex and age 
at neuroimaging assessment, maternal age at enrollment, educational level, smoking and alcohol use during 
pregnancy, diet quality, family income, and maternal plasma total fatty acids concentration (mg/L), and was 
weighted by inverse probability to count for attrition. N=1397.
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Table S1. Full profile of maternal plasma fatty acids
Fatty acids1
Relative concentration




Mytistic acid (C14:0) 0.68 (0.18) 11.2 (3.4)
Palmitic acid (C16:0) 30.7 (1.1) 507.3 (71.5)
Margaric acid (C17:0) 0.35 (0.05) 5.8 (0.98)
Stearic acid (C18:0) 11.3 (0.74) 186.5 (27.3)
Monounsaturated fatty acids (cis)
Pentadecanoic acid (C15:1ω-5) 0.07 (0.02) 1.1 (0.3)
Palmitoleic acid (C16:1ω-7) 0.79 (0.28) 13.2 (5.4)
Vaccenic acid (C18:1ω-7) 1.5 (0.2) 25.1 (4.2)
Oleic acid (C18:1ω-9) 10.8 (1.1) 177.8 (30.0)
Eicosenoic acid (C20:1ω-9) 0.2 (0.04) 3.3 (0.65)
Polyunsaturated fatty acids
α-Linolenic acid (C18:3ω-3) 0.34 (0.1) 5.6 (1.8)
Eicosatrienoic acid (C20:3ω-3) 0.1 (0.02) 1.6 (0.39)
Eicosapentaenoic acid (C20:5ω-3) 0.62 (0.33) 10.2 (5.5)
Docosapentaenoic acid (C22:5ω-3) 0.8 (0.22) 13.2 (4.0)
Docosahexaenoic acid (C22:6ω-3) 5 (1.1) 82.3 (19.6)
Linoleic acid (C18:2ω-6) 21.5 (2.5) 354.9 (58.9)
γ-linolenic acid (C18:3ω-6) 0.09 (0.04) 1.5 (0.66)
Eicosadienoic acid (C20:2ω-6) 0.51 (0.09) 8.4 (1.7)
Dihomo-γ-linolenic acid (C20:3ω-6) 3.8 (0.68) 63.8 (15.4)
Arachidonic acid (C20:4ω-6) 9.5 (1.4) 156.2 (30.8)
Adrenic acid (C22:4ω-6) 0.41 (0.1) 6.9 (2.0)
Osbond acid (C22:5ω-6) 0.47 (0.16) 7.8 (2.9)
Mead acid (C20:3ω-9) 0.15 (0.06) 2.5 (1.1)
Trans fatty acids
C16:1t 0.06 (0.02) 0.93 (0.26)
C18:1t 0.23 (0.1) 3.8 (1.7)
C18:2tt 0.07 (0.02) 1.2 (0.39)
Sum 100 1651.9 (216.5)
1.  Fatty acids with a chain length between 14 and 22 carbon atoms were assessed.
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Age at enrollment, year 31.9 (4.0) 30.9 (4.7) <0.001
Educational level
 Primary or below 25 (1.6) 96 (5.4)
<0.001 Secondary 527 (33.9) 742 (41.9)
 Higher 1001 (64.5) 933 (52.7)
Marital status (with partner) 1462 (94.1) 1600 (91.3) 0.002
Pre-pregnancy BMI 23.1 (3.9) 23.4 (4.1) 0.07
Psychopathology during pregnancy (GSI)2 0.2 (0.2) 0.2 (0.3) 0.002
Smoking during pregnancy
 Never 1192 (76.8) 1164 (69.7)
<0.001 Smoked until pregnancy was known 153 (9.9) 146 (8.7)
 Continued smoking throughout pregnancy 208 (13.4) 361 (21.6)
Alcohol drinking during pregnancy
 Never 451 (29.0) 592 (34.5)
0.002
 Drank until pregnancy was known 244 (15.7) 282 (16.4)
 Continued drinking occasionally 660 (42.5) 665 (38.8)
 Continued drinking frequently3 198 (12.7) 176 (10.3)
Family income, €/month
 < 1200 63 (4.1) 135 (8.7)
<0.001 1200-2000 206 (13.3) 227 (14.6)
 > 2000 1284 (82.7) 1190 (76.7)
Vitamin supplementation use (yes) 620 (39.9) 534 (33.6) <0.001
Total energy intake, kcal 2154.9 (483.7) 2141.5 (528.1) 0.47
Diet quality, score 8.1 (1.5) 7.8 (1.6) <0.001
Gestational age at fatty acid assessment, week 20.6 (1.1) 20.7 (1.2) 0.004
Plasma total fatty acid concentration, mg/L 1651.9 (216.5) 1620.9 (214.2) <0.001
Plasma ω-3 LC-PUFAs4 concentration, %, wt:wt5 6.5 (1.4) 6.2 (1.4) <0.001
Plasma ω-6 LC-PUFAs4 concentration, %, wt:wt5 14.7 (1.6) 14.6 (1.7) 0.08
Child
Sex (male), n (%) 771 (49.6) 923 (51.4) 0.32
Age at neuroimaging assessment, year, n (%) 10.1 (0.6) 10.3 (0.9) 0.17
1.  Continuous variables are presented as mean (SD) and compared using t-test or Wilcoxon test; categorical 
variables were presented as number (%) and compared using Chi-square test. Statistics of the first imputed 
dataset were reported for respondents.
2.  GSI - global severity index.
3.  Defined as ‘1 or more glasses of alcohol per week in at least two trimesters’.
4.  LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 20 to 22 
carbon atoms in this study.
5.  Weight percentage of all glycerophospholipid fatty acids.
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Table S3. Maternal LC-PUFAs concentrations during pregnancy in relation to child brain volumes at age 10 




Total gray matter volume (cm3) Total white matter volume (cm3)




ω-3 2.0 -1.4, 5.4 0.26 2.5 -0.47, 5.5 0.10
ω-6 0.10 -3.0, 3.2 0.95 1.3 -1.1, 3.7 0.30
non-linear model
ω-3 22.8 -1.8, 47.4 0.07 19.2 -1.1, 39.5 0.06
(ω-3)^2 -1.5 -3.3, 0.20 0.08 -1.2 -2.7, 0.22 0.10
ω-6 -13.6 -47.8, 20.7 0.44 4.3 -26.4, 35.1 0.78




ω-3 1.7 -1.1, 4.5 0.23 1.5 -0.75, 3.7 0.19
ω-6 0.78 -1.6, 3.2 0.52 1.2 -0.72, 3.1 0.22
non-linear model
ω-3 13.5 -4.5, 31.6 0.14 13.4 -0.40, 27.2 0.06
(ω-3)^2 -0.85 -2.1, 0.38 0.18 -0.86 -1.8, 0.08 0.07
ω-6 20.0 -11.0, 51.1 0.21 27.1 0.41, 53.8 0.05
(ω-6)^2 -0.66 -1.7, 0.38 0.22 -0.88 -1.8, 0.02 0.06
1.  LC-PUFAs - long-chain polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 20 to 22 
carbon atoms in this study.
2.  Linear regression was used to examine maternal LC-PUFAs concentrations in relation to child brain volumes. 
β’s represent differences in child brain volumes per 1 %, wt:wt increase in ω-3 or ω-6 LC-PUFAs concentra-
tions. All models were adjusted for child age at neuroimaging, maternal age at enrollment, educational level, 
smoking and alcohol use in pregnancy, diet quality in pregnancy, family income, and maternal plasma total 
fatty acids concentration (mg/L), and were weighted by inverse probability to count for attrition. N=1397.
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Table S4. Maternal PUFAs concentrations during pregnancy in relation to child brain volumes at age 10 years1,2
PUFAs 
concentrations
Total gray matter volume (cm3) Total white matter volume (cm3)
β 95% CI p-value β 95% CI p-value
linear model
ω-3
Model 1 4.3 1.8, 6.9 <0.001 3.0 0.97, 5.1 0.004
Model 2 1.9 -0.30, 4.1 0.09 2.1 0.23, 3.9 0.03
Model 3 1.93 -0.36, 4.1 0.10 2.03 0.12, 3.9 0.04
ω-6
Model 1 -2.1 -3.8, -0.52 0.01 -1.5 -2.7, -0.28 0.02
Model 2 -1.3 -2.8, 0.27 0.11 -1.2 -2.4, 0.04 0.06
Model 3 -1.3 -2.8, 0.25 0.10 -1.23 -2.5, 0.005 0.05
non-linear model (results from Model 3 only)
ω-3 17.6 2.0, 33.2 0.03 16.4 3.5, 29.4 0.01
(ω-3)^2 -1.1 -2.1, -0.07 0.04 -1.0 -1.9, -0.15 0.02
ω-6 25.8 -11.8, 63.5 0.18 31.3 2.6, 60.1 0.03
(ω-6)^2 -0.37 -0.90, 0.15 0.16 -0.45 -0.85, -0.05 0.03
1.  PUFAs - polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 18 to 22 carbon atoms in 
this study.
2.  Linear regression was used to examine maternal PUFAs concentrations in relation to child brain volumes. β’s 
represent volumetric differences per 1 %, wt:wt increase in ω-3 or ω-6 PUFAs concentrations. Model 1 was 
adjusted for child sex and age at neuroimaging. Model 2 was additionally adjusted for maternal age at enroll-
ment, educational level, smoking and alcohol use in pregnancy, diet quality in pregnancy, and family income. 
Model 3 was additionally adjusted for maternal plasma total fatty acids concentration (mg/L). All models 
were weighted by inverse probability to count for attrition. N=1397.
3.  Using likelihood-ratio test, non-linear model shows better model fit than the linear model.
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Global Fractional Anisotrophy Global Mean Diffusivity
β 95% CI p-value β 95% CI p-value
ω-3
Model 1 0.06 -0.02, 0.14 0.17 -0.0001 -0.01, 0.01 0.99
Model 2 0.01 -0.07, 0.09 0.80 -0.001 -0.01, 0.01 0.78
Model 3 0.01 -0.06, 0.09 0.77 -0.002 -0.01, 0.01 0.73
ω-6
Model 1 -0.03 -0.08, 0.02 0.28 -0.003 -0.01, 0.004 0.39
Model 2 -0.01 -0.07, 0.04 0.70 -0.003 -0.01, 0.01 0.43
Model 3 -0.01 -0.07, 0.04 0.72 -0.004 -0.01, 0.01 0.42
1.  PUFAs - polyunsaturated fatty acids, referring to polyunsaturated fatty acids with 18 to 22 carbon atoms in 
this study.
2.  Linear regression was used to examine maternal PUFAs concentrations in relation to child white matter mi-
crostructure. β’s represent differences in the indicators of white matter microstructure per 1 %, wt:wt increase 
in ω-3 or ω-6 PUFAs concentrations. Model 1 was adjusted for child sex and age at neuroimaging assessment. 
Model 2 was additionally adjusted for maternal age at enrollment, educational level, smoking and alcohol use 
during pregnancy, diet quality, and family income. Model 3 was additionally adjusted for maternal plasma 
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ABSTRACT
Importance: Preterm and post-term births are associated with adverse neuropsychiat-
ric outcomes. However, it remains unclear whether variation of gestational age within 
the 37- to 42-week range of term deliveries is associated with neurodevelopment.
Objective: To investigate the association of gestational age at birth (GAB) with struc-
tural brain morphometry in children aged 10 years.
Design, setting, and participants: This population-based cohort study included 
pregnant women living in Rotterdam, the Netherlands, with an expected delivery 
date between April 1, 2002, and January 31, 2006. The study evaluated 3079 singleton 
children with GAB ranging from 26.3 to 43.3 weeks and structural neuroimaging at 10 
years of age from the Generation R Study, a longitudinal, population-based prospective 
birth cohort from early pregnancy onward in Rotterdam. Data analysis was performed 
from March 1, 2019, to February 28, 2020, and at the time of the revision based on 
reviewer suggestions.
Exposures: The GAB was calculated based on ultrasonographic assessment of crown-
rump length (<12 weeks 5 days) or biparietal diameter (≥12 weeks 5 days) in dedicated 
research centers.
Main outcomes and measures: Brain structure, including global and regional brain 
volumes and surface-based cortical measures (thickness, surface area, and gyrifica-
tion), was quantified by magnetic resonance imaging.
Results: In the 3079 children (1546 [50.2%] female) evaluated at 10 years of age, GAB 
was linearly associated with global and regional brain volumes. Longer gestational 
duration was associated with larger brain volumes; for example, every 1-week-longer 
gestational duration corresponded to an additional 4.5 cm3/wk (95%CI, 2.7-6.3 cm3/
wk) larger total brain volume. These associations persisted when the sample was re-
stricted to children born at term (GAB of 37-42 weeks: 4.8 cm3/wk; 95%CI, 1.8-7.7 
cm3/wk). No evidence of nonlinear associations between GA and brain morphometry 
was observed.
Conclusions and relevance: In this cohort study, gestational duration was linearly as-
sociated with brain morphometry during childhood, including within the window of 
term delivery. These findings may have marked clinical importance, particularly given 
the prevalence of elective cesarean deliveries.
4.1. Gestational duration and child brain
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INTRODUCTION
Gestational age at birth (GAB) is an important determinant of child health and 
development. Worldwide, approximately 13 million newborns are born preterm 
(GAB<37weeks) annually.1 Prematurity is associated with morbidity and mortality,2,3 
including neurodevelopmental problems, such as cerebral palsy, intellectual disability, 
learning disability, and poor motor development.4-6 Preterm birth is reportedly associ-
ated with increased risks of attention-deficit/ hyperactivity disorder (ADHD), autism 
spectrum disorder,7-9 and psychiatric disorders in adulthood.10 In some countries, 
post-term birth (GAB≥42 weeks) accounts for up to 10% of births11 and is associated 
with adverse birth outcomes, increased neonatal mortality, cognitive impairment, and 
increased risk of ADHD.12
Few studies13,14 have investigated the associations of GAB with brain structures 
despite the dynamic neurodevelopment that occurs during early life. During the third 
trimester of gestation, there is a 4-fold increase in brain size accompanied by marked 
growth of brain surface area, resulting in the emergence of sulci and gyri.15,16 Thus, 
birth before the presumed optimal gestational duration (approximately 40 weeks) may 
be associated with disruption of neurodevelopmental processes in late pregnancy that 
persist during postnatal life.
Prior studies17-22 often focused on children born extremely preterm (<28weeks of 
gestation) or very preterm (<34 weeks of gestation) and found less gray and white mat-
ter volumes in premature children and adolescents. These studies17-22 used categorical 
indexes for GAB based on somewhat arbitrary cutoffs (e.g., extremely, very, or late 
preterm) rather than gestational duration as a quantitative trait of fetal maturity. Few 
studies23,24 have examined the associations of gestational duration with developmental 
outcomes in children born at term. Longer gestation in term-born children has been 
associated with higher scores of cognitive and motor development early in life. In addi-
tion, 2 neuroimaging studies that used a group of approximately 100 term-born children 
(aged 6-10 years) found that longer gestational duration was associated with larger gray 
matter volumes, in particular temporal and parietal regions,25 and linear associations of 
larger GAB with enhanced local and global network efficiency of structural networks.26
Given the novelty of investigating brain morphometric outcomes among children 
born at term, we examined the prospective association of GAB as a quantitative trait 
with brain morphometry assessed 10 years later using structural neuroimaging in a 
large population-based cohort. We used an exploratory approach that involved both 
global and regional metrics of brain development without defining specific regions of 
interest. We hypothesized that higher GAB would be associated with larger global and 
regional brain volumes, even within the term range of gestational duration. Mechanis-
tically, we hypothesized that a higher GAB is positively associated with cortical surface 
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area and gyrification (i.e., cortical folding) because of rapid expansion of the cerebral 
cortex in the third trimester of pregnancy.
METHODS
Setting and Design
This cohort study was embedded in the Generation R Study, a population-based cohort 
in Rotterdam, the Netherlands. Pregnant women living in Rotterdam with an expected 
delivery date between April 1, 2002, and January 31, 2006, were invited to participate.27 
Enrolled children were followed up from fetal life onward. Data analysis was performed 
from March 1, 2019, to February 28, 2020, and at the time of the revision based on re-
viewer suggestions. Written informed consent was obtained from all participants, and 
all data are deidentified. The Generation R Study was approved by the Medical Ethical 
Committee of the Erasmus Medical Center, Rotterdam. All procedures were conducted 
in accordance with the World Medical Association Declaration of Helsinki.28
Study Population
The study enrolled 9778 mothers who gave birth to 9749 live born children (eFigure 
1 in the Supplement). Twin pregnancies were excluded because of the increased risk 
of prematurity and twin-related complications,29 resulting in 9418 singletons with 
information on GAB. Of these, 8270 children were invited to the research center at 
10 years of age. All 5669 children visiting the center were invited to undergo brain 
magnetic resonance imaging (MRI). In total, 3857 children underwent neuroimaging. 
The final study population comprised 3079 children after excluding 23 children with 
major incidental findings, 89 with missing T1-weighted MRIs or artifacts because of 
braces or retainers, 44 with heterogeneous scanning parameters, and 622 with insuf-
ficient image quality (based on visual inspection of T1-weighted MRIs and FreeSurfer 
reconstructions).30,31
Gestational Age at Birth
Gestational age was determined by ultrasonography during prenatal visits at the re-
search center. Standard methods of fetal ultrasonographic measurements have been 
previously described.32 Inter-observer and intra-observer intra-class correlation coef-
ficients were greater than 0.98.32 Crown-rump length was used for pregnancy dating 
until a gestational age of 12 weeks 5 days (<65mm, n = 902). Biparietal diameter was 
used for pregnancy dating from12 weeks 5 days onward (>23 mm, n = 1790). For the 
387 women who did not attend the prenatal visits, we retrieved gestational age from the 
Netherlands National Obstetric Register. Preterm birth was defined as delivery occur-
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ring at less than 37 weeks of gestation (n = 138), term birth as GAB in the window of 
37 weeks 0 days through 41 weeks 6 days (n = 2718), and post-term birth as GAB of 42 
weeks or greater (n = 223).33 For illustrative purposes, in eFigure 2 in the Supplement, 
we subdivided term birth into categories of early, full, and late term.33
Image Acquisition and Processing
Brain images were acquired on a 3.0-T MRI scanner (Discovery MR750, GE Healthcare) 
using an 8-channel head coil. After a localizer, T1-weighted structural images were 
acquired with an inversion recovery-prepared fast spoiled gradient recalled sequence. 
Sequence parameters (option BRAVO) were as follows: repetition time, 8.77 millisec-
onds; echo time, 3.4 milliseconds; inversion time, 600 milliseconds; flip angle, 10°; field 
of view, 220 × 220 mm; acquisition matrix, 220 × 220; slice thickness, 1mm; number of 
slices, 230; voxel size, 1 × 1 × 1 mm; and arc acceleration, 2.34 Images were processed 
using FreeSurfer, version 6.0, an open source software for analyzing brain images.35,36 
Global and regional volumes, including total brain, cerebral and cerebellar gray, and 
white matter volumes, as well as subcortical gray matter volumes, including the thala-
mus, amygdala, hippocampus, putamen, pallidum, caudate, and nucleus accumbens, 
were measured. A surface-based stream quantified cortical thickness, cortical surface 
area, and gyrification. FreeSurfer morphometry had good test-retest reliability across 
scanners and field strengths.37,38 FreeSurfer reconstructions were visually inspected,30,31 
and images not suitable for analysis were excluded. An automated quality metric39 
found no correlation with GAB (r = −0.01, P = .53).
Covariates
Potential confounding variables were selected based on the existing literature.40,41 
Self-reported questionnaire data and medical record data measured before child birth 
provided information on maternal ethnicity,42 age at intake, marital status, educational 
level, psychopathologic symptoms,43,44 smoking and alcohol use during pregnancy, and 
family income. Medical registries provided information on obstetric variables, includ-
ing fetal distress, mode of delivery, 5-minute Apgar score, and calendar year of birth. 
Child sex and age at neuroimaging were also included.
Statistical Analysis
For descriptive purposes, children were categorized as preterm(< 37weeks), term(≥ 
37and < 42 weeks), and post-term(≥ 42weeks) delivery. Linear regression was used to 
investigate the association of the quantitative trait GAB with global and regional brain 
volumes (eFigure 3 in the Supplement). Subcortical volumes were standardized to 
enable comparison of the effect estimates of GAB between subcortical structures. Non-
linear associations of GAB with brain morphometry were examined using quadratic 
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models and models with natural cubic splines with knots at 30, 32, 34, 37, 38, 39, 40, 
and 42 weeks. We performed additional analyses among children born at term to exam-
ine whether associations were also present in this narrow range of gestational duration. 
To investigate the association between GAB and surface-based cortical measures, we 
used vertex-wise linear regression models with a custom in-house QDECR package. 
To compare the results with existing studies17-22 using clinically defined categories, we 
also applied linear regression models with the preterm, term, and post-term categories; 
term-born children served as the reference group.
Model 1 was minimally adjusted for child sex and age at neuroimaging assessment. 
Model 2 was further adjusted for maternal characteristics, including ethnicity, age at 
intake, marital status, educational level, psychopathologic symptoms, smoking and 
alcohol use during pregnancy, and family income. Calendar year of birth was not 
included as a covariate because it was not associated with GAB or brain characteristics. 
Models with subcortical outcomes were additionally adjusted for intracranial volume.
In addition, we examined whether the association of GAB with brain morphometry 
was moderated by sex. To ensure that the associations of GAB with brain volumes 
were not driven by adverse perinatal events, children exposed to perinatal complica-
tions, including maternal preeclampsia, diabetes, pregnancy-induced hypertension, 
urgent cesarean delivery, intrauterine growth restriction, low birth weight (<2500 g), 
suspected fetal distress, a 5-minute Apgar score below 7, and premature or post-term 
birth, were excluded in sensitivity analyses.
Missing values of the covariates were imputed using multivariate imputation by 
chained equations with 10 imputations.45 We report pooled results. Statistical signifi-
cance was defined as α < .05 (2-sided). In the primary analyses, a false discovery rate 
correction was applied to minimize false-positive findings attributable to multiple 
comparisons.46 Surface-based analyses were corrected for multiple testing using built-
in Gaussian Monte Carlo simulations.47 The cluster-forming threshold was set to P = 
.001 because this value corresponds closely to a false-positive rate of 0.05,48 with further 
Bonferroni correction for independent analysis of each hemisphere (P < .025 cluster-
wise). All statistical analyses were performed using R statistical software, version 3.5.1 
(R Foundation for Statistical Computing).
For nonresponse analyses, we used analyses of variance or the Kruskal-Wallis test for 
continuous variables and the χ2 test for categorical variables to compare maternal and 
child characteristics between responders and non-responders at follow-up.




This study evaluated 3079 children (1546 [50.2%] female) at 10 years of age.  Table 
1  presents information on the study population. Mothers of preterm-born children 
less frequently had a partner (109 [79.0%] vs 2405 [88.5%],  P = .001), had a lower 
educational level (53 [38.4%] vs 1411 [51.9%], P = .01), and had a lower family income 
(<€1200 [US $1550] per month: 33 [23.9%] vs 423 [15.6%], P < .001) than did mothers 
of children born at term. Mothers of children born preterm more often had preeclamp-
sia, diabetes, and pregnancy-related hypertension (22 [15.9%] vs 179 [6.6%], P < .001) 
and more often underwent cesarean delivery (33 [23.9%] vs 306 [11.3%], P < .001). Ma-
ternal sociodemographic or lifestyle factors did not differ between the post-term and 
the term-born groups. However, children born post-term more often were delivered via 
cesarean (43 [19.3%] vs 306 [11.3%], P < .001) and more often had signs of fetal distress 
(27 [12.1%] vs 195 [7.2%], P = .01).








Age at intake, mean (sd), year 31.0 (4.9) 30.7 (5.1) 31.4 (4.5)
Multiparous (%) 11.9 12.3 10.3
Pregnancy complications (%) b 6.6 15.9 4.9
Ethnicity (%)
 Dutch 57.7 50.7 59.2
 Non-Dutch Western 11.9 11.6 16.1
 Non-Dutch Non-Western 30.4 37.7 24.7
Educational level (%)
 Primary or lower 7.2 9.4 5.8
 Secondary 40.9 52.2 36.8
 Higher 51.9 38.4 57.4
Family income, per month (%)
 Less than €1200 15.6 23.9 15.2
 €1200 to €2000 17.0 24.6 10.3
 More than €2000 67.4 51.4 74.4
Marital status, married or with partner (%) 88.5 79.0 90.6
Smoking during pregnancy (%)
 Never in pregnancy 77.3 75.4 78.9
 Until pregnancy was known 8.6 7.2 10.3
 Continued in pregnancy 14.2 17.4 10.8
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Global and Regional Brain Volumes
Table 2  and  Figure 1  report a positive association of GAB with total brain volume 
(B = 4.5 cm3/wk; 95% CI, 2.7-6.3 cm3/wk). In addition, GAB was positively associated 
with cerebral gray matter (2.8 cm3/wk; 95% CI, 1.8-3.7 cm3/wk), cerebral white matter 
(1.2 cm3/wk; 95% CI, 0.3-2.0 cm3/wk), cerebellar gray matter (0.4 cm3/wk; 95% CI, 0.2-
0.5 cm3/wk), cerebellar white matter (0.1 cm3/wk; 95% CI, 0.1-0.2 cm3/wk), and sub-
cortical gray matter (0.2 cm3/wk; 95% CI, 0.1-0.2 cm3/wk) volume. These associations 
remained after correction for multiple comparisons. Of importance, the associations 
and effect estimates of GAB with global and regional brain volumes remained intact 
when restricting the sample to children born at term with the exception of cerebellar 
gray matter (Table 2 and Figure 1). Furthermore, we did not observe any interaction of 
sex in the association of GAB with global brain volumes (eTable 1 in the Supplement).
Post hoc analyses found that longer gestational duration was associated with larger 
volumes of the thalamus, caudate, putamen, and pallidum (eFigure 4 in the Supple-
ment). No associations were observed between GAB and amygdala, hippocampus, or 
nucleus accumbens volume.







Alcohol use during pregnancy (%)
 Never in pregnancy 40.2 38.4 39.9
 Until pregnancy was known 14.0 15.9 11.2
 Continued in pregnancy, occasionally 36.2 35.5 38.1
 Continued in pregnancy, frequently c 9.6 10.1 10.8
Psychopathology, mean (sd) 0.3 (0.4) 0.4 (0.4) 0.3 (0.4)
Birth and child characteristics
Cesarean delivery (%) 12.3 23.4 20.2
Suspected fetal distress (%) 7.2 10.9 12.1
Apgar at 5 minutes below 7 (%) 1.0 2.9 0.9
Gestational age at birth, mean (sd), week 40.0 (1.1) 34.6 (2.7) 42.3 (0.3)
 Range 37.0 – 41.9 26.3 – 36.9 42.0 – 43.4
Birth weight, mean (sd), gram 3472.6 (485.9) 2345.6 (654.7) 3785.7 (475.6)
Sex, boy (%) 49.3 47.1 57.4
Age at MRI scan, mean (sd), year 10.1 (0.6) 10.2 (0.6) 10.1 (0.6)
Abbreviation: MRI, magnetic resonance imaging.
a. No data were missing for these variables because they were imputed using multiple imputation methods. 
Categorization was based on gestational age at birth: term birth (gestational age of 37-42 weeks), preterm birth 
(gestational age <37 weeks), and post-term birth (gestational age of ≥ 42 weeks).
b. Pregnancy complications included preeclampsia, diabetes, and/or pregnancy induced hypertension.
c. Frequent continued alcohol use is defined as one or more glasses of alcohol per week in at least two trimesters.
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Table 2. Association of gestational age at birth with global brain volumesa
Model



















Model 1 6.1 (4.2 to 8.0) <.001 3.7 (2.7 to 4.7) <.001 1.7 (0.9 to 2.6) <.001
Model 2 4.5 (2.7 to 6.3) <.001c 2.8 (1.8 to 3.7) <.001c 1.2 (0.3 to 2.0) .006c
Term children 
(n=2718)
Model 1 6.7 (3.6 to 9.7) <.001 3.8 (2.2 to 5.4) <.001 2.3 (0.9 to 3.7) .002
Model 2 4.8 (1.8 to 7.7) .002c 2.8 (1.2 to 4.3) <.001c 1.6 (0.3 to 3.0) .02c





















Model 1 0.5 (0.3 to 0.7) <.001 0.2 (0.1 to 0.2) <.001 0.2 (0.1 to 0.2) <.001
Model 2 0.4 (0.2 to 0.5) <.001c 0.1 (0.1 to 0.2) <.001c 0.2 (0.1 to 0.2) <.001c
Term children 
(n=2718)
Model 1 0.4 (0.1 to 0.8) .01 0.1 (0.05 to 0.2) .003 0.1 (0.01 to 0.2) .03
Model 2 0.2 (-0.1 to 0.6) .13 0.1 (0.03 to 0.2) .01c 0.1 (0.01 to 0.2) .03c
Abbreviations: GAB, gestational age at birth.
a In the results of these regression models, the effect estimates represent the difference in cubic centimeters for 
brain volumes per 1-week-longer gestational duration. Model 1 is a minimally adjusted model corrected for 
child sex and age at the neuroimaging assessment. Model 2 is a fully adjusted model, corrected for child sex and 
age at the neuroimaging assessment, maternal ethnicity, age at intake, marital status, educational level, psycho-
pathologic condition, smoking and alcohol use during pregnancy, and family income.
b Intracranial volume was additionally adjusted for in both models.
c The associations survived a false discovery rate correction for multiple testing (applied model 2 only).
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Cerebral Cortex Morphometry
Cortical thickness and GAB were associated in a few small regions of the superior 
temporal lobe, cuneus, and inferior parietal lobe, exhibiting local reduction of cortical 
thickness (Figure 2A). In contrast, the association of GAB with cortical surface area 
was widespread across the neocortex (Figure 2B). Longer gestational duration was as-
sociated with larger surface area in the inferior and superior parietal regions, inferior 
and middle temporal regions, middle frontal and orbitofrontal regions, rostral anterior 
cingulate, and fusiform gyrus. Likewise, widespread positive associations of GAB and 
neocortical gyrification, including superior parietal lobe postcentral region, fusiform 
gyrus, insular cortex, and anterior cingulate cortex, were observed (Figure 2C). Results 
were similar in children born at term (Figure 3). Gestational age at birth was associated 
with a thinner cortex in the superior temporal region (Figure 3A), with larger surface 
area and gyrification in the frontal, parietal, and temporal regions (Figure 3B and 
C). Specific information on the associated brain regions (size, Talairach coordinates, 
and P values) are presented in eTables 2 and 3 in the Supplement.
Figure 1. Linear relationship between gestational age at birth and total brain volume in all children (left, 
n=3079) and only the term birth children (right, n=2718) at age 10 years. Models were fully adjusted and cor-
rected for child sex, age at the neuroimaging assessment, and maternal ethnicity, age at intake, marital status, 
educational level, psychopathology during pregnancy, smoking and alcohol use during pregnancy, and family 
income. Shaded areas indicate the 95%CIs of the predicted values.
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Figure 2. Gestational age at birth and cortical thickness, surface area, and gyrification in all children.
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Nonlinear Associations
We found no evidence of nonlinear associations of GAB with brain volume and mor-
phometry. Models with quadratic or natural cubic splines did not improve model fit 
compared with linear models (eTable 4 in the Supplement).
Categorical Analyses
With the use of a categorical approach, children born preterm had a smaller total brain 
volume, cerebral gray matter volume, subcortical gray matter volume, cerebellar gray 
matter volume, and cerebellar white matter volume. Total brain volume of children 
born preterm had an adjusted difference of 26.5 cm3 compared with children born at 
term (B = −26.5; 95% CI, −42.1 to −11.0). Children born post-term had a larger cerebral 
gray matter volume and subcortical gray matter volume (eTable 5 in the Supplement).
Figure 2. Gestational age at birth and cortical thickness, surface area, and gyrification in all children (contin-
ued). Surface-based analysis was performed for 3065 children with a gestational age at birth ranging from 26.3 
to 43.4 weeks. The model was adjusted for child sex, age at neuroimaging, maternal ethnicity, age at intake, 
marital status, educational level, psychopathology during pregnancy, smoking and alcohol use during preg-
nancy, and family income. The color bar shows the -log p-value of the cluster. Colored clusters represent regions 
of the brain that were positively (red to yellow) and negatively (dark to light blue) associated with gestational 
age at birth that survived the cluster-wise (Monte Carlo simulation with 5,000 iterations) correction for multiple 
comparisons (P < .001) (eTable 2 in the Supplement). A indicates anterior; I, inferior; L, lateral; LH, left hemi-
sphere; M, medial; P, posterior; RH, right hemisphere; S, superior.
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Sensitivity Analyses
Sensitivity analyses of children born at term without perinatal complications (n = 2264) 
showed similar associations between GAB and total brain matter (5.5 cm3/wk; 95% 
CI, 2.2-8.7 cm3/wk), cerebral gray matter (3.1 cm3/wk; 95% CI, 1.4-4.8 cm3/wk), cere-
bral white matter (2.1 cm3/wk; 95% CI, 0.5-3.6 cm3/wk), cerebellar white matter (0.1 
cm3/wk; 95% CI, 0.02-0.2 cm3/wk), and subcortical gray matter (0.1 cm3/wk; 95% CI, 
0.01-0.2 cm3/wk) volumes. However, in this subgroup, GAB was not associated with 
cerebellar gray matter volume (0.1 cm3/wk; 95% CI, −0.2 to 0.5 cm3/wk).
Nonresponse Analyses
Respondents differed from nonrespondents (eTable 6 in the Supplement). Specifically, 
respondents were older, were more likely of Dutch origin, had a higher educational 
level, and were less likely to smoke during pregnancy.
Figure 3. Gestational age at birth and cortical thickness, surface area, and gyrification in children born at term.
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Figure 3. Gestational age at birth and cortical thickness, surface area, and gyrification in children born at term 
(continued). Surface-based analysis was performed for 2706 children with a gestational age at birth ranging 
from 37.0 weeks to 41.9 weeks. The model was adjusted for child sex, age at neuroimaging, maternal ethnicity, 
age at intake, marital status, educational level, psychopathology during pregnancy, smoking and alcohol use 
during pregnancy, and family income. The color bar shows the -log p-value of the cluster. Colored clusters rep-
resent regions of the brain that were positively (red to yellow) and negatively (dark to light blue) associated with 
gestational age at birth that survived the cluster-wise (Monte Carlo simulation with 5,000 iterations) correction 
for multiple comparisons (P < .001) (eTable 3 in the Supplement). A indicates anterior; I, inferior; L, lateral; LH, 
left hemisphere; M, medial; P, posterior; RH, right hemisphere; S, superior.
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DISCUSSION
In this longitudinal, population-based cohort study, we found that GAB was positively 
associated with global and regional brain volumes in children at 10 years of age. Our 
findings suggest that the volumetric association with GAB is a consequence of larger 
cortical surface area and gyrification in the absence of widespread differences in corti-
cal thickness. Our results were robust to confounding by several sociodemographic 
and lifestyle characteristics. Of importance, we found that these associations remained 
present when restricting the analyses exclusively to children born at term, which 
supports a model in which gestational duration should be viewed as a continuum of 
development throughout pregnancy. Moreover, we observed no evidence of nonlinear 
associations using spline regression analyses, a flexible and sensitive method for assess-
ing nonlinearity. In addition, child sex did not moderate the association of GAB with 
brain morphometry. Overall, these findings suggest that a cutoff for the designation 
of preterm birth as less than 37 weeks of gestation may not be consistent with brain 
development.
By reporting associations of GAB with global and regional brain volumes, our find-
ings complement previous neuroimaging studies demonstrating that longer gestational 
duration was associated with larger temporal and parietal gray matter volumes25 and 
reporting linear associations of higher GA with enhanced local and global network ef-
ficiency.26 These results are further supported by our findings that GAB was associated 
with brain regions that are functionally and structurally integrated (e.g., the cerebel-
lum and thalamus) (eFigure 4 in the Supplement). In addition, temporal and parietal 
regions (Figure 2  and  Figure 3) are involved in higher-order cognitive processes, 
including auditory perception and processing, language production and perception, 
and declarative memory. Even though larger brain size typically has been associated 
with enhanced cognitive functioning (including general cognitive ability, working 
memory, reading, vocabulary, and set-shifting tasks) in children and adolescents,49,50 a 
previous longitudinal study51 found that neuroanatomical correlates of intelligence, for 
example, are dynamic and change throughout life. The association between psychiatric 
disorders and brain size is less evident, but clinical studies52-54 in children with ADHD 
found smaller volumes in frontal, parietal, and cerebellar structures. Furthermore, 
individual variations in brain size and shape occur.55 Caution is warranted regarding 
potential functional consequences of the observed association between GAB and brain 
morphometry.
Several mechanisms are possible. First, the largest absolute volumetric increase in 
brain volume during fetal development occurs during the third trimester, in particular, 
the expansion of cortical gray matter.13,56-58 The growth rate of the cerebellum also peaks 
during the third trimester.59 Therefore, on the basis of the observed linear association 
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with global brain volume across the full range of GAB, a parsimonious explanation 
could be that birth is necessary and sufficient to attenuate the rapid expansion of the 
neocortex in the late third trimester. In contrast, we did not observe extensive differ-
ences by GAB in cortical thickness. Cortical neurogenesis and proliferation are largely 
complete by the middle of gestation.13,14 In addition, cortical lamination (i.e., inside-out 
layering of the cortex) is already well established by the eighth month of pregnancy, 
although timing appears to differ slightly among brain regions.14
Second, GAB is often associated with multiple factors,60  including psychological 
distress, maternal age, substance use, poor nutrition, or fetal growth restriction. Such 
stress-associated factors may affect the timing of birth and fetal maturation. In line 
with the developmental origins of health and disease framework, the current study 
suggests that even small variations in GAB may be associated with fetal programming 
differences in neurodevelopment.61 Our results suggest that among healthy term-born 
children, GAB may be linearly and positively associated with brain volume, surface 
area, and gyrification when assessed in childhood at 10 years of age. Although we con-
sidered a variety of confounding factors, we cannot exclude the possibility of residual 
confounding.
Third, our results could potentially be explained by genetic predisposition. Previous 
studies30,62-65 reported genetic variations that are associated with gestational duration. 
For instance, Adkins et al62  found polymorphisms of insulin and insulin-like growth 
factor 2 associated with an increased risk of being small for gestational age. Moreover, 
several maternal and fetal genes have been identified through recent genome-wide 
association studies63,64  of gestational duration and preterm birth. Genetic factors as-
sociated with global and specific brain volumes have also been reported.30,65 Thus, our 
findings potentially can be explained by a shared genetic susceptibility that is associ-
ated with gestational duration and brain morphometry. However, it is likely that both 
genetic and environmental factors explain the observed associations.
Further research is needed to investigate underlying mechanisms and causal path-
ways of the association between GAB and childhood brain structure and function. The 
results would be particularly important for obstetricians, neonatologists, and pediatri-
cians. The findings of the present study have substantial potential clinical importance, 
considering the discussions regarding expectant management vs labor induction66 and 
the increasing prevalence of elective cesarean deliveries worldwide, which are typically 
planned 1 or 2 weeks before the estimated full-term date.67 In line with recommenda-
tions of the World Health Organization, our results cautiously support a reduction of 
elective cesarean deliveries.
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Strengths and Limitations
Study strengths were the prospective design, which enabled a temporal association 
between GA and brain morphometry; measurement of GAB by ultrasonography; 
adjustment for multiple confounders; and large-scale pediatric neuroimaging (>3000 
children), allowing for detection of small effect sizes.
Several limitations should also be mentioned. First, brain morphometry was 
measured only once, at 10 years of age; thus, whether the observed differences were 
transient or persistent is unknown. Second, although childhood brain structure has 
been associated with a diversity of cognitive, emotional, and sensorimotor functions 
in the general population,68 we cannot yet address the functional implications of the 
observed morphologic differences. Although the current study was specifically focused 
on examining brain morphometry, future studies should investigate the associations 
of GAB with repeated assessments of brain morphometry and multimodal imaging 
in combination with behavioral and cognitive outcomes in large population-based 
cohorts. Third, the nonresponse analyses suggested a possible selection bias. Fourth, 
because this was an observational study, unmeasured residual (genetic and environ-
mental) confounding limited the ability to establish causal inferences.
CONCLUSIONS
The findings of this study suggest that GAB is associated with widespread differences in 
childhood brain morphometry in children born at term. Longer gestational duration 
was associated with larger brain volume, cortical surface area, and cortical gyrifica-
tion. Thus, physiologic processes during in utero development may have an enduring 
influence across the life span. Our findings highlight the importance of the last few 
weeks of pregnancy in association with neurodevelopment for which additional studies 
are warranted to evaluate the potential effect on international clinical guidelines for 
elective cesarean delivery.
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9506 singleton live children 
9418 children with information on gestational age at birth 
88 without information on gestational age at birth 
5669 children visited the research center at 9-12 years 
1148 withdrawn or loss to follow-up 
3857 children underwent neuroimaging assessment 
1812 did not have neuroimaging assessment 
3079 children with usable neuroimaging data 
44 with heterogeneous scanning parameters  
89 with missing T1-weighted MRIs or artifacts 
23 with major incidental findings 
622 with insufficient image quality 
8270 children were invited at 9-11 years 
2601 did not show up 
eFigure 1. Flow diagram
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eFigure 2. Global brain volumes in children born early term, full term and late term. Brain volumes of children 
born at term (n=2718) are represented in three subgroups (early term, n=506; full term, n=1599; and late term, 
n=613). Early term are births occurring between 37 weeks 0 days and 38 weeks 6 days; full term children are 
those at 39 weeks 0 day through 40 weeks 6 days; late term refers to those at 41 weeks 0 day through 41 weeks 
6 days. Covariates including child sex, age at MRI scan, maternal ethnicity, age at intake, marital status, educa-
tional level, psychopathology during pregnancy, smoking and alcohol use during pregnancy, and family income 
were adjusted. The model with subcortical gray matter as the outcome was additionally adjusted for intracranial 
volume. Statistical differences as indicated by the * p<.01 or p<.05 are comparisons of the three groups with 
children born full term as the reference.
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eFigure 3. Linear relationship between gestational age at birth and total brain volume in all children (left, 
n=3079) and only the term birth children (right, n=2718) at age 10 years visualized with an additional heatmap. 
Models were fully adjusted, corrected for child sex, age at the neuroimaging assessment, and maternal ethnicity, 
age at intake, marital status, educational level, psychopathology during pregnancy, smoking and alcohol use 
during pregnancy, and family income.
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eFigure 4. The association of gestational age at birth with subcortical gray matter volumes in children. Estimated 
differences (with 95% confidence intervals) in subcortical gray matter structures (in standardized z-scores) per 
week increase in gestational age at birth were computed using regression analyses in n=3079 children. Model 1 
was a minimally adjusted model, corrected for child sex, age at the neuroimaging assessment, and intracranial 
volume. Model 2 was a fully adjusted model, corrected for child sex, age at the neuroimaging assessment, and 
intracranial volume, maternal ethnicity, age at intake, marital status, educational level, psychopathology during 
pregnancy, smoking and alcohol use during pregnancy, and family income.
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eTable 1. Gestational age at birth and brain volumes at age 10 years: interaction of GA with sex
Global brain volumes
Statistics of GAB × sex (interaction term)
Difference 95% CI P-value
Total brain 0.3 -3.3 to 3.9 0.88
Cerebral gray matter 0.3 -1.6 to 2.2 0.74
Cerebral white matter 0.1 -1.5 to 1.8 0.89
Cerebellar gray matter -0.2 -0.6 to 0.2 0.37
Cerebellar white matter 0.003 -0.1 to 0.1 0.96
Subcortical gray matter * 0.01 -0.1 to 0.1 0.85
The linear regression model examined the association of gestational age at birth (GAB) with global brain vol-
umes in n=3079, in combination with an interaction term of GAB and sex. The model was adjusted for child sex 
and age at MRI scan, maternal ethnicity, age at intake, marital status, educational level, psychopathology during 
pregnancy, smoking and alcohol use during pregnancy, and family income.
* Intracranial volume was additionally adjusted for.
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Thickness Left superior temporal 446.2 -45.7 6.2 -22.3 .0001
Left superior frontal 404.0 -12.5 53.9 4.2 .0001
Left cuneus 230.0 -5.8 -96.7 11.5 .003
Right superior temporal 371.7 46.6 12.1 -27.1 .0001
Right inferior parietal 171.0 33.2 -68.8 26.6 .02
Surface area Left post central 5831.4 -58.1 -17.4 19.3 .0001
Left inferior parietal 3132.5 -32.9 -76.5 21.4 .0001
Left rostral anterior 
cingulate
2442.3 -5.3 16.9 -6.8
.0001
Left middle temporal 2220.1 -60.8 -17.8 -16.3 .0001
Left caudal middle frontal 1347.2 -33.3 11.2 27.2 .0001
Left inferior temporal 937.1 -46.0 -50.6 -12.4 .0001
Left superior parietal 403.0 -16.0 -86.0 36.5 .007
Right middle temporal 16130.7 57.8 -16.1 -17.7 .0001
Right inferior parietal 5130.1 34.3 -71.5 23.9 .0001
Right fusiform 1176.6 39.5 -65.3 -15.6 .0001
Right rostral anterior 
cingulate
866.8 5.4 19.6 -7.2
.0001
Right lateral orbitofrontal 457.5 41.1 26.3 -14.6 .004
Right medial orbitofrontal 320.0 8.7 61.5 -4.6 .02
Gyrification Left superior parietal 27509.9 -14.6 -86.2 36.0 .0001
Left post central 11987.8 -46.7 -11.8 17.6 .0001
Left fusiform 642.5 -40.6 -55.4 -14.2 .002
Right insula 35998.0 37.9 -13.7 21.5 .0001
Right rostral anterior 
cingulate
4780.7 10.2 40.2 4.8
.0001
# Brain regions represent colored areas in Figure 2A, 2B and 2C.
A surface-based analysis was performed in n=3065 children. The model was adjusted for child sex, age at MRI 
scan, maternal ethnicity, age at intake, marital status, educational level, psychopathology during pregnancy, 
smoking and alcohol use during pregnancy, and family income. The list of clusters represent brain regions of 
surface-based metrics that were associated with gestational age at birth, which survived the cluster-wise correc-
tion for multiple comparisons.
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Thickness Left superior temporal 242.3 -41.4 8.4 -27.5 .003
Surface area Left inferior parietal 1995.7 -30.8 -70.7 29.2 .0001
Left lateral orbitofrontal 865.1 -11.5 58.3 -17.6 .0001
Left middle temporal 419.4 -61.9 -35.9 -14.1 .006
Left caudal middle frontal 345.6 -35.2 14.2 30.2 .01
Left inferior temporal 342.8 -51.4 -42.9 -24.0 .02
Right superior frontal 2270.4 19.4 16.8 58.2 .0001
Right superior temporal 820.6 52.6 -26.7 -0.7 .0001
Right frontal pole 781.9 7.8 63.7 -5.9 .0001
Right middle temporal 672.1 63.0 -12.4 -18.5 .0002
Right pars opercularis 535.9 50.4 8.7 1.5 .001
Right superior parietal 458.4 10.4 -84.2 37.0 .004
Right superior parietal 308.1 30.8 -59.0 45.2 .02
Gyrification Left precuneus 8230.8 -7.7 -51.2 52.5 .0001
Left post central 4942.1 -40.8 -15.9 20.7 .0001
Left superior frontal 4024.7 -14.3 46.5 2.0 .0001
Left inferior parietal 1138.2 -45.3 -75.9 12.5 .0001
Left supra marginal 913.1 -56.3 -52.9 18.0 .0001
Left fusiform 501.0 -39.4 -45.1 -19.0 .005
Right superior parietal 9412.3 24.3 -74.1 39.9 .0001
Right insula 8625.0 36.7 -27.0 6.2 .0001
Right medial orbitofrontal 3335.2 9.3 56.5 -3.3 .0001
# Brain regions represent colored areas in Figure 3A, 3B and 3C.
A surface-based analysis was performed in 2706 children born at term. The model was adjusted for child sex, 
age at MRI scan, maternal ethnicity, age at intake, marital status, educational level, psychopathology during 
pregnancy, smoking and alcohol use during pregnancy, and family income. The list of clusters represent brain 
regions of surface-based metrics that were associated with gestational age at birth, which survived the cluster-
wise correction for multiple comparisons.
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All children (N=3079) Children born at term (N=2718)
Linear Quadratic Natural cubic 
splines
Linear Quadratic Natural cubic 
splines
Reference P-value P-value Reference P-value P-value
Total brain - .33 .31 - .25 .31
Cerebral gray 
matter
- .17 .16 - .50 .63
Cerebral white 
matter
- .52 .50 - .23 .26
Cerebellar gray 
matter
- .90 .86 - .06 .06
Cerebellar white 
matter
- .26 .27 - .26 .23
Subcortical gray 
matter*
- .84 .75 - .90 .86
In all children (n=3079) and children born at term (n=2718), nonlinear models with a quadratic term or natural 
cubic splines were compared to linear models using likelihood ratio test. P-value <.05 would have suggested 
improved model fit of the non-linear models. For the natural cubic splines model the knot was set at 37 weeks 
(for all children) or 40 weeks (for children born at term). All models were corrected for child sex and age at the 
neuroimaging assessment, maternal ethnicity, age at intake, marital status, educational level, psychopathology, 
smoking and alcohol use during pregnancy, and family income.
* Intracranial volume was additionally adjusted for.
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eTable 5. The association of gestational age at birth in categories with global brain volumes
Group Model N
Total brain volume Cerebral gray matter 
volume




P-value Difference (95% 
CI)






2718 Reference - Reference - Reference -
Preterm 138 -35.4 (-51.6 to 
-19.1)
<.001 -22.1 (-30.7 to 
-13.5)









2718 Reference - Reference - Reference -
Preterm 138 -26.5 (-42.1 to 
-11.0)
<.001# -17.3 (-25.5 to 
-9.1)
<.001# -5.8 (-12.9 to 1.4) .12
Post-
term
223 10.5 (-1.9 to 
22.8)
.10 7.7 (1.2 to 14.2) .02# 1.6 (-4.1 to 7.3) .58
Group Model N
Cerebellar gray matter 
volume
Cerebellar white matter 
volume




P-value Difference (95% 
CI)






2718 Reference - Reference - Reference -
Preterm 138 -3.5 (-5.3 to -1.8) <.001 -0.9 (-1.3 to -0.4) <.001 -0.8 (-1.3 to -0.4) <.001
Post-
term




2718 Reference - Reference - Reference -
Preterm 138 -2.6 (-4.3 to -1.0) .002# -0.8 (-1.2 to -0.3) .002# -0.8 (-1.3 to -0.4) <.001#
Post-
term
223 0.7 (-0.6 to 2.0) .31 0.4 (-0.01 to 0.7) .06 0.7 (0.3 to 1.0) <.001#
In the results of these regression models, the effect estimates represent the difference in cm3 for brain volumes in 
preterm or post-term born children compared to term born children. Model 1 is a minimally adjusted model cor-
rected for child sex and age at the neuroimaging assessment. Model 2 is a fully adjusted mode, corrected for child 
sex and age at the neuroimaging assessment, maternal ethnicity, age at intake, marital status, educational level, 
psychopathology, smoking and alcohol use during pregnancy, and family income.
* Intracranial volume was additionally adjusted for in both models.
# The associations survived a false discovery rate correction for multiple testing (applied model 2 only).
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Age at intake, mean (sd), year 31.1 (4.9) 29.3 (5.5) <0.001
Multiparous (%) 11.8 16.3 <0.001
Pregnancy complications (%) b 6.4 7.3 0.14
Ethnicity (%)
<0.001
 Dutch 57.5 46.0
 Non-Dutch Western 12.2 11.1
 Non-Dutch Non-Western 30.3 43.0
Educational level (%)
<0.001
 Primary or lower 7.2 13.8
 Secondary 41.1 48.8
 Higher 51.7 37.4
Family income, per month (%)
<0.001
 Less than €1200 15.9 24.8
 €1200 to €2000 16.9 20.2
 More than €2000 67.2 55.1
Marital status, married or with partner (%) 88.2 83.9 <0.001
Smoking during pregnancy (%)
<0.001
 Never in pregnancy 77.3 71.3
 Until pregnancy was known 8.6 8.3
 Continued in pregnancy 14.1 20.4
Alcohol use during pregnancy (%)
<0.001
 Never in pregnancy 40.1 52.0
 Until pregnancy was known 13.9 12.6
 Continued in pregnancy, occasionally 36.3 29.3
 Continued in pregnancy, frequently c 9.7 6.1
Psychopathology, mean (sd) 0.3 (0.4) 0.3 (0.4) <0.001
Birth and child characteristics
Cesarean delivery (%) 12.4 12.6 0.96
Suspected fetal distress (%) 7.7 7.8 0.88
Apgar at 5 minutes below 7 (%) 1.1 1.4 0.31
Gestational age at birth, mean (sd), week 39.9 (1.8) 39.7 (2.0) <0.001
 Range 3444.8 (554.1) 3391.4 (566.9) <0.001
Birth weight, mean (sd), gram 49.8 51.1 0.25
Sex, boy (%) 10.1 (0.6) 10.2 (0.8) 0.68
Age at MRI scan, mean (sd), year 31.1 (4.9) 29.3 (5.5) <0.001
Abbreviation: MRI, magnetic resonance imaging
Non-respondents are participants with data on gestational age at baseline, but no neuroimaging data at follow-
up. P-values were derived from t-tests for or Wilcoxon tests for continuous variables and chi-square tests for 
categorical variables.
a. Imputed data were reported.
b. Included occurrence of preeclampsia, diabetes, and/or pregnancy induced hypertension.






Chapter 5. General discussion
225
DISCUSSION
Investigations of child brain development that could underlie the associations of ma-
ternal adversities during the perinatal period with child cognitive and neuropsychiatric 
outcomes remain scarce. This thesis examined several perinatal determinants including 
maternal depressive symptoms, nutrient status, and gestational duration in relation to 
child brain morphology and white matter microstructure in a population-based neu-
roimaging study. In this chapter, the main findings are summarized and elucidated, 
methodological considerations for relevant studies are suggested, and clinical implica-
tions and future scientific directions are provided.
Main findings and interpretation
Perinatal determinants of child brain morphology
In chapter 2, we first investigated prenatal and postnatal maternal depressive symptoms 
in relation to offspring brain morphology, including white matter microstructure, in 
childhood and preadolescence. We showed that exposure to prenatal maternal depres-
sive symptoms was associated with lower fractional anisotropy (FA) and higher mean 
diffusivity (MD) in specific tracts of the limbic system in children aged 6-9 years, 
although the lower FA in the cingulum could potentially be explained by genetic pre-
disposition and shared environmental family factors. In the second study, we presented 
single-time-point analysis and trajectory analysis of maternal depressive symptoms, 
showing that maternal depressive symptoms during the perinatal period predicted 
lower total gray matter and total white matter volumes as well as lower FA in chil-
dren at age 9-11 years. Maternal depressive symptoms at child age of 2 months likely 
play a more prominent role for offspring brain development than symptoms during 
pregnancy. Further, no evidence for associations of maternal depressive symptoms in 
childhood (i.e., at 3 years and 10 years) with offspring brain development at age 6-11 
years was observed.
In chapter 3, multiple nutrients of the mother during pregnancy in relation to child 
brain development were examined. In chapter 3.1, no evident associations between ma-
ternal gestational vitamin D status at single assessments (i.e., in mid-gestation and upon 
delivery) and child brain morphology were found. However, compared to children with 
persistently sufficient vitamin D levels [i.e., 25(OH)D ≥ 50 nmol/L] from mid-gestation 
to birth, those persistently exposed to deficient vitamin D status [i.e., 25(OH)D < 25 
nmol/L] displayed lower brain volumes and cortical differences, e.g., less surface area in 
the frontal lobe in the right hemisphere and less gyrification in the temporal lobe in the 
left hemisphere. In chapter 3.2, we reported that children exposed to maternal folate 
deficiency (i.e., <7 nmol/L) during pregnancy had lower total brain volume and white 
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matter volume. We also performed an analysis on repeated brain measures, showing 
that the global volumetric differences originated from the third trimester and persisted 
across childhood. In chapter 3.3 and 3.4, we examined maternal fatty acid concentra-
tions during pregnancy and child brain development. The results suggested an inverted 
U-shaped association between maternal ω-3 polyunsaturated fatty acids (PUFAs) levels 
and child total gray and total white matter volumes. Further, we showed that higher 
maternal trans fatty acids (TFAs) concentrations during pregnancy predicted smaller 
fetal head circumference (HC) in the third trimester as well as lower fetal head growth 
rate across the second and third trimesters, and these findings were supported by an 
instrumental variable (IV) analysis using calendar time as the IV (i.e., TFAs concentra-
tion decreased with time due to the TFAs reduction initiatives in the Netherlands). 
We found no evidence for associations between maternal TFAs concentration during 
pregnancy and child global brain volumes at age 9-11 years.
Finally, we showed a linear association between gestational duration and child brain 
morphology in chapter 4.1, whereas most previous studies had focused on preterm 
children only. Specifically, children with a longer gestational duration had larger global 
and regional brain volumes, as well as larger cortical surface area and more gyrification 
at age 9-11 years. Consistent results were obtained when children born preterm and/or 
with maternal or obstetric complications were excluded from the analysis, suggesting 
that every week of gestational duration counts for brain development on the long term. 
These findings are in line with the WHO’s recommendation on reducing unnecessary 
cesarean sections.
Table 5.1 presents an overview of the main findings of this thesis.
Some key messages conveyed from these findings deserve interpretation beyond the 
specific study context. First, in epidemiological studies, commonly reported statistics 
such as p-value suggest the presence of an effect rather than its magnitude, while effect 
size describes the strength of an effect that is independent of sample size and thus 
provides more insight into the clinical importance of the finding.1 Depending on the 
independent variable of interest (i.e., continuous vs. categorical), Cohen’s f2 or Cohen’s 
d (Hedges’ g when the sample size is below 20) can be used to measure effect size in 
a regression model, with Cohen’s f2 < 0.02 or Cohen’s d < 0.2 representing small ef-
fect sizes.2,3 In chapter 2.2, we reported the Cohen’s f2 measures for the association of 
maternal depressive symptoms at postnatal 2 months with offspring total gray matter 
volume and white matter integrity. Both estimates suggested small effect sizes (Cohen’s 
f2=0.004 and 0.003, respectively). When focusing on child total brain volume (TBV) 
as an outcome of interest in the other studies, exposure to persistent 25(OH)D defi-
ciency from mid-gestation to delivery (chapter 3.1, Cohen’s d=0.35) suggested a small 
to medium effect, while gestational folate deficiency (chapter 3.2, Cohen’s d=0.015) 
and gestational duration (chapter 4.1, Cohen’s f2=0.008) both suggested small effects. 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Adjusting for covariates in observational studies contributes to better control of con-
founding bias with the price of reduced effect estimates. This is particularly relevant 
in the current work, where we adjusted for multiple factors on socioeconomic status 
(SES, e.g., maternal education and family income) and lifestyle (e.g., maternal diet, 
smoking, and alcohol use), which are commonly correlated with each other. In addi-
tion, the small effect sizes of maternal depressive symptoms and gestational duration 
are not surprising, because we analyzed all determinants along a continuum and that 
has the advantage of enabling researchers to detect subtle effects.4 It is also important to 
note that birth weight can be a potential intermediate in the relation between maternal 
depressive symptoms and child brain development, thus adjusting for birth weight in 
the regression (chapter 2.1 and 2.2) takes away the indirect effect from the total effect.5 
The population-based nature of the Generation R Study may also explain the small 
effect sizes we reported, because the effects of exposure to adversities in pregnancy may 
be underestimated in a relatively healthy population with few subjects being exposed. 
However, importantly, small effect sizes cannot be interpreted as being ignorable.6 This 
can be particularly true for the health of a population level. In addition, it is likely that 
exposure to multiple adversities during the perinatal period exerts cumulative effects 
on child brain development, and the cumulative effects can be of particular clinical 
relevance for low- and middle-income countries where undernutrition is still common 
among pregnant women.7,8 Furthermore, characterizing effect sizes as small, medium, 
or large using the global conventions has been questioned, especially when differences 
between disciplines and between study designs are dramatic.9 Instead, it is recom-
mended to relate findings to comparable studies with similar characteristics.10 This can 
be implemented in the future with the advance of large-scaled neuroimaging studies.
Second, due to limited prior knowledge, we used an exploratory and hierarchical 
approach that started with examining global brain morphological and white matter 
microstructure measures followed by investigating specific regional structures. Overall, 
our studies showed that the investigated perinatal determinants were related to global 
brain measures including TBV, total gray and white matter volumes, and global FA 
rather than regional measures such as the volumes of the amygdala and hippocampus. 
Most likely, the global effects can be explained by the rapid and tremendous brain 
growth in fetal life that is not specific to certain structures. In addition, because nu-
trients such as vitamin D and folate are involved in multiple physiological functions, 
the impact of exposure to insufficient levels during fetal life on brain development 
can be systematic, i.e., not limited to the generation and growth of specific brain cells. 
Moreover, methods used to investigate effects on regional brain structures independent 
of global effects deserve discussion. Three methods are commonly used to adjust for 
head size (e.g., intracranial volume or TBV) to remove global effects: 1) the propor-
tion approach, namely dividing the region of interest (ROI) volumes by the measure of 
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head size; 2) the analysis of covariance (ANCOVA) approach, namely adjusting for the 
head size as a covariate in the regression model; and 3) the residual approach, namely 
regressing the ROI volume on the head size and extracting the individual residuals as 
the new dependent variable in the regressions of primary interest. Although aiming at 
the same purpose, these methods are not necessarily interchangeable in all settings. For 
example, the ANCOVA approach is superior to the proportion approach when the ROI 
volumes grow at a proportionally slower rate than the global brain volume.11 Therefore, 
different adjustment approaches may yield heterogeneous results, although we only 
used the ANCOVA approach without comparing results using all strategies in the 
current work. Also, notably, by removing global effects, the research question changes 
from ‘whether there is an absolute volumetric difference of the ROI’ to ‘whether there 
is a relative volumetric difference of the ROI (i.e., the volumetric difference of the 
ROI is not proportional to that of global brain volume)’, and their interpretations are 
also different. Here I use subcortical gray matter volume as an example. In chapter 
3.2, we could conclude that prenatal exposure to folate deficiency was related to an 
absolute lower subcortical gray matter volume that could be completely explained by 
the lower global brain volume, thus intrauterine low folate levels likely exert a global 
effect on long-term brain development. In contrast, gestational duration was positively 
related to subcortical gray matter volume regardless of adjustment for intracranial 
volume, suggesting that the absolute larger subcortical gray matter also counts for a 
larger proportion of the whole brain. Absolute subcortical volumes are often collected 
when establishing the volume trajectory across the lifespan,12 while relative subcortical 
volumes are mostly used in clinical research to investigate the morphological basis for 
neuropsychiatric outcomes.13-15 In this thesis, we chose not to adjust for intracranial 
volume in analyses of global measures such as TBV and total gray and white matter 
volumes given their high correlations (i.e., around or above 0.9) that are commonly 
seen in pediatric populations. We decided not to adjust for intracranial volume when 
examining less global measures such as cerebellar volume and frontal lobar volume 
either, because they are moderately-to-highly correlated with intracranial volume (i.e., 
0.6 to 0.8). However, there could be some space for augment and debate concerning 
these structures.
Child brain morphology and neurocognitive outcomes
One central goal of neuroimaging studies is to translate findings to clinical outcomes.1 
While our primary goal was to identify perinatal determinants of child brain mor-
phometry, we also examined if the observed brain differences were associated with 
cognitive and neuropsychiatric outcomes using mediation analysis.16,17 In chapter 2.2, 
we reported that total gray matter volume mediated the relation between maternal 
depressive symptoms at postnatal 2 months and child attention problems at age 10 
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years. However, in the other studies of this thesis there was no evidence for mediation 
by brain morphology in the associations of the various determinants with cognitive 
and behavioral outcomes after adjustment for covariates.
Several explanations for the few associations with neuropsychiatric outcomes 
mediated by brain morphological differences are possible. First, null findings of the 
fully corrected mediation analyses may be attributed to insufficient statistical power. 
Although we had large sample sizes for neuroimaging analyses, not all children had 
neuropsychiatric data that could be used for mediation analyses. Except for chapter 2.2 
where the Brief Problem Monitor (BPM) data were available in 1760 children, we com-
monly ended up with much smaller sample sizes for mediation analyses. For example, 
we showed in chapter 3.3 that an indirect effect was only found in the unadjusted model 
with a sample size of 484. Covariates might explain the heterogeneous findings, but 
the possibility that the mediation analysis became underpowered due to the inclusion 
of model parameters (i.e., covariates) could not be ruled out.18 Second, we used child-
report BPM in chapter 2.2 and maternal-report Child Behavior Checklist (CBCL) in 
chapter 3.2 to assess child emotional and behavioral problems, and the CITO (Centraal 
Instituut voor Test Ontwikkeling, English: Central Institute for Test Development) test 
(chapter 3.3) to indicate child cognitive performance. These specific measurements 
obtained from a certain informant were selected in accordance with the study design 
to reduce bias due to single informant (i.e., systematically biased responses), because 
other informants had reported on the determinant.19 However, it is important to note 
that significant within and between-subject variation of behavior and cognition may 
be observed in the specific contexts.20 Indeed, previous work in our research group 
has shown divergent scores when using child emotional and behavioral data reported 
by different informants.21 Therefore, a null finding from the mediation analysis can be 
attributed to child neurocognitive measures of inadequate validity due to not combin-
ing multi-informant data.22 Third, since most of the neuropsychiatric outcomes used 
in the current thesis were collected at the same age as the neuroimaging assessment 
(i.e., 9-11 years), it is possible that offspring mental disorders with elevated incidence 
in adolescence and early adulthood, such as depression and schizophrenia, can only 
be predicted by brain morphological differences occurring earlier in life, thus with a 
latency period.23,24 Importantly, the ongoing data collection of the Generation R Study 
using a clinical psychiatric interview between the age of 17-19 years will enable such 
follow-up investigations.




Nutritional data in most large epidemiological studies in humans are based on 
questionnaire-based food intake measurements, which are inherently challenged by 
information bias.25 In chapter 3.2, we observed a positive relation between maternal 
plasma folate concentration and child total brain volume, whereas no association was 
found when examining maternal folic acid supplementation use after adjusting for all 
covariates. Despite the self-report nature that affects reliability, folic acid supplementa-
tion use is correlated with SES indicators including education and employment status 
(a proxy of income).26 Consequently, adjusting for SES indicators in the regression 
model likely also takes away the effects of folic acid supplementation. In addition, 
absorption function of the gastrointestinal tract and genetic variance play vital roles in 
the metabolism of nutrients such as folate and fatty acids, leading to a low correlation 
between dietary questionnaire assessments and circulating biomarkers.27-29 Therefore, 
biomarkers of food intake should be preferred when the goal is to validly assess the 
bio-availability of nutrients with minimal misclassification.30
Moreover, it is common that various biomarkers can be used to measure one nutri-
ent, and biomarkers can be categorized into short-term (reflecting intake over past 
hours/days), medium-term (reflecting intake over weeks/months) and long-term 
markers (reflecting intake over months/years) depending on the type of sample used.31 
For example, maternal folate was assessed from venous blood and expressed as plasma 
concentration in our study (chapter 3.2), but folate availability can also be quantified 
using red blood cell (RBC, or erythrocyte) folate assay. Compared to plasma folate, RBC 
folate is less correlated with homocysteine and may give a better assessment of folate 
status in special cases such as after hemodialysis and between pregnancies, but its assay 
has higher costs.32 There is evidence showing that RBC folate measurements and plasma 
folate measurements provide equivalent information on identifying folate deficiency,33 
although the relation between RBC and plasma folate concentrations can be modified 
by factors such as BMI and genotype.34 In addition, plasma folate concentrations are 
more sensitive to folic acid supplementation than RBC folate concentrations.35 Given 
a lack of indications, we see no superiority of using one measure over the other in our 
study context. Similarly, both plasma fatty acids and RBC fatty acids can be assessed to 
quantify fatty acid availability, and they are moderately to strongly correlated with fatty 
acid intake assessed by food frequency questionnaire (FFQ). However, RBC fatty acids 
are superior to plasma fatty acids as biomarkers reflecting long-term fatty acids intake 
given the much longer half-life of RBC than that of plasma lipoproteins.36 Since fatty 
acids were only assessed once during pregnancy in our studies (chapter 3.3 and 3.4), 
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maternal RBC fatty acids might be a better measure than plasma fatty acids to reflect 
the overall fatty acids levels throughout gestation.
Longitudinal data modeling
Longitudinal data with repeated measurements over time are common especially in 
psychological and clinical research. Analysis associating determinants assessed at each 
time point with the outcome separately (or vice versa) can be easily performed to exam-
ine cross-sectional associations. However, modeling repeatedly measured determinants 
or outcomes simultaneously provides valuable insight on potential interaction of the 
determinant with time and/or cumulative effects. Due to the correlation between re-
peatedly measured data, conventional regressions that are subject to the ‘independence’ 
assumption cannot be used for obtaining valid results. In this section, three techniques 
used for modeling repeated measurements in this thesis are elaborated, namely growth 
mixture model (GMM)/latent class growth analysis (LCGA, chapter 2.2), linear mixed 
model (LMM, chapter 3.2), and two-stage mixed effect model (chapter 3.4).37 Other 
methods such as generalized additive mixed model (GAMM) and clustering are also 
available to handle repeatedly measured data,38 but they are not discussed here in detail.
For illustrative purpose I start with methods based on linear regression. LMM con-
tains both fixed effect (i.e., predictions on population level) and random effects (i.e., 
predictions accounting for individual variance) which allow for modeling dependent 
data, and an interaction term between determinant and time variable can be included 
to explore whether the effect of the determinant at baseline on the outcome of interest 
changes over time along the follow-up. In chapter 3.2, we applied LMM to investigate 
maternal folate status during pregnancy in relation to offspring brain developmental 
trajectories across fetal life and childhood, and found no interaction between maternal 
gestational folate status and child age, suggesting that the differences in global brain 
volume we observed in late childhood originated from the third trimester and persisted 
throughout childhood, thus there was no evidence for accelerated brain growth of chil-
dren exposed to deficient folate status in gestation at this stage. In addition, LMM can 
be extended to generalized linear mixed model (GLMM) to cope with outcome data 
from non-normal distributions (e.g., binomial or Poisson).
However, one caveat of LMM is that it cannot be used when the determinants, instead 
of the outcomes, are repeatedly measured. In such case, two-stage mixed effects model 
relating individual patterns of determinant to outcome is a viable approach that can be 
easily implemented. The main idea of this method is to model the repeatedly measured 
determinant Xik using a random intercept and random slope: Xik = θ0i + θ1i × tik + εik, 
where k represents the measurement occasion. The person-specific random intercepts 
θ0i and slopes θ1i jointly describe the pattern of exposure for individual i, which can be 
then associated with the outcome.37 Although this approach is mostly developed for 
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repeatedly measured determinants, it can be used for repeatedly measured outcomes as 
well. For example, we applied this method in chapter 3.4 to only examine the individual 
slopes of fetal HC repeatedly measured in the second and third trimesters (i.e., fetal 
HC growth rate between the two assessments) because we found no differences in the 
intercepts (i.e., fetal HC in the second trimester), and we found children exposed to 
higher maternal TFAs concentrations during pregnancy had slower HC growth. Using 
LMM yielded consistent results in our study, but whether results from two-stage mixed 
effects model and LMM are also comparable when modeling outcome data of three or 
more time points warrants further investigations. It is also important to note that, we 
used these approaches in the above studies because brain growth across mid-gestation 
and childhood is approximately linear.39-41 When non-linear relations are suspected, 
GAMM and/or addition of polynomial terms (or splines) should be considered, with 
the price of complicating the interpretation.
GMM and LCGA are latent variable mixture modeling (LVMM) used for longitu-
dinal data (latent profile analysis or latent class analysis is commonly used for cross-
sectional data).42,43 Conventional regression belongs to variable-centered approaches 
with the assumption that all individuals come from a single population with common 
parameters. In contrast, LVMM is a person-centered approach focusing on similarities 
and differences among people. For example, although allowing for random effects, 
LMM assumes that the growth trajectory of all individuals can be well described using 
a single estimate. However, GMM/LCGA assumes heterogeneity of growth trajectories 
within the whole population.44 In addition, GMM/LCGA applies to both determi-
nant and outcome data with repeated measurements and is very feasible to capture 
non-linear relations by adding polynomial terms based on model fit comparison. In 
chapter 2.2, given the complexity of the course of depression and previous evidence on 
heterogeneity of maternal depressive symptoms during the perinatal period, we applied 
LCGA to model maternal depressive symptoms trajectories from gestation to child-
hood. Interestingly, we identified a group of women with persistently clinically relevant 
depressive symptoms across all four assessments, which was related to smaller brain 
and altered white microstructure of the offspring. This finding complements the single-
time-point analyses, suggesting the potential cumulative effect of exposure to maternal 
depression during the perinatal period on brain development in childhood. LCGA is 
a special case of GMM whereby within-class variance is set to zero, assuming homo-
geneous individual growth trajectories within classes. We used LCGA in this study 
because it contributes to clearer identification of classes, which is in line with our focus 
on between-group difference. In addition, LCGA has substantially less computational 
burden than GMM, especially in large samples with numerous model parameters where 
GMM can easily fail due to statistical problems.44 Further, LVMM determines the most 
likely membership based on posterior probability, thus uncertainty in grouping raises a 
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threat of misclassification of individuals and biased estimates of the relations between 
the latent classes and the auxiliary variables.45 Several approaches are proposed to ad-
dress this issue, but there is a lack of universal solutions.46
The basic features of the three methods discussed in this section are summarized in 
Table 5.2.
Positivity violation in epidemiological studies
In epidemiological studies using observational data, the importance of adequate con-
trol for confounding variables for causal inference is well-known. Moreover, although 
perhaps less-recognized, sufficient variability in treatment (or exposure) assignment 
within strata of confounders, termed as the positivity assumption, is also required to 
obtain valid effect estimates.  Violations and near violations of the positivity assump-
tion can increase both the variance and bias of causal effect estimates.48 Positivity viola-
tions in observational data may be deterministic or random. Deterministic violation 
occurs when participants at 1 or more levels of the confounders cannot receive at least 
1 level of the exposure due to study design or theoretical impossibility, while random 
violation takes place by chance and is commonly seen when the sample size of specific 
treatment groups is small given a relatively large number of confounders.49 Chapter 3.2 
gives a typical example of random positivity violation: when maternal plasma folate 
levels were dichotomized using 7 nmol/L, only 103 children were exposed to folate 
deficiency during pregnancy. The estimated propensity score (i.e., the probability of 
being exposed to folate deficiency) given all covariates was very small, indicating near 
violation of positivity.
Considering the trade-off between bias due to positivity violations and bias due to 
confounding is recommended.50 Practical approaches for this aim include restricting 
the adjustment set (i.e., excluding covariates), restricting the sample (i.e., discarding 
classes of subjects), changing the intervention of interest, and utilizing causal effect 
estimators that are robust to positivity violations.48 Compared to naïve regression, G-
computation and inverse probability of treatment weighting (IPTW), target maximum 
likelihood estimation (TMLE) is a semiparametric method estimating double-robust 
estimators that are less subject to bias due to positivity violation as well as model mis-
classification.51 Therefore, in the sensitivity analysis of chapter 3.2, we applied TMLE 
Table 5.2. Comparison of the three methods for modeling repeatedly measured data
Methods Determinant Outcome Linear assumption
LMM no yes yes*
two-stage mixed effects model yes yes yes*
GMM/LCGA yes yes no
* Polynomial terms or splines can be used for non-linear relations.
Chapter 5. General discussion
235
with the SuperLearner package that improves the performance of TMLE by adaptively 
combining different machine-learning algorithms, and obtained consistent results with 
the primary analysis, suggesting the validity of our findings. However, the slightly dif-
ferent effect estimates (and confidence intervals) obtained from the naïve regression 
and TMLE may be worth noting, especially when the precision of effect estimation is 
crucial. Moreover, since TMLE is an emerging causal inference technique that has not 
been extensively used in epidemiological studies, further empirical investigations are 
needed to evaluate its performance in addressing positivity violation in comparison 
with other approaches.
Clinical implications
Although it is often challenging to utilize group-level differences identified in neuro-
imaging studies to aid decision making for an individual in clinical practice,52 several 
clinical and public health implications can be delivered from the findings of this thesis.
Needs for perinatal maternal depression screening and intervention
Our studies show that maternal depressive symptoms during the entire perinatal pe-
riod may contribute to suboptimal brain development of the offspring, and that the 
substantial brain morphological differences may underlie neuropsychiatric outcomes 
in childhood. These findings highlight the importance of screening and interven-
ing maternal depression throughout the perinatal period to prevent abnormal brain 
development of the offspring, which can hardly be performed with current medical 
technologies. A systematic review shows that the prevalence of maternal depression 
is significantly higher in low- and middle-income countries compared to high income 
countries in both the prenatal and postnatal periods.53 However, most of the screening 
and interventions programs targeting perinatal maternal depression are conducted in 
high-income countries. Furthermore, even in these high-income countries, the uptake 
rates of referrals to on-site assessment or treatment after screening with positive results 
are less than 50%.54 Therefore, policy makers and public health practitioners should 
increase investments on facilitating cost-effective maternal depression screening and 
interventions in low and middle income countries, and it is critical for physicians and 
mental health professionals to promote engagement in perinatal depression interven-
tions after screening among women.
Hints on nutritional recommendations
Chapter 3 of this thesis investigated several nutrients of the mother during pregnancy 
in relation to child brain development, shedding lights on making proper recommen-
dations on nutrients for clinicians and nutritionists. First, we showed that although 
maternal vitamin D levels at single assessments during pregnancy were barely related 
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to child brain development at 10 years, brain morphological differences such as lower 
volume and less gyrification were observed in children exposed to persistently low 
(i.e., insufficient or deficient) vitamin D levels from mid-gestation to birth, and these 
children counted for 57.8% of those with data at both assessments. These findings 
suggest cumulative effects of exposure to inadequate nutrients in utero, advocating 
maintaining sufficient levels of essential nutrients, including but not limited to vita-
min D, throughout the entire pregnancy for offspring brain development. Second, in 
addition to using dichotomized folate status using the cut-off value established based 
on hematologic outcomes or risk of neural tube defects (NTDs), we found a positive 
linear association between maternal plasma folate concentrations along a continuum 
and child total brain volume at age 10 years. Despite the exploratory nature of our 
study, and the fact that amending nutritional recommendations can be a sophisticated 
process involving enormous work such as randomized controlled trials (RCTs) and 
economic assessments,55,56 it may be worth thinking about developing cut-off values 
of nutritional biomarkers that benefit the overall health in both short and long terms. 
Third, industrial trans fatty acids content in food is a global public health concern 
because it is well-known to increase the risk of adverse cardiovascular events. Our 
study showed that higher trans fatty acids levels of the mother during pregnancy also 
predicted smaller HC and slower HC growth of the fetus, justifying the importance 
of reducing trans fatty acids for an optimal neurodevelopment of the offspring. This 
message is particularly relevant in countries and regions where industrial trans fatty 
acids are still widely used.
Reduce cesarean sections for a natural gestational duration
Cesarean sections have become increasingly common worldwide since 1985, when 
the ideal rate for cesarean sections was considered to be between 10% and 15%.57 
Latin America and the Caribbean region had the highest rates of cesarean section (i.e., 
more than 40%) in 2015, while the eastern Europe and central and south Asia regions 
experienced the most rapid increase between 2000 and 2015.58 In the most updated 
recommendation, the WHO concludes that cesarean sections are only required for 
medical indicated reasons.57 Despite the previous findings on the long-term outcomes 
such as increased risk of asthma and obesity in children with a cesarean delivery,59 in 
chapter 4.1 of this thesis we showed that shortened gestational duration as a byproduct 
of cesarean sections was associated with a smaller brain in children, even among those 
born after 37 weeks of gestation. In line with the current WHO recommendations on 
reducing unnecessary cesarean sections, these findings provide evidence for long-term 
impact of shortened gestational duration on child brain development. However, with 
the current evidence it remains controversial to advocate late intervention on delivery, 
because post-term birth has been related to negative cognitive outcomes and more 
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emotional and behavioral problems in childhood and adolescence.60,61 In addition, a 
recent meta-analysis of RCTs suggests better perinatal outcomes such as lower mortal-
ity and fewer neonatal macrosomia in nulliparous women undergoing induction of 
labor at 41 weeks than those receiving expectant management until 42 weeks.62 Further 
investigations, preferably RCTs, may contribute to determining a potential gestational 
duration that optimizes neurodevelopment in childhood and beyond while taking into 
account other health aspects.
Future scientific directions
Based on the Developmental Origins of Health and Disease (DOHaD) theoretical 
frame, this thesis focused on disentangling the research gap: little is known about the 
perinatal determinants of child brain development. Further studies are warranted to 
address caveats of the current studies and examine follow-up questions in this scientific 
direction. First, the studies in this thesis primarily focused on brain morphology at 
age 9-11 years. The growth of the human brain continues across childhood and early 
adulthood with a non-linear developmental pattern as a result of cortical thinning that 
typically accelerates in adolescence.63 To track the subsequent brain development over 
a life course, studies examining neuroimaging outcomes at later ages are needed. Also, 
diffusion tensor imaging (DTI) measures of individual tracts deserve more research 
because they may provide more information on specific brain functions and conditions 
than the global measures. Second, we could not conclude an inverse relation between 
prenatal exposure to high ω-3 PUFAs levels and brain volume in childhood because 
of limited subjects being exposed that resulted in wide confidence intervals of the 
estimates. Follow-up studies should recruit sufficient pregnant women with high ω-3 
PUFAs concentrations to justify whether the inverse relation exists, or there are simply 
ceiling effects. In addition, previous studies on ω-3 PUFAs mostly focused on a few 
ω-3 PUFAs such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), but 
our findings show that neither EPA nor DHA counts for the relation between prenatal 
ω-3 PUFAs exposure and total gray matter volume in childhood. Therefore, the role of 
other individual ω-3 PUFAs in brain development awaits further investigations. Third, 
the observational nature impeded us from inferring causal relations. Future studies 
using an RCT design (if feasible) or implementing methods such as IV analysis and 
target trial emulation in observational studies can help justify causality, based on which 
policies, guidelines and recommendations can be developed.64 Last but not the least, 
in addition to environmental determinants, genetic and epigenetic mechanisms can-
not be ignored in brain development and functioning.65,66 Genetic variants can also be 
used in Mendelian randomization for causal inference. Our attempts to incorporate 
genetic and epigenetic variables into the present work were not successful because of 
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insufficient power due to limited subjects with complete information. Future studies 
including adequate genetic and/or epigenetic data are needed.
Conclusion
The human brain is such a complex organ of our body that I, perhaps also many oth-
ers, constantly wonder whether it is a paradox that the brain is studied by the human 
whose mind is produced by the brain itself. Our exploration of the brain may never 
end, and I would be pleased if this work contributes to a small step forward in this brain 
research marathon. Regardless of all caveats, and despite the fact that some questions 
remain not fully answered and that new knowledge makes new questions arise, our 
work highlights the importance of maintaining a good mental and nutritional status 
during the perinatal period not only for the health of the mother, but also for optimal 
brain development of the next generation.
Chapter 5. General discussion
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SUMMARy
Based on previous evidence suggesting associations of exposure to adversities during 
the perinatal period with cognitive and neuropsychiatric outcomes, this thesis investi-
gated perinatal determinants of brain development in a prospective population-based 
cohort of children and their parents.
Following a brief overview of the human brain structure and developmental process, 
chapter 1 elaborates the ‘Developmental Origins of Health and Disease’ (DOHaD) hy-
pothesis that serves as the theoretical framework for the current efforts, and illustrates 
prior knowledge on the topics of interest. The general and specific aims and setting of 
this thesis are described at the end of this chapter.
In chapter 2, we investigated maternal depressive symptoms in relation to child brain 
development. Chapter 2.1 shows that maternal depressive symptoms during pregnancy 
were related to differences in white matter microstructure in the uncinate fasciculus 
and the cingulum bundle in children aged 6-9 years, but some of these associations 
could be confounded by genetic predisposition or shared family factors (as paternal 
exposure to depressive symptoms also showed association, albeit with smaller effect 
estimates). In chapter 2.2, we used data on maternal depressive symptoms assessed 
repeatedly from pregnancy to late childhood and child neuroimaging data at age 9-11 
years. The single-time-point analysis showed that maternal depressive symptoms at 2 
months postnatally predicted lower total gray matter volume in children aged 9-11 years, 
which also mediated the relation between postnatal maternal depressive symptoms (2 
months) and child attention problems assessed at the 9-11 years visit. The latent growth 
class analyses further suggested that children born to mothers with persistent elevated 
depressive symptoms across the perinatal period had lower total gray and white matter 
volumes as well as reduced global fractional anisotropy. Maternal depressive symptoms 
assessed at 3 years or 10 years were not related to child brain development.
In chapter 3, we examined the associations between intrauterine exposure to sev-
eral nutrients and brain development in childhood. In chapter 3.1, although we found 
little evidence for associations between maternal vitamin D [quantified by 25(OH)D] 
concentrations at single assessments and child brain morphology, children exposed to 
persistently deficient vitamin D levels [25(OH)D < 25 nmol/L] showed less total gray 
and total white matter volumes, as well as regional cortical differences such as smaller 
surface area and less gyrification. These findings suggest the importance of maintain-
ing adequate vitamin D levels throughout the second half of gestation on favorable 
brain development in childhood. As a follow-up of the previous work of our research 
group, chapter 3.2 investigated maternal folate levels during pregnancy and child brain 
morphology assessed at 9-11 years, showing that children exposed to folate deficiency 
(i.e., maternal plasma folate concentration < 7 nmol/L) in utero had lower total brain 
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volume and smaller cerebral white matter compared to the control group. Moreover, 
the analysis of repeated measurements showed that the reduced global brain volume 
originated from the third trimester and persisted until late childhood. In chapter 3.3 and 
3.4, we explored maternal fatty acids status in relation to child brain development. First, 
we found an inverted U-shape relation between maternal plasma ω-3 polyunsaturated 
fatty acids (PUFAs) concentrations and child total gray and white matter volumes at age 
9-11 years, albeit the inverse association at the high-end was not clear given the broad 
confidence intervals. A similar relation was found between maternal docosahexaenoic 
acid (DHA) concentrations and child total white matter volume. No associations were 
observed between maternal PUFAs levels during pregnancy and child white matter 
microstructure. Next, we focused on trans fatty acids (TFAs), a group of fatty acids that 
are mainly artificial and mostly well-known for their adverse effects on cardiovascular 
and metabolic health. Using conventional regression, we found that higher maternal 
TFAs concentrations predicted smaller fetal head circumference in the third trimester 
and slower head growth from the second to the third trimester, although no differences 
in global brain volumes of the child at age 9-11 years were observed. These findings 
were further supported by an instrumental variable analysis using the calendar time of 
maternal TFAs assessment as the instrumental variable.
In chapter 4, we investigated the association of gestational age at birth along a 
continuum with child brain morphometry at age 9-11 years. The results showed that 
gestational age at birth was positively and linearly associated with global and regional 
brain volumes, as well as widespread surface area and gyrification of the child. These 
associations remained consistent, even in the absence of preterm birth or complica-
tions. This study suggests that every gestational week counts for brain development 
and thus unnecessary cesarean sections should be reduced, which is line with the WHO 
recommendation.
Finally, chapter 5 summarizes and interprets the main findings from the above stud-
ies, elucidates methodological considerations, highlights clinical implications, and 
gives future scientific directions.
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SAMENVATTING
Op basis van eerder bewijs dat blootstelling aan moeilijkheden tijdens de perinatale pe-
riode en cognitieve en neuropsychiatrische uitkomsten geassocieerd zijn, onderzocht 
dit proefschrift perinatale determinanten van hersenontwikkeling in een prospectief 
populatiecohort van kinderen en hun ouders.
Na een kort overzicht van de structuur en het ontwikkelingsproces van de menselijke 
hersenen, wordt in hoofdstuk 1 de ‘Developmental Origins of Health and Disease’ 
(DOHaD) -hypothese uitgewerkt die dient als het theoretisch raamwerk voor de 
huidige studies en beschrijf ik bestaande kennis over de besproken onderwerpen. De 
algemene en specifieke doelen en setting van dit proefschrift worden aan het einde van 
dit hoofdstuk beschreven.
In hoofdstuk 2 onderzochten we depressieve klachten van de moeder in relatie 
tot de hersenenontwikkeling van kinderen. Hoofdstuk 2.1 laat zien dat depressieve 
klachten van de moeder tijdens de zwangerschap gerelateerd waren aan verschillen in 
de microstructuur van witte stof in de uncinate fasciculus en de cingulum-bundel in 
kinderen van 6-9 jaar. Sommige van deze associaties kunnen vertroebeld  worden door 
genetische aanleg of gedeelde familiefactoren (blootstelling van vaders aan depressieve 
klachten vertoonde bijvoorbeeld ook associaties, hoewel de grootte van het effect klei-
ner was). In hoofdstuk 2.2 hebben we gegevens over depressieve klachten van de moe-
der, die herhaaldelijk zijn gemeten vanaf de zwangerschap tot de late kinderjaren, en 
neuroimaging-gegevens van kinderen op de leeftijd van 9-11 jaar gebruikt. De analyse 
waarin één tijdspunt meegenomen is, toonde aan dat maternale depressieve klachten 
op 2 maanden postnataal een lager totaal grijze stof volume voorspelden in kinderen 
van 9-11 jaar. Dit lagere grijze stof volume medieerde ook de relatie tussen postnatale 
maternale depressieve klachten (2 maanden) en aandachtsproblemen in kinderen op 
9-11 jaar. De latent class growth analyses suggereerden verder dat kinderen van moe-
ders met aanhoudend verhoogde depressieve klachten gedurende de perinatale periode 
lagere totale grijze en witte stof volumes, en ook verminderde globale fractionele aniso-
tropie hadden. Maternale depressieve klachten, beoordeeld op 3 jaar of 10 jaar, waren 
niet gerelateerd aan de ontwikkeling van de hersenen van kinderen.
In hoofdstuk 3 onderzochten we de associaties tussen intra-uteriene blootstelling aan 
verschillende voedingsstoffen en de ontwikkeling van de hersenen tijdens de kindertijd. 
In hoofdstuk 3.1 vonden we weinig bewijs voor associaties tussen maternale vitamine 
D [gekwantificeerd door 25(OH)D] concentraties (gemeten op één moment) en de 
hersenmorfologie van kinderen. Kinderen die werden blootgesteld aan aanhoudende 
vitamine D deficiëntie [25(OH)D <25 nmol/L] vertoonden lagere totale grijze en totale 
witte stof volumes, maar ook regionale corticale verschillen zoals een kleiner oppervlak 
en minder gyrificatie. Deze bevindingen suggereren dat het belang van is gezonde 
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vitamine D spiegels te behouden gedurende de tweede helft van de zwangerschap 
voor een gunstige hersenontwikkeling tijdens de kindertijd. Als vervolg op eerder 
werk van onze onderzoeksgroep, onderzocht hoofdstuk 3.2 de foliumzuur spiegels van 
de moeder tijden de zwangerschap en de hersenmorfologie van het kind beoordeeld 
op 9-11 jaar. Hierin werd aangetoond dat kinderen die werden blootgesteld aan een 
foliumzuurdeficiëntie (d.w.z., foliumzuur concentratie van de moeder <7 nmol/L) in 
utero, een lager totaal hersenvolume en lager cerebraal witte stof volume hadden, ver-
geleken met de controlegroep. Bovendien toonde de analyse met herhaalde metingen 
aan dat het verminderde globale hersenvolume ontstond in het derde trimester en bleef 
tot in de late kinderjaren bestaan. In hoofdstuk 3.3 en 3.4 hebben we de maternale 
vetzuurstatus onderzocht in relatie tot de hersenenontwikkeling van kinderen. Ten 
eerste vonden we een omgekeerd U-vormige relatie tussen maternale plasmaconcen-
traties van ω-3 meervoudig onverzadigde vetzuren (Engelse afkorting: PUFAs) en de 
totale grijze en witte stof volumes van kinderen op de leeftijd van 9-11 jaar, hoewel de 
omgekeerde associatie aan de bovenkant van het spectrum niet duidelijk was door de 
brede betrouwbaarheidsintervallen. Een vergelijkbare relatie werd gevonden tussen de 
docosahexaeenzuur concentraties van de moeder en het totale witte stof volume van het 
kind. Er werden geen associaties gevonden tussen maternale PUFA spiegels tijdens de 
zwangerschap en de microstructuur van witte stof in kinderen. Vervolgens hebben we 
ons gericht op transvetzuren (Engelse afkorting: TFAs), een groep vetzuren die voorna-
melijk kunstmatig is en vooral bekend staat  om nadelige effecten op de cardiovasculaire 
en metabolische gezondheid. Door conventionele regressie te gebruiken, ontdekten we 
dat hogere TFA concentraties van de moeder een kleinere hoofdomtrek van de foetus 
in het derde trimester en een langzamere groei van het hoofd tussen het tweede en 
het derde trimester voorspelden, hoewel er geen verschillen werden waargenomen in 
het globale hersenvolume van het kind op de leeftijd van 9-11 jaar. Deze bevindingen 
werden verder ondersteund door een analyse van instrumentele variabelen waarbij de 
kalendertijd van de meting van TFAs bij de moeder als instrumentele variabele werd 
gebruikt.
In hoofdstuk 4 onderzochten we de associatie van zwangerschapsduur bij de geboorte 
als een continuüm met de morfometrie van de hersenen van kinderen op de leeftijd van 
9-11 jaar. De resultaten toonden aan dat de zwangerschapsduur bij de geboorte positief 
en lineair geassocieerd was met globale en regionale hersenvolumes, maar ook met op-
pervlakte en gyrificatie in een groot deel van de hersenen van het kind. Deze associaties 
bleven consistent, zelfs zonder vroeggeboorte of complicaties. Deze studie suggereert 
dat elke zwangerschapsweek aan de ontwikkeling van de hersenen bijdraagt en dat dus 
onnodige keizersneden verminderd moeten worden, wat in overeenstemming is met 
de WHO-aanbeveling.
Chapter 6. Summary / Samenvatting
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Hoofdstuk 5 vat de belangrijkste bevindingen van de bovenstaande studies samen, 
interpreteert de methodologische overwegingen, belicht de klinische implicaties en 
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